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ABSTRACT 
Overweight and obesity is becoming more prevalent in adults across the United 
States. Overweight or obese adults are at an increased risk for the development of 
cardiometabolic disorders. Glycemic variability has recently been introduced as a 
sensitive measurement of glycemic health as it incorporates oscillations in glucose 
concentrations over an extended period. Further, evidence has suggested that glycemic 
variability plays a pivotal role in the induction of oxidative stress commonly found in 
adults diagnosed with cardiometabolic disorders. Physical activity (PA) and exercise 
have been utilized as therapeutic treatments for overweight and obesity related 
complications. Therefore, the overall goal of this dissertation was to investigate the 
relationship between PA with glycemic variability and oxidative stress, and to examine 
the influence of exercise training on glycemic variability and oxidative stress in non-
diabetic overweight or obese adults. 
Three studies were conducted utilizing different designs to (study 1) inspect the 
current findings linking the relationship between sedentary behavior and physical activity 
(PA) with, and the influence of exercise on, continuous glucose monitor (CGM) assessed 
glycemic variability, (study 2; n=28) examine the cross-sectional relationship between 
objectively measured sedentary time and PA with glycemic variability and oxidative 
stress, and (study 3; n=8) evaluate the impact of a 12-week aerobic exercise intervention 
on glycemic variability and oxidative stress. The first study was a critical review of the 
vi 
literature, while the second study utilized baseline data collected from the Weight 
Outlooks by Restriction of Diet and Sleep (WORDS) and the Aerobic Treadmill Exercise 
and Metabolism (A-TEAM) studies, and the third study utilized data collected for 
individuals that completed the A-TEAM study. For study two, objective assessment of 
sedentary time and PA was performed, while for study two and three glucose 
concentrations and glycemic variability were assessed via CGM and oxidative stress 
assessed as nitric oxide and myeloperoxidase concentrations in human serum (WORDS) 
or plasma (A-TEAM). 
The first study found that a relationship between sedentary behavior and PA with 
glycemic control and glycemic variability exists in non-diabetic and diabetic adults. 
However, there were differential findings when examining the effect of a single bout of 
exercise or repeated bouts of exercise on glycemic control and glycemic variability 
between populations, while exercise training improved glycemic control and glycemic 
variability in type 2 diabetic adults. In the second study, a relationship was observed 
between PA minutes and energy expenditure of varying intensities with glucose 
concentrations, but not glycemic variability, and myeloperoxidase concentration, while 
fasting glucose concentration correlated with nitric oxide and myeloperoxidase 
concentrations, and the oxidative stress ratio in non-diabetic overweight or obese adults. 
The third study found that, although myeloperoxidase concentration decreased and the 
oxidative stress ratio improved, glucose concentrations and glycemic variability did not 
change following exercise training in non-diabetic overweight or obese adults. Yet, CGM 
placement at post-intervention, as well as average total daily mealtime changes, may have 
influenced our findings. 
vii 
Overall, this dissertation found that a relationship exists between PA with glucose 
concentrations and oxidative stress. However, glycemic variability may not be positively 
influenced by exercise training in non-diabetic overweight or obese adults even in the 
presence of improvements in biological markers of oxidative stress. Collectively, habitual 
PA may influence glycemic variability differently than structured PA, known as exercise, 
in our participants. However, these findings are speculative and further research is needed 
in this population.
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Currently, ~70% of adults in the United States are considered overweight or obese 
with obesity largely considered the public health crisis of the current generation (Flegal 
MF, Kruszon-Moran D, Carroll MD, Fryar CD, & Ogden CL, 2016; Centers for Disease 
Control and Prevention 2017; National Institutes of Health 2018). The Centers for 
Disease Control and Prevention announced that the medical care cost of obesity and its 
associated disorders were $147 billion in 2008 (Finkelstein EA, Trogdon JG, Cohen JW, 
& Dietz, W, 2009; Centers for Disease Control and Prevention 2017). Being overweight 
or obese leads to an increased risk of development of diseases or diseased states such as 
impaired glucose tolerance and cardiovascular disease (Bray GA 2004; O’donovan G, 
Kearney EM, Nevill AM, Woolf-May K, & Bird SR, 2005). Moreover, fasting and 
postprandial hyperglycemia are independent risk factors for cardiovascular disease with 
and without the presence of type 2 diabetes mellitus and are increased in overweight and 
obesity (Mokdad AH, Bowman BA, & Ford ES, 2001; Hanire H, Bertrand M, Guerci B, 
Anduze Y, Guillaume E, & Ritz P, 2011; Little JP, Jung ME, Wright AE, Wright W, & 
Manders RJ, 2014). Unlike hepatic regulation of glucose in a fasted state, and how 
effective muscle glucose disposal is in a glucose challenged state, such as during an oral 
glucose tolerance test (OGTT), the measurement of glycemic variability allows for the 
observation of excursions that consider nadirs, peaks, and troughs of glucose 




Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, & DeVries JH, 
2010; Anderwald C, Gastaldelli A, Tura A, Krebs M, Promintzer-Schifferl M, Kautzy-
Willer A, Stadler M, DeFronzo RA, Pacini G, & Bischof MG, 2011; Petersen MC, 
Vatner DF, & Shulman GI, 2017). Recently, increased glycemic variability has been 
shown to be associated with the risk of development of type 2 diabetes mellitus, with 
overweight and obese adults having higher glycemic variability compared to normal 
weight (Ma C-M, Yin F-Z, Wang R, Qin C-M, Lou D-H, & Lu Q, 2011). Additionally, it 
has been suggested that glycemic variability may be a more important clinical 
measurement of not only glucose metabolism, but cardiovascular and overall general 
health (Monnier L, Colette C, & Owens DR, 2008; Rodbard D 2011; Nusca A, 
Tuccinardi D, Albano M, Cavallaro C, Ricottini E, Manfrini S, Pozzilli P, & Di Sciascio 
G, 2018). As technology for the assessment of glycemic variability utilizing continuous 
glucose monitoring (CGM) continues to increase, the implications of this maker of 
metabolic health outside of a clinical setting becomes of further importance. 
Furthermore, increased glycemic variability has recently been associated with 
oxidative stress and thus linked with increased risk of cardiovascular disease in people 
with and without type 2 diabetes mellitus (Saisho Y 2014). Oxidative stress plays a 
crucial role in the development of vascular complications leading to increased risk of 
development of cardiovascular disease. It is increased in overweight and obese 
populations, and further complicated by hyperglycemia (Pitocco D, Tesauro M, 
Alessandro R, Ghirlanda G, & Cardillo C, 2013). In 2006, Monnier et al., reported a 
strong correlation between glycemic variability assessed by mean amplitude of glucose 




activation of oxidative stress in a type 1 and 2 diabetic population, which was the first 
study to utilize CGM to assess this relationship (Monnier L, Mas E, Ginet C, Michel F, 
Villon L, Cristol JP, & Colette C, 2006). In vitro and in vivo animal studies indicate that 
glycemic variability, compared to sustained hyperglycemia, promotes oxidative stress 
and worsens vascular damage; however, how glycemic variability and oxidative stress 
relate to and interact with each other remains unclear (Saisho Y 2014). Glycemic 
variability has previously been shown to be associated with oxidative stress formation in 
type 2 diabetes mellitus, but no studies have been performed to examine the relationship 
between glycemic variability, specifically in a “free-living” condition, and oxidative 
stress in overweight or obese adults not diagnosed with diabetes (Monnier L, Mas E, 
Ginet C, Michel F, Villon L, Cristol JP, & Colette C, 2006; Wentholt IME, Kulik W, 
Michels RP, Hoekstra JB, DeVries JH, 2008; Siegelaar SE, Barwari T, Kulik W, 
Hoekstra JB, & DeVries JH, 2011). Therefore, the potential relationship and clinical 
implications of the relationship between glycemic variability and oxidative stress, which 
serve as markers for the risk of development of metabolic and cardiovascular disease, 
needs to be further explored (Monnier L, Colette C, & Owens DR, 2008; Wentholt IME, 
Kulik W, Michels RPJ, Hoekstra JBL, & DeVries JH, 2008). 
As of 2015, the Centers for Disease Control and Prevention estimated that 
~20.5% of American adults met the minimum guidelines for being physically active 
(Centers for Disease Control and Prevention 2017). Decreased physical activity (PA) of 
light-intensity (LPA), moderate-intensity (MPA), vigorous-intensity (VPA), a 
combination of moderate-to-vigorous-intensity (MVPA), and even total PA are not only 




Høstmark AT, 2017), but postprandial glucose concentrations (Høstmark AT, Ekeland 
GS, Beckstrøm AC, & Meen HD, 2006), and increase risk for the development of 
cardiovascular disease (Carnethon MR, Evans NS, Church TS, Lewis CE, Schreiner PJ 
Jacobs Jr DR, Sternfel B, & Sidney S, 2010) with no current knowledge surrounding 
whether sedentary time and PA of varying intensities are associated with glycemic 
variability or oxidative stress.  
Additionally, evidence suggests regular exercise can influence PA and may 
provide a protective effect against exercise and non-exercise induced oxidative stress in 
healthy weight adults (Radak Z, Chung HY, & Got S, 2008); however, how this 
protective effect may be altered in persons with decreased glycemic control at risk for the 
development of diabetes remains uncertain (Sen CK, Atalay M, & Hänninen O, 1994; 
Atalay M, Laaksonen DE, Niskanen L, Uusitupa M, Hänninen O, & Sen SK, 1997). 
Moreover, there remains unclear evidence to suggest how exercise training may influence 
glycemic variability and oxidative stress in sedentary, overweight or obese, but otherwise 
healthy adults. 
SCOPE OF THE STUDY 
Therefore, the overall purpose of this dissertation is 1) to examine the current 
literature surrounding sedentary time and PA, glycemic variability, and oxidative stress, 
2) to determine the associations between sedentary time and PA of varying intensities, 
glycemic variability, and oxidative stress in currently overweight or obese adults in a 
cross-sectional setting, and 3) to examine the effect a 12-week aerobic exercise 
intervention has on glycemic variability and oxidative stress in currently overweight or 




various intensities of PA will be associated with CGM assessed glycemic variability and 
oxidative stress, and that incorporation of an aerobic exercise intervention will decrease 
glycemic variability and improve measures of oxidative stress in overweight or obese 
adults. 
Specific Aim 1 
To perform a critical review of the current literature surrounding the relationship 
between sedentary time and PA, glycemic variability, and oxidative stress. 
Sub-Aim 1.1: To summarize and describe the known relationship between 
sedentary time and PA, glycemic variability, oxidative stress. 
Sub-Aim 1.2: To summarize how acute exercise affects glycemic variability. 
Sub-Aim 1.3: To summarize how repeated bouts of exercise and exercise training 
affects glycemic variability. 
Specific Aim 2 
To examine the cross-sectional associations between sedentary time and PA, 
glycemic variability, and biological markers of oxidative stress in overweight or obese 
adults. 
Sub-Aim 2.1: To examine the associations between daily sedentary time, 
glycemic variability, and oxidative stress. 
Sub-Aim 2.2: To examine the associations between daily LPA and MVPA, 
glycemic variability, and oxidative stress. 
Sub-Aim 2.3: To examine the associations between daily total PA, glycemic 





Specific Aim 3 
To examine the effect of a 12-week aerobic exercise intervention on glycemic 
variability and oxidative stress. 
Sub-Aim 3.1: To examine the effect of a 12-week aerobic exercise intervention on 
glycemic variability. 








The prevalence of adults in the United States classified as either overweight or 
obese has continued to increase throughout the years, with ~39.8% or 93.9 million 
considered obese in 2015-2016 (Hales CM, Carroll MD, Fryar CD, & Ogden CL, 2017). 
Overweight and obesity remains a complex public health issue to address and results 
from a combination of causes and contributing factors, including, but not limited to 
behavioral factors, such as diet and physical activity, genetic and environmental factors, 
and even sociodemographic status (Centers for Disease Control and Prevention 2017). 
Adults classified as overweight or obese, when compared to healthy weight adults, are at 
an increased risk for all cause morbidity and mortality (National Institutes of Health 
2013), and are at a greater predisposition for the development of type 2 diabetes mellitus, 
and cardiovascular disease risk factors and cardiovascular disease (National Institutes of 
Health 1998). 
 Glycemic variability has recently been thought of as a sensitive measurement for 
glycemic control, with excess glycemic variability shown to increase the risk for the 
development of type 2 diabetes mellitus in overweight or obese adults and may provide 
greater insight into metabolic health compared to fasting blood glucose concentration and 
during an OGTT (Umpierrez GE & Kovatchev BP, 2018). Glycemic variability allows 




more sensitive analysis compared to other clinical measures of glucose metabolism and 
tolerance. As technology has continued to advance, glycemic variability assessment has 
become a non-invasive procedure utilizing CGM technology, which allows for the device 
be worn during everyday life and aids in the management of not only diabetes, but 
assessment for those at risk for the development of type 2 diabetes mellitus (National 
Institutes of Health 2017). Thus, glycemic variability measurement utilizing CGM 
technology plays an important role in assessment of diabetes risk in overweight or obese 
adults by allowing for observation in a “free living” environment in addition to common 
clinical measures glycemic health. 
Oxidative stress has been utilized as a clinical measurement for the development 
of atherosclerosis, which is the leading cause of cardiovascular disease, and has been 
associated with the development and progression of cardiovascular disease risk factors, 
such as overweight and obesity, hypertension, and dyslipidemia, and cardiovascular 
disease (Gracia KC, Llanas-Cornejo D, & Husi H, 2017). Additionally, overweight and 
obesity has been recently thought to increase chronic low grade systemic inflammation 
and, in turn, induce greater amounts of oxidative stress leading to further overweight and 
obesity related complications (Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole 
J, Nichols A, Ross JS, Tartaglia LA, & Chen H, 2003). Therefore, oxidative stress 
measurement serves as an excellent biological marker for risk of the development of 
cardiovascular disease risk factors and cardiovascular disease, especially in an 
overweight or obese population. Additionally, increased glycemic variability has been 
shown to be associated with greater reactive oxygen species production, oxidative stress, 




diabetes (Saisho Y 2014). Hence, management of glycemic variability may reduce 
oxidative stress and the risk for the development of cardiovascular disease in those at risk 
for the development of type 2 diabetes mellitus. 
 According to the Behavioral Risk Factor Surveillance System, in 2017 greater 
than 25% of adults in the United States engage in no leisure time PA with less than 50% 
meeting the minimum physical activity guidelines (Centers for Disease Control and 
Prevention 2017). Increased sedentary time and decreased PA of any intensity, including 
leisure time PA, are known to affect overall health and has been shown to increase the 
risk for the development of type 2 diabetes mellitus, and cardiovascular disease risk 
factors and cardiovascular disease (Flegal KM, Carroll MD, & Ogden CL, 2002; Carter 
S, Hartman Y, Holder S, Thijssen DH, & Hopkins ND, 2017; Joseph JJ, Echouffo-
Tcheugui JB, Golden SH, Chen H, Jenny NS, Carnethon MR, Jacobs Jr D, Burke GL, 
Vaidya D, Ouyang P, & Bertoni AG, 2017). Time spent sedentary and performing PA 
have been widely studied in regards to their positive effects on overweight or obesity, 
glucose tolerance, and cardiovascular health (Jiménez-Pavón D, Ortega FB, Valtueña J, 
Castro-Piñero J, Gómez-Martínez S, Zaccaria M, Gottrand F, Molnár D, Sjöström M, 
González-Gross M, Castillo MJ, Moreno LA, & Ruiz JR, 2012; Miguel-Berges ML, 
Reilly JJ, Moreno Aznar LA, & Jiménez-Pavón D, 2018). However, the relationship 
between metabolic and cardiovascular health and PA remains complex with the majority 
of data suggesting that PA of any intensity may promote overall health benefits (Ortega 
FB, Artero EG, Jiménez-Pavón D, & Ruiz JR, 2018). Therefore, further examination as 
to how sedentary time and PA affect glycemic variability and oxidative stress in 




 Exercise has often been utilized as a part of the therapeutic method to combat 
overweight and obesity, diabetes risk, and cardiovascular disease. Acute and chronic 
exercise have both been shown to improve glycemic control and glucose tolerance 
(Goodyear LJ & Kahn BB, 1998), but no studies to date have examined the effect of 
chronic aerobic exercise on glycemic variability. Additionally, even though acute 
exercise is shown to increase oxidative stress post-exercise, physiological adaptations to 
chronic aerobic exercise has been shown to decrease oxidative stress at rest and post-
exercise (Reid MB 1985; Baltaci SB, Mogulkoc R, & Baltaci AK, 2016). Moreover, no 
studies have sought to examine how glycemic variability and oxidative stress change in 
overweight or obese adults undergoing chronic aerobic exercise. Thus, this dissertation 
proposes to fill some of these gaps by direct assessment of changes in clinically relevant 
indices of glycemic variability and measurement of biomarkers associated with oxidative 
stress in overweight or obese adults undergoing a 12-week aerobic exercise intervention. 
OVERWEIGHT, OBESITY, AND CARDIOMETABOLIC RISK 
The prevalence of overweight and obesity has continued to increase over the past 
several decades, is considered an important public health issue, and has been identified as 
1 of the 10 leading health indicators (Office of the Surgeon General 2001; Hedley AA, 
Ogden CL, & Johnson CL, 2004; Fryar CD, Carroll MD, & Ogden CL, 2016; Ogden C, 
Carroll MD, Lawman HG, Fryar CD, Kruszon-Moran D, Kit BK, & Flegal KM, 2016). 
The state of being overweight or obese leads to an increase risk of a number of medical 
conditions and substantial health care costs (Birmingham CL, Muller JL, Palepu A, 
Spinelli JJ, & Anis AH, 1999; Katzmarzyk PT & Janssen I, 2004; McCormick B & Stone 




This includes, but is not limited to, type 2 diabetes mellitus (Hartemink N, Boshuizen 
HC, Nagelkerke NJ, Jacobs MA, & van Houwelingen HC, 2006) and cardiovascular 
disease (Wilson PWF, D’Agostino RB, Sullivan L, Parise H, & Kannel WB, 2002). 
According to the American Diabetes Associations and the Centers for Disease 
Control and Prevention, 30.3 million adults in the United States have diabetes, while an 
additional 84.1 million have prediabetes (National Center for Chronic Disease and 
Prevention and Health Promotion 2017). Overweight and obesity have been associated 
with the development of type 2 diabetes mellitus, which leads to a further increase in all 
cause morbidity and mortality for adults in the United States (Mokdad AH, Bowman BA, 
Ford ES, Vivicor F, Marks JS, & Koplan JP, 2001). Adults who are obese have 7.37 
greater odds of diagnoses of type 2 diabetes mellitus with the diagnosis of type 2 diabetes 
mellitus increasing by ~8.2% in recent years (Mokdad AH, Ford ES, & Bowman BA, 
2003). Additionally, ~90% of type 2 diabetics have a body mass index (BMI) of ≥23 
kg/m2, which, even though this includes adults considered healthy weight, remains one 
the most significant contributors to decreased overall health (Kopelman P 2007; Haslam 
DW & James WPT, 2005). Furthermore, the increase in relative risk for the development 
of type 2 diabetes mellitus has been reported as 1.18 per unit increase of BMI (Hartemink 
N, Boshuizen HC, Nagelkerke NJD, Jacobs MAM, & van Houwelingen HC, 2006). 
However, the relationship between BMI and the relative risk for type 2 diabetes mellitus 
and several studies suggest there may be a threshold effect and certain cut-point of BMI 
once considered overweight (Modan M, Karasik A, Halkin H, Fuchs Z, Lusky A, Shitrit 




Cardiovascular disease is the primary cause of mortality in the United States 
(Kochanek KD, Murphy SL, Xu J, & Tejada-Vera B, 2016) and about half of adults in 
the United States have been diagnosed with cardiovascular disease risk factors, such as 
hypertension or dyslipidemia (Fryar CD, Chen T, & Li X, 2012). The state of being 
overweight or obese has been established as a major risk factor for the development of 
cardiovascular disease, specifically if excess body fat has been primarily stored centrally 
or abdominally (Van Gaal LF, Mertens IL, & De Bock CE, 2006; Din-Dzietham R, Liu 
Y, Bielo MV, & Shamsa F, 2007), and has been associated with hypertension, 
dyslipidemia, and elevated levels of C-reactive protein, all of which increase the risk for 
development of cardiovascular disease (Ritchie SA & Connell JM, 2007). Additionally, 
overweight and obese men with cardiovascular disease risk factors and cardiovascular 
disease have a higher risk for all cause and cardiovascular disease mortality compared 
with healthy weight men (Wei M, Kampert, JB, Barlow CE, Nichaman MZ, Gibbon LW, 
Paffenbarger Jr RS, & Blair SN, 1999). Furthermore, it has been hypothesized that being 
overweight and obese does not directly translate to increased risk of cardiovascular 
disease; however, it may be the interaction of obesity developed insulin resistance and 
glucose intolerance related cardiovascular disease risk factors that leads to the 
development of cardiovascular disease (Reaven G 2005). Therefore, the development of 
type 2 diabetes mellitus may play a contributing factor in the development of 
cardiovascular disease risk factors and cardiovascular disease in overweight or obese 
adults. 
The Framingham Study was among the initial observational longitudinal studies 




cardiovascular disease risk factors and mortality in men and women diagnosed with type 
2 diabetes mellitus compared to their non-diabetic counterparts (Kannel WB & McGee 
DL, 1979). This study pioneered research related to the risk for development of diabetes 
and cardiovascular disease. The Multiple Risk Factor Intervention Trial reported that 
cardiovascular disease mortality was much higher for diabetic versus nondiabetic men for 
every age, race, and income (Stamler J, Vaccaro O, Neaton JD, Wentworth D, & The 
Multiple Risk Factor Intervention Trial Research Group, 1993). Furthermore, risk for 
cardiovascular disease mortality increased more steeply for diabetic men for each 
diagnosis of each additional cardiovascular disease risk factor (Stamler J, Vaccaro O, 
Neaton JD, Wentworth D, & The Multiple Risk Factor Intervention Trial Research 
Group, 1993). Additionally, hyperglycemia, which normally accompanies type 2 diabetes 
mellitus, has major direct and indirect effects on the human vascular tree, which are 
considered the major sources of morbidity and mortality in type 2 diabetes mellitus, with 
the negative effects of hyperglycemia including macrovascular complications such as 
coronary artery disease (Fowler MJ 2008). 
GLYCEMIC VARIABILITY 
Chronic hyperglycemia is a primary risk factor for the development of 
complications in type 2 diabetes mellitus; however, it is believed that frequent or 
exacerbated fluctuations in glucose concentrations may independently contribute to 
diabetes-related complications (Suh S & Kim JH, 2015). Glycemic variability refers to 
the peaks, troughs, and nadirs in glucose concentration levels and alludes to blood 
glucose oscillations that occur throughout the day, which includes glycemic excursions 




negative consequence of physiological dysfunction, rather sometimes it is a product of 
circadian rhythm of endogenous hormones, ingestion of calorie containing items, or PA, 
and is observed in individuals with normal glucose tolerance (Wang S, Lv L, Yang Y, 
Chen D, Liu G, Chen L, Song Y, He L, Li X, Tian H, Jia W, & Ran X, 2012). However, 
glycemic variability has been observed to be increased in sedentary, overweight or obese 
individuals (Salkind SJ, Huizenga R, Fonda SJ, Walker MS, & Vigersky RA, 2014), who 
have a greater risk for the development of impaired glucose regulation and cardiovascular 
disease morbidity and mortality (Nalysnyk L, Hernandez-Medina M, & Krishnarajah G, 
2010; Gerbaud E, Darier R, Montaudon M, Beauvieux M-C, Coffin-Boutreux C, Coste P, 
Douard H, Ouattara A, & Catargi B, 2019). In order to effectively determine glycemic 
control in overweight and obese adults at risk for the development of type 2 diabetes 
mellitus or cardiovascular disease, glycemic variability must be assessed. 
Intra- versus inter-day variability refers to the outcomes of data either collected on 
the same day or on different days, which is of importance when considering glycemic 
variability, as variability throughout the day may be more indicative of glucose 
metabolism as opposed to over multiple days, or even vice-versa. Even though intra-day 
glycemic variability can be useful throughout a 24-hour period, more sensitive measures 
are preferred to account for the degree of glucose excursions that occur over more than a 
single day. Measuring inter-day glycemic variability in addition to intra-day glycemic 
variability allows insight into the differences between day-to-day glycemic profile (Mori 
H, Okada Y, Kurozumi A, Narisawa M, & Tanaka Y, 2017). Glycemic variability may 
not only be dependent on each individual’s lifestyle but may change day-to-day 




throughout the week (Bennet B & Sothern MS, 2009). With this in mind, measuring 
intra- and inter-days glycemic variability provides a greater insight into glycemic health 
and how glycemic variability may be influenced by changes in an individual’s daily life. 
However, most studies have not examined the intra- and inter-day glycemic variability 
during either the same observation period or following a lifestyle intervention. Therefore, 
when examining glycemic variability in overweight or obese adults at risk for the 
development of impaired glucose tolerance and type 2 diabetes mellitus, it is pertinent to 
investigate both the intra- and inter-day glycemic variability that will allow for a more in-
depth insight into glycemic control. 
The MAGE was introduced as a measurement of glycemic variability to aid in the 
treatment and further refinement of the characterization of diabetic instability, and has 
been shown to be lower in non-diabetic subjects compared to subjects with stable and 
unstable type 2 diabetes mellitus (Service FJ, Molnar GD, Rosevear JW, Ackerman E, 
Gatewood LC, & Taylor WF, 1970). MAGE has traditionally been estimated with a 
graphical approach that represents the arithmetic mean of the difference between 
consecutive peaks and troughs exceeding one standard deviation around the respective 
24-hour glucose mean (Service FJ & Nelson RL, 1980). Assessment of MAGE over 
multiple days allows for an impactful outlook into inter-day glycemic variability and is 
considered an essential index for glycemic variability assessment (Monnier L, Colette C, 
& Owens DR, 2008; Fritzsche G, Kohnert K-D, Heinke P, Vogt L, & Salzsierder E 
2011). In additional to MAGE, CONGA is thought of an important additional measure of 
glycemic variability as CONGA can be analyzed in shorter time components throughout 




4 hours (Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, & 
Tamborlane WV, 2002). The CONGA equation was originally derived by McDonnell, et 
al., to allow for the time periods corresponding to different activities performed 
throughout the day (CONGA of 1 hour; CONGA-1), time consuming snacks throughout 
the day (CONGA of 2 hour; CONGA-2), or time between standard meals, such as 
breakfast, lunch, and dinner (CONGA of 4 hour; CONGA-4) (McDonnell CM, Donath 
SM, Vidmar SI, Werther GA, & Cameron FJ, 2005; Rodrigues R, de Medeiros LA, 
Cunha LM, Garrote-Filho MDS, Bernardino Neto M, Jorge PT, Resende ES, & Penha-
Silva N, 2018). This calculation of CONGA allows for each glucose concentration 
observation after the initial observation to be identified and the difference between the 
initial observation and the second observation is calculated and is considered the standard 
deviation of the differences with higher values indicating increase glycemic variability 
(McDonnell CM, Donath SM, Vidmar SI, Werther GA, & Cameron FJ, 2005). Utilizing 
both MAGE and CONGA measurements of glycemic variability allow for a broad-
spectrum approach to establish intra- and inter- day glycemic variability. This method 
also allows for a validated inter-day measurement of glycemic variability, while also 
incorporating a sensitive measure of intra-day glycemic variability. Measuring both intra- 
and inter-day glycemic variability may also serve as a tool for the examination of time 
spent hyperglycemic and hypoglycemic as both are considered to be increased risks for 
the development of type 2 diabetes mellitus (Satya Krishna SV, Kota SK, & Modi KD, 
2013). In turn, this method permits a greater insight into glycemic variability as not only 





As previously stated, the state of being overweight or obese leads to increased risk 
for the development of type 2 diabetes mellitus (Mokdad AH, Bowman BA, Ford ES, 
Vivicor F, Marks JS, & Koplan JP, 2001). However, overweight and obesity also leads to 
impaired glucose tolerance prior to diagnosis of type 2 diabetes mellitus (Ferrannini E & 
Camastra S, 1998). The major limitation of evaluating glucose tolerance, especially in 
overweight or obese adults, is a result of only testing fasting blood glucose levels, or 
during a glucose challenged state, such as an OGTT, which provides a snapshot of 
glycemic health as opposed to observation in a “free-living” environment. Glycemic 
variability has been reported to be higher in adults with type 2 diabetes mellitus 
compared to adults with normal glucose tolerance (Mazze RS, Strock E, Wesley D, 
Borgman S, Morgan B, Bergenstal R, & Cuddihy R, 2008). Previously, Ma et al., found 
that glycemic variability was higher in abdominally obese compared to non-abdominally 
obese men (Ma C-M, Yin F-Z, Wang R, Qin C-M, Liu B, Lou D-H, & Lu Q, 2011). 
Additionally, glycemic variability has been shown to be higher in obese adults who have 
normal glucose tolerance and insignificantly different from prediabetic adults (Salkind 
SJ, Huizenga R, Fonda SJ, Walker MS, & Vigersky RA, 2014). Thus, glycemic 
variability may provide greater insight and be more clinically relevant to evaluate 
metabolic health. 
OXIDATIVE STRESS 
The imbalance between oxidants and antioxidants in favor of the oxidants 
potentially leading to vascular damage has primarily been utilized as the definition of 
oxidative stress (Keaney Jr JF 2000). Additionally, oxidative stress has been coined a 




oxygen species in the cells of tissues, as well as the ability of a biological system to 
detoxify these reactive products (Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, 
Arcoraci V, Squadrito F, Altavilla D, & Bitto A, 2017). When reactive oxygen species 
production increases, creating greater oxidative stress, they increase the risk of harmful 
effects on important cellular structures such as proteins, lipids, and nucleic acids (Wu JQ, 
Kosten TR, & Zhang XY, 2013). Furthermore, evidence suggests that oxidative stress 
may be responsible, with varying degree of importance, for the onset and/or progression 
of several diseases, such as type 2 diabetes mellitus and cardiovascular disease 
(Taniyama Y & Griendling KK, 2003). Reactive oxygen species, when maintained at low 
or moderate levels, are of crucial importance to not only metabolic and cardiovascular, 
but overall health (Pacher P, Beckman JS, & Liaudet L, 2007). Moreover, oxidative stress 
plays a key role in the risk for the development of type 2 diabetes mellitus, cardiovascular 
disease risk factors and cardiovascular disease, as well as all-cause mortality in 
overweight or obese adults (Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di 
Rosa G, Gitto E, & Arrigo T, 2015). 
Nitric oxide is an inorganic free radical gas that is synthesized by vascular 
endothelial cells from L-arginine via nitric oxide synthases as a transcellular signal of 
oxidative stress (Knowles RG & Moncada S, 1994). Nitric oxide is considered a potent 
vasodilator released by vascular endothelial cells and accounts for the relaxation of 
vascular tissue, inhibits platelet aggregation and platelet adhesion attributed to 
endothelium-derived relaxing factor, and reduces proliferation of the intima of vascular 
tissue (Palmer RMJ, Ashton DS, & Moncada S, 1998). Enhanced nitric oxide inhibition 




factors (Förstermann U, Nakane M, Tracey WR, & Pollock JS, 1993). Additionally, 
reactive oxygen species, that contribute to the underlying mechanisms of vascular 
dysfunction and oxidative stress, may reduce the amount of bioactive nitric oxide by 
chemical inactivation of nitric oxide synthase, which may in-turn cause the nitric oxide 
synthase to become dysfunctional and contribute further to oxidative stress (Förstermann 
U 2010). Increased bio-active concentrations of nitric oxide are often associated with a 
decrease in reactive oxidative species, a subsequent decreased oxidative stress, and, in-
turn, risk for the development of cardiovascular disease risk factors (Förstermann U & 
Münzel T, 2006). Inversely, myeloperoxidase, a heme protein released by leukocytes, 
plays a crucial role in inflammation and oxidative stress at the cellular level, which 
affects the arterial endothelium and impairment of nitric oxide-induced vascular 
relaxation, and has been speculated to be a major oxidative stress pathway (Anatoliotakis 
A, Deftereos S, Bouras G, Giannopoulos G, Tsounis D, Angelidis C, Kaoukis A, & 
Stafanadis C, 2013). Similarly, to nitric oxide, there exists mechanistic links between 
myeloperoxidase activity and manifestations of cardiovascular disease (Brennan M-L & 
Hazen SL, 2003). Therefore, evidence suggests determining both nitric oxide and 
myeloperoxidase together when examining oxidative stress as nitric oxide may inhibit 
production of myeloperoxidase, while myeloperoxidase may decrease nitric oxide 
concentrations. 
It has been well established that obesity is associated with low-grade chronic 
systemic inflammation in adipose tissue, which is a condition influenced by the activation 
of adipose tissue immune response that promotes oxidative stress and is associated with 




Susceptibility to oxidative damage during times of increased oxidative stress is even 
greater in obesity due to depleted antioxidant sources, which are used to aid in clearance 
of reactive oxygen species associated with oxidative stress, compared to healthy weight 
(Amirkhizi F, Siassi F, Minaie S, Djalali M, Rahimi A, & Chamari M, 2007). There are 
several prevailing theories as to the mechanism involved in the generation of oxidative 
stress in obesity, including the release of adipokines (adipose tissue inflammatory 
molecules), increased cellular apoptosis (cellular death), and excessive hepatic 
lipogenesis (formation of adipose tissue) (Hensley K, Robinson KA, Gabbita SP, 
Salsman S, & Floyd RA, 2000). Biomarkers of oxidative damage are higher in 
individuals with obesity and correlate directly with BMI and the percentage of body fat 
(Pihl E, Zilmer K, Kullisaar T, Kairane C, Mägi A, & Zilmer M, 2006). However, the 
evidence remains inconsistent as an inverse relationship between body fat, central 
adiposity, and antioxidant capacity has been suggested (Chrysohoou C, Panagiotakos DB, 
Pitsavos C, Skoumas I, Papademetriou L, Economou M, & Stefanadis C, 2007). Insulin 
resistance is a characteristic feature of type 2 diabetes mellitus and obesity and promotes 
oxidative stress-induced atherogenesis even in the absence of hyperglycemia (Yip J, 
Facchini FS, & Reaven GM, 1998). Likewise, Du et al., provided evidence that insulin 
resistance increases mitochondrial reactive oxygen species production implicated in 
hyperglycemia-induced vascular damage and inactivation of enzymes involved in 
atherogenesis leading to the development of atherosclerosis related to obesity and type 2 
diabetes mellitus (Du X, Edelstein D, Obici S, Higham N, Zou MH, & Brownlee M, 




Oxidative stress has been previously shown to be associated with glycemic 
variability in type 1 and type 2 diabetes mellitus (Monnier L, Mas E, & Ginet C, 2006; 
Rodrigues R, de Medeiros LA, Cunha LM, Garrote-Filho MDS, Bernardino Neto M, 
Jorge PT, Resende ES, & Penha-Silva N, 2018). Additionally, a study performed by 
Rizzo et al., in patients with type 2 diabetes mellitus inadequately controlled by 
metformin found that MAGE correlated with biological markers of oxidative stress 
(Rizzo MR, Barbieri M, Marfella R, & Paolisso G, 2012) However, no studies have 
sought to examine the relationship in overweight or obese adults, who are at higher risk 
for developing cardiometabolic disorders. Hence, when examining the effect of 
overweight and obesity-induced oxidative stress, it remains important to not only assess 
oxidative stress, but risk factors for the development of type 2 diabetes mellitus, such as 
increased glycemic variability, in overweight and obese adults. 
GLYCEMIC VARIABILITY AND OXIDATIVE STRESS 
Management of glycemic variability may reduce oxidative stress-induced 
cardiovascular disease in patients with diabetes (Saisho Y 2014). Ceriello et al., evaluated 
the effect of oscillating glucose concentrations on endothelial function and oxidative 
stress in normoglycemic and adults diagnosed with type 2 diabetes mellitus and found 
that that higher oscillating glucose concentration, increased glycemic variability, results 
in greater endothelial dysfunction and oxidative stress than lower oscillating glucose 
concentration, decreased glycemic variability, in both normoglycemia and type 2 diabetes 
mellitus (Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, & 
Giugliano D, 2008). Di Flaviani et al., noted a significant association between intra-day 




without metformin administration (Di Flaviani A, Picconi F, Di Stefano P, Giordani I, 
Malandrucco I, Maggio P, Palazzo P, Sgreccia F, Peraldo C, Farina F, Frajese G, & 
Frontoni S, 2011). Additionally, Monnier et al., reported a strong positive correlation 
between inter-day glycemic variability and oxidative stress in adults diagnosed with type 
2 diabetes mellitus (Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, & Colette 
C, 2006). However, most studies performed to evaluate the relationship between 
glycemic variability and oxidative stress have been in diabetic, not overweight or obese, 
normoglycemic adults at risk for the development of type 2 diabetes mellitus. Thus, this 
creates a gap in the literature that must be addressed when assessing not only if a 
relationship exists between glycemic variability and oxidative stress, but to establish to 
what extent this relationship exists in overweight or obese adults. 
RELATIONSHIP BETWEEN SEDENTARY TIME, PHYSICAL ACTIVITY, GLYCEMIC 
VARIABILITY, AND OXIDATIVE STRESS 
It has been well established that decreasing sedentary time and increasing PA of 
all intensities is beneficial to overall health and may be potentially altered in overweight 
or obese adults. Additionally, overweight and obesity increases the risk for the 
development of type 2 diabetes mellitus and cardiovascular disease, which is further 
exacerbated by physical inactivity (Chan CB, Ryan DAJ, & Tudor-Locke CT, 2004; Van 
Gaal FL & Maggioni AP, 2013). However, there is little information regarding the 
relationship between sedentary time and physical activity, glycemic variability, and 
oxidative stress. Increase sedentary time and decreased PA of any intensity has been 
shown to be detrimental to overall health; however, how glycemic variability and 
oxidative stress outcomes may be associated with sedentary behavior and PA in 




men and women appear to be protected against the hazards of overweight or obesity, 
including a stronger protective effect in obese adults compared to their healthy weight or 
overweight counterparts when examining diagnosis of type 2 diabetes mellitus, 
cardiovascular disease risk factors and cardiovascular disease mortality (Blair SN & 
Brodney S, 1999). However, it has been observed that overweight or obese adults tend to 
spend more time sedentary and perform less PA than healthy weight adults (Tudor-Locke 
C, Brashear MM, Johnson WD, & Katzmarzyk PT, 2010). Cooper et al., found that 
healthy weight and overweight adults performed similar amounts of PA, while obese 
adults performed less PA than healthy weight or overweight adults (Cooper AR, Page A, 
Fox KR, & Mission J, 2000). Even though decreasing sedentary time and increasing PA 
is believed to benefit metabolic and cardiovascular health, the results remain 
controversial regarding the effect on overweight and obese adults, as the energy cost of 
PA is not believed to be a major cause of obesity, rather a primary contributor and 
remains a public health strategy of choice in the prevention of obesity (Hill JO & 
Melanson EL, 1999). 
Sedentary Time, Physical Activity, and Glycemic Variability 
Limited data exist regarding the effect of sedentary time and PA on glycemic 
variability; however, it is known that decreasing time spent sedentary and increasing PA 
improves fasting blood glucose and glucose control during an OGTT or timed feeding in 
normoglycemic and diabetic populations (Dunstan DW, Barr EL, Healy GN, Salmon J, 
Shaw JE, Balkau B, & Owen N, 2010; Veerman JL, Healy GN, Cobiac LJ, Vos T, 
Winkler EA, Owen N, & Dunstan DW, 2012). In nondiabetic adults, sedentary behavior 




glucose metabolism, elevated fasting insulin concentration, and impaired glucose 
tolerance (Helmerhorst HJ, Wijndaele K, Brage S, Wareham NJ, & Ekelund U, 2009; 
Ford ES, Zhao G, & Li C, 2010; Thorp AA, Healy GN, Owen N, Slamon J, Ball K, Shaw 
JE, & Dunstan DW, 2010; Lahjibi E, Heude B, Dekker JM, Højlund K, Laville M, Nolan 
Jn & Balkau B, 2013). Furthermore, in adults diagnosed with type 2 diabetes mellitus, 
more time spent sedentary was predictive of significant increases in time spent in 
hyperglycemia (Fritchi C, Park, H, Richardson, A, Park C, Collins EG, Mermelstein R, 
Riesche L, & Quinn L, 2016). Swindell et al., evaluated the impact between 
accelerometer-based measurement of sedentary time and PA of varying intensities, and 
cardiometabolic risk in adults with prediabetes, and found that MVPA and total PA 
counts was negatively associated with 2-hour glucose concentration (Swindell N, 
Mackintosh K, McNarry M, Stephens JW, Sluik D, Fogelholm M, Drummen M, 
MacDonald I, Martinez JA, Handjieva-Darlenska T, Poppitt SD, Brand-Miller J, Larsen 
TM, Raben A, & Stratton G, 2018). Even though these studies highlighted that sedentary 
time and time spent performing PA are shown to be related to glucose concentration and 
glucose tolerance, very few studies have emphasized this relationship with glycemic 
variability. Paing et al., sought to examine the associations between objectively measured 
sedentary time and breaks in sedentary time with 24-hour glycemic control in type 2 
diabetes mellitus and found that increased sedentary time was found to be positively 
associated with time spent hyperglycemic, with more breaks in sedentary time positively 
associated with time spent euglycemic (Paing AC, McMillan KA, Kirk AF, Collier A, 
Hewitt A, & Chastin SFM, 2018). The prevailing theory for the mechanism of action is 




amounts of PA have increased insulin-stimulated glucose control and skeletal muscle 
glucose disposal than those who spend more time performing sedentary behavior (Berger 
M, Kemmer FW, Becker K, Herberg L, Schwenen M, Gjinavci A, & Berchtold, 1979; 
Hollenbeck CB, Haskell W, Rosenthal M, & Reaven GM, 1985). However, the 
relationship between sedentary time and PA of any intensity has only been minimally and 
inadequately evaluated in those who have developed impaired glucose metabolism and 
has yet to be examined in a population at risk for the development of type 2 diabetes 
mellitus, such as sedentary, overweight or obese adults. 
Sedentary Time, Physical Activity, and Oxidative Stress 
As limited as the data is on the relationship between sedentary time and PA with 
glycemic variability, there are even more limited findings available on the relationship 
between sedentary time and PA with oxidative stress. Sedentary lifestyle is a major risk 
factor for cardiovascular disease and is primarily believed to be due to oxidative stress 
induced arterial stiffness (Lessiana G, Santilli F, Boccatonda A, Iodice P, Liana R, 
Tripaldi R, Saggini R, & Davi G, 2016). Additionally, those who engage in PA has been 
shown to have lower oxidative stress compared to their sedentary counterparts (Carraro 
E, Schilirò T, Biorci F, Romanazzi V, Degan R, Buonocore D, Verri M, Dossena M, 
Bonetta S, & Gilli G, 2018). Furthermore, Yang et al., examined the association between 
PA and oxidative stress in a large sample of generally healthy women and found that 
higher levels of PA were associated with a decrease in oxidative stress, with an even 
greater association in a subset of women who performed vigorous-intensity PA (Yang S, 
Jensen MK, Mallick P, Rimm EB, Willett WC, & Wu T, 2015). However, this is one of 




intensities related to oxidative stress, but only utilized a subjective PA questionnaire to 
derive PA intensities, as opposed to objective accelerometry-derived measures of PA. 
Therefore, there remains a need to examine how objectively measured sedentary time and 
PA relate to oxidative stress, especially in overweight and obese adults at an increased 
risk for development of cardiovascular disease. 
IMPACT OF AEROBIC EXERCISE ON GLYCEMIC VARIABILITY AND OXIDATIVE STRESS 
Aerobic Exercise and Glycemic Variability 
Exercise is defined as structured PA performed with an underlying purpose or 
goal, and has been shown to influence insulin resistance and glucose tolerance, as well as 
is commonly utilized as a treatment for both non-insulin and insulin-dependent type 2 
diabetes mellitus (Joslin EP, Root HF, White P, & Marble A, 1935; Goodyear LJ & Kahn 
BB, 1998). When discussing glucose homeostasis, even a single bout of exercise can 
positively impact whole-body glucose disposal and increase the uptake of glucose into 
skeletal muscle (Pruett EDR & Oseid S, 1970; Bogardus C, Thuillex P, Ravussin E, 
Vasquez B, Narimiga M, & Azhar S, 1983; Richter EA, Mikines KJ, Galbo H, & Kiens 
B, 1989; Wang X, Patterson BW, Smith GI, Kampelman J, Reeds DN, Sullivan SA, & 
Mittendorfer B, 2013), which may persist several hours after completion of exercise 
(Devlin JT & Horton ES, 1985; Devlin JT, Hirshman MF, Horton ES, & Horton ED, 
1987; Mikines KJ, Sonne B, Farrell PA, Tronier B, & Galbo H, 1988). Another study 
even sought the impact of frequent breaks from sitting with and without moderate 
exercise and found that 24-hour glycemic control was positively impacted, with a more 
positive impact in glycemic control found in those undergoing additive exercise, 




spent sedentary (Blankenship JM, Granados K, & Braun B, 2014). Furthermore, 
epidemiological studies have determined that chronic exercise can reduce the risk for 
developing non-insulin-dependent diabetes (Helmrich SP, Ragland DR, Leung RW, & 
Paffenbarger RS, 1991; Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC, 
Krolewski AS, Rosner B, Hennekens CH, & Speizer FE, 1991; Manson JE, Nathan DM, 
Krolewski AS, Stampfer MJ, Willett WC, & Hennekens CH, 1992). A brief review and 
preliminary evidence published by Holloszy et al., suggest that a decline in glucose 
tolerance and insulin sensitivity can be prevented by performing regular exercise, and 
that prolonged and frequent exercise can normalize glucose tolerance by decreasing 
resistance to insulin in some individuals with impaired glucose tolerance (Holloszy JO, 
Schultz J, Kusnierkiewicz J, Hagberg JM, & Ehsani AA, 1986). However, no studies 
have evaluated glycemic variability following a chronic exercise intervention. Little et 
al., examined the impact of acute high-intensity interval training compared to continuous 
moderate-intensity exercise on postprandial hyperglycemia following standardized 
dietary conditions over 24 hours in overweight or obese adults, and found that overall 
postprandial glucose response and area under the curve reduced in both exercise groups 
compared to matched control group (Little JP, Jung ME, Wright AE, Wright W, & 
Manders RJF, 2014). An additional study by Figueira et al., evaluated the effects of a 
single session of aerobic exercise alone or aerobic exercise combined with resistance 
exercise on glucose levels and glycemic variability in type 2 diabetes mellitus currently 
taking metformin, resulted in no significant differences between either exercise condition 
in glucose concentration or glycemic variability, and decreased glucose concentrations 




of glycemic variability (e.g. MAGE) was performed (Figueira FR, Umpierre D, Casali 
KR, Tetelbom PS, Henn NT, Ribeiro JP, & Schaan BD, 2013). Therefore, these 
previously mentioned studies necessitate the further exploration as to how glycemic 
variability may be influenced by structured exercise following a chronic exercise 
intervention. As well as, the less than ideal literature available regarding alterations in 
glycemic variability in adults that are sedentary, overweight or obese and at an increased 
risk for the development of type 2 diabetes mellitus undergoing an aerobic exercise 
intervention remains to be addressed. 
Aerobic Exercise and Oxidative Stress 
Cardiovascular disease is a largely preventable condition with many of the 
cardiovascular risk factors considered modifiable by leisure time PA, which includes 
exercise (Warburton DE, Nicol CW, & Bredin SS, 2006; Hamer M & Chida Y, 2008; 
Agarwal S 2012). Exercise has been suggested to induce oxidative stress acutely, which 
may subside following chronic physiological adaption to exercise and potentially be 
considered an antioxidant (Bouzid MA, Filaire E, Matran R, Robin S, & Fabre C, 2018). 
Acutely, accumulating evidence suggests that reactive oxygen species and, in turn, 
oxidative stress is generated during exercise and modulate muscle contraction, which 
contributes to the development of muscle fatigue (Reid MB 1985). However, oxidative 
stress in the context of chronic exercise and cardiovascular health has a differing 
relationship. Chronic, moderate aerobic exercise has been demonstrated to be useful in 
the prevention of oxidative stress, and, in turn serves as primary and secondary protection 
from oxidative stress-induced cardiovascular disease (Baltaci SB, Mogulkoc R, & Baltaci 




regular exercise, due to an adaptive physiological response, accumulate lower levels of 
reactive oxygen species and oxidative stress at rest and following a single bout of 
exercise compared to untrained adults (Simioni C, Zauli G, Martelli AM, Vitale M, 
Sacchetti G, Gonelli A, & Neri LM, 2018). Miyazaki et al., evaluated whether high-
intensity endurance training would alleviate exercise-induced oxidative stress in 
untrained males following 12-weeks during which all participants exercised for 60 
minutes a day, 5 days per week at 80% maximal exercise heart rate, and found an 
increase in antioxidant enzyme activity and subsequent decrease in oxidative stress 
following exercise training at rest and following an exhaustive exercise bout (Miyazaki 
H, Oh-ishi S, Ookawara T, Kizaki T, Toshinai K, Ha S, Ji LL, & Ohno H, 2001). 
However, the intensity of the exercise in this study was high and may not be 
generalizable to those who meet the minimum guideline for participating in exercise. 
Medeiros et al., aimed to evaluate oxidative stress in obese adults undergoing 5-8 weeks 
of moderate-intensity concurrent training under two differing conditions, 3 days per week 
compared to 5 days per week for 70 minutes each session, and found that measures of 
oxidative stress decreased in both concurrent training groups, with the group completing 
3 days per week eliciting a greater decrease in measures of oxidative stress (Medeiros 
NS, de Abreu FG, Colato AS, de Lemos LS, Ramis, TR, Dorneles GP, Funchal C, & 
Dani C, 2015).  
Additionally, potential changes in glycemic variability due to exercise training 
may contribute to this observed reduction in oxidative stress after exercise training, 
which has yet to be elucidated. Thus, when examining oxidative stress, it is important to 




training, which further implores the inclusion of glycemic variability as an important 






The first study that comprises this dissertation is a critical review of sedentary 
time and PA, glycemic variability assessed via CGM technology, and measures of 
oxidative stress in overweight or obese individuals. The second study combines two 
clinical trials, Weight Outlooks by Restriction of Diet and Sleep (WORDS) and Aerobic 
Treadmill Exercise and Metabolism (A-TEAM) studies, to examine the associations 
between sedentary time, PA of varying intensities, glycemic variability, and oxidative 
stress prior to either study’s intervention. The WORDS study (ClinicalTrials.gov 
identifier: NCT02413866) was designed to examine the effects of chronic moderate sleep 
restriction on body composition and energy expenditure in individuals undergoing a 
hypocaloric dietary weight loss program, however, we will only be utilizing participants 
that completed baseline testing for the measurement of the outcomes pertinent to this 
dissertation, while the A-TEAM study (ClinicalTrials.gov identifier: NCT03162991) 
examined the effects of a moderate-intensity aerobic treadmill-based exercise 
intervention on glucose concentrations utilizing CGM technology in sedentary, 
overweight or obese adults. The third study utilized data collected from the A-TEAM 
study to examine the effect of a moderate-intensity aerobic treadmill-based exercise 




STUDY 1 METHODOLOGY- CRITICAL REVIEW ON CURRENT LITERATURE REVOLVED 
AROUND SEDENTARY TIME AND PHYSICAL ACTIVITY, GLYCEMIC VARIABILITY, AND 
OXIDATIVE STRESS IN ADULTS 
Purpose 
This study addresses specific aim 1 and focuses on performing a critical review of 
literature on the topics of sedentary time and PA, glycemic variability, and oxidative 
stress. A critical review can be considered the summarization and evaluation of the ideas 
and information in an article. It predominantly expresses the writer’s point of view in the 
light of what the writer has already obtained knowledge on the subject being discussed 
and what is acquired from related texts. Additionally, reviewing critically means thinking 
carefully and clearly and taking into consideration both the strengths and weaknesses in 
the material under review. This critical review focuses primarily on relevant research 
based on objectively measured sedentary time and PA, CGM assessed glycemic 
variability, and biomarkers of oxidative stress in adults. 
Sub-Aim 1.1: To summarize and describe the known relationship between 
sedentary time and PA, glycemic variability, oxidative stress. 
Sub-Aim 1.2: To summarize how acute exercise affects glycemic variability. 
Sub-Aim 1.3: To summarize how repeated bouts of exercise and exercise training 
affects glycemic variability. 
Study Design 
This study is a critical review of the current literature surrounding sedentary time, 







Research Design and Methods 
Data Sources and Searches 
 To address sub-aim 1.1, which will be to establish what is known regarding the 
relationship between sedentary time and PA, glycemic variability, and oxidative stress, 
we plan to search the electronic databases PubMed, Google Scholar, Web of Science, 
BioMed Central, Cumulative Index of Nursing and Allied Health Literature (CINAHL), 
and SCOPUS databases up until December 2018. A variety of search terms were utilized 
for sedentary time, PA, continuous glucose monitoring, glycemic variability, and 
oxidative stress (outcome variables of interest). We plan to limit sedentary time and PA 
to objectively measured outcomes by validated accelerometry, but plan to include 
objectively assessed sedentary time and PA if yielded few search results. Glycemic 
variability will include only CGM assessed glycemic variability and oxidative stress will 
include any studies that examined the associations between biological markers of 
oxidative stress with glycemic variability. Studies will be included even if no relationship 
is found between sedentary time and PA and glycemic variability, or between glycemic 
variability and oxidative stress as research design and analysis of findings are of 
importance for this critical review. The search will be limited to adults; however, will 
include adults that are overweight or obese, have impaired glycemic states, diagnosed 
with type 1 or 2 diabetes, or cardiovascular disease risk factors in the presence or absence 
of medication which may affect outcomes of interest (population). These populations will 
be accounted for as age, body weight and health status, and medication usage may alter 




 Similar to sub-aim 1.1, to address sub-aim 1.2, which will be to examine how the 
acute response to exercise affects the relationship on glycemic variability, we plan to 
search the electronic databases PubMed, Google Scholar, Web of Science, BioMed 
Central, CINAHL, and SCOPUS databases up until December 2018. Similar variables as 
of interest Sub Aim 1.1 will be utilized as search terms, including continuous glucose 
monitoring and glycemic variability; however, to examine the effect on the outcomes of 
interest, we will also perform a search to include acute aerobic exercise. Acute exercise 
will include monitored, clinically validated submaximal and maximal bout of exercise, 
including, but not limited to upper arm and lower leg ergometry, and treadmill based 
aerobic activity, and high-intensity interval training (HIIT) (treatments). We plan to limit 
glycemic variability to include only CGM assessed glycemic variability. 
 Lastly, to address sub-aim 1.3, which will be to examine how repeated bouts of 
exercise or exercise training affects glycemic variability, we will perform the same search 
as sub-aims 1.1 and 1.2, on the electronic databases PubMed, Google Scholar, Web of 
Science, BioMed Central, CINAHL, and SCOPUS databases up until December 2018. 
The same outcome variables of interest will be utilized as search terms, continuous 
glucose monitoring and glycemic variability as sub-aims 1.1 and 1.2; however, to expand 
upon findings from aim 1.2, we plan to examine the effect of repeated bouts of exercise 
and exercise training on glycemic variability, and a search including any repeated type of 
exercise, including short-term and chronic aerobic exercise interventions (treatment) on 
glycemic variability. This includes standardized or individualized and monitored exercise 
interventions, including HIIT training, performed in adults that do not have any 




perform aerobic exercise based on the criteria established by the American College of 
Sports Medicine, unless under clinical supervision during the exercise intervention 
(American College of Sports Medicine 2017). 
 For sub-aims 1.1, 1.2, and 1.3, we will limit the date range to December 2018 and 
will not place any language restrictions. We will include any duration of acute 
submaximal and maximal bouts of exercise and will define the acute response as 
immediately post-exercise up to 48 hours post-exercise, as long as the exercise bout is 
monitored and clinically validated. If studies included longer acute-phase durations past 
48 hours post-exercise, they will be evaluated and included accordingly. Additionally, we 
will include repeated exercise and exercise interventions of all lengths in duration as long 
as they meet the minimum guidelines established for being considered physically active 
by the American College of Sports Medicine (American College of Sports Medicine 
2017). Our secondary search strategy will include scanning bibliographies of the 
retrieved articles and searching for unpublished studies using key trial registries 
(clinicaltrials.gov and https://www.isrctn.com/). 
Data Extraction and Study Quality 
 Initial selection will be based on title and abstract. The original article will be 
obtained and subsequently determined if the research study met the inclusion criteria 
established for the critical review. One reviewer will select the study independently and, 
if unsure about the reliability of the study in question, will seek a second reviewer to aid 
in the decision to include or exclude the article in the critical review. If there is 
disagreement between the primary and secondary reviewer, a third reviewer will be 




the critical review. Reasons for exclusion will be documented and are available from the 
authors upon request. 
 Even though not a systematic review, data extraction and quality assessment will 
be based on the template from the Centre for Review and Dissemination (CRD) for 
systematic review guidelines (Tables 3.1. and 3.2.) (Centre for Reviews and 
Dissemination 2009). Extracted data will include details of the population, treatment, 
outcome variables of interest, and areas of potential bias. Biases evaluated in randomized 
controlled trials included adequate sequence generation, follow-up and exclusion biases, 
and intention to treat analysis. In non-randomized control trials, we plan to evaluate any 
baseline differences in participants, biases in allocation, follow-up and exclusion, and if 




Table 3.1. Article Evaluation and Data Extraction Form (Sub-Aim Aim 1.1) 
Article Details 
• Study ID (First Author Name and Publication Date) 
             
• Title of the Article 
             
• Country 
             
• Language 
             
• Database 
             
Study Details 
• Aim of the Study 
             
• Study Design 
             
• Setting of the Study 
             
• Duration of the Study 
             
Methods 
• Inclusion and/or Exclusion Criteria 
             
• Outcome Measures 
             
• Outcome Measure Method 
             
• Outcome Evaluation Method 
             
• Statistical Analysis 
             
Participant Characteristics 
• Number Enrolled and Number Analyzed 
Enrolled:             
Analyzed:             
• Age 
             
• Sex Composition (M/F), n (%) 
             
• Race Composition 
             
• Weight and BMI 






• Primary Findings 
             
• Additional Findings 
             
Conclusions 
             
• Areas of Bias:           
• Strengths:            
• Weaknesses:            
Additional Comments 
             




Table 3.2. Article Evaluation and Data Extraction Form (Sub-Aims 1.2 and 1.3) 
Article Details 
• Study ID (First Author Name and Publication Date) 
             
• Title of the Article 
             
• Country 
             
• Language 
             
• Database 
             
Study Details 
• Aim of the Study 
             
• Study Design 
             
• Setting of the Study 
             
• Duration of the Study 
             
Methods 
• Inclusion and/or Exclusion Criteria 
             
• Randomization (If More than One Treatment) 
             
• Allocation 
             
• Blinding 
             
• Outcome Measures 
             
• Outcome Measure Method 
             
• Outcome Evaluation Method 
             
• Statistical Analysis 
             
• Notes 
             
Participant Characteristics 
• Number Enrolled, Number Randomized, and Number Analyzed 
Enrolled:             
Randomized:             





             
• Sex Composition (M/F), n (%) 
             
• Race Composition 
             
• Weight and BMI 
             
• Noted Differences between Randomization Groups 
             
• Intervention Type and Intervention Descriptions 
             
• Control Type and Control Description (If a Control Group is Included) 
             
• Follow-Up Description 
             
Results 
• Primary Findings 
             
• Additional Findings 
             
Conclusions 
             
• Areas of Bias:           
• Strengths:            
• Weaknesses:            
Additional Comments 
             




Strengths and Limitations of Study 1 
 Overall, there is a lack of well-documented studies that examine the relationship 
between sedentary time and PA with glycemic variability and oxidative stress, with even 
less information regarding the effect of acute and chronic aerobic exercise on glycemic 
variability. This study aims to be among the first to critically examine the current 
literature available regarding sedentary time and PA with glycemic variability and 
oxidative stress and compile a critical review to examine the current known information 
and delineate the gaps in the literature that need to be addressed. Specifically, this critical 
review aims to be the first to address this relationship in adults in a non-treatment and 
completing a treatment procedure (acute aerobic exercise and chronic aerobic exercise 
intervention). This critical review plans to include information from multiple sources, 
including PubMed, Google Scholar, Web of Science, BioMed Central, CINAHL, and 
SCOPUS databases up until December 2018. Additionally, a variety of search terms for 
each outcome variable of interest will be utilized to fully assess the relationship between 
sedentary time, PA, glycemic variability, and oxidative stress, as well as how glycemic 
variability may be altered due to acute and chronic aerobic exercise. There are several 
limitations to this study. The first will the primary use of objectively assessed sedentary 
time and PA; however, subjectively assessed sedentary time and PA will be incorporated 
as a secondary measure to fully elucidate this relationship, but have been shown to often 
lack validity, reliability, and reproducibility (Prince SA, Adamo KB, Hamel ME, Hardt J, 
Gorber SC, & Tremblay M, 2008). Additionally, only compiling articles utilizing CGM 
assessed glycemic variability has an inherent limitation as other clinical measures of 




to other clinical measurements, such as fasting glucose concentrations and the glucose 
response during a glucose challenged state, as they may not be truly representative of 
glycemic variability that occurs over an extended period of time, or in a “free-living” 
environment, which will allow for greater insight into glycemic health. Furthermore, the 
accuracy of CGM measurements have been validated with clinical measures, such as 
venous blood sampling, in normo-glycemic individuals (Akintola AA, Noordam R, 
Jansen SW, de Craen AJ, Ballieux BE, Cobbaert CM, Mooijaart SP, Pijl H, Westendorp 
RG, & van Heemst D, 2015). We plan to include studies that examined the relationship 
between sedentary time and PA, continuous glucose monitor assessed glycemic, and 
biological markers of oxidative stress, as well as discuss oxidative stress markers that 
may have no existing relationship with sedentary time and PA or glycemic variability and 
mechanisms as to why when appropriate. Additionally, as the primary outcome variables 
of interest aim to address the overall research question regarding how sedentary time and 
PA interact with glycemic variability, we plan to incorporate how glycemic variability is 
altered following an acute aerobic exercise bout, and chronic aerobic exercise 
intervention. Lastly, the inclusion of a adults diagnosed with cardiometabolic disease, 
such as diabetes or cardiovascular disease risk factors, is a limitation, but will allow for a 
meaningful observation as to how sedentary time and PA relate to glycemic variability 
and oxidative stress in non-clinical and clinical populations, as well as provide greater 
insight into the acute and chronic response to aerobic exercise. As previously stated, even 
the presence of overweight and obesity immediately predisposes individuals to impaired 
glucose metabolism and cardiovascular disease risk factors, which will allow us to 




oxidative stress in an at-risk, non-disease state population. Overall, we plan to ensure 
included studies did not incorporate an adolescent or aging population to limit the effect 
of age on the outcome variables of interest, as well as guarantee that all populations in the 
articles included in this critical review are, other than potentially have impaired 
cardiometabolic status, otherwise healthy, presented with no complications or 
contraindications to exercise as described by the American College of Sports Medicine 
(American College of Sports Medicine 2017), or were appropriately monitored by trained 
medical staff. Moreover, as this study seeks to be the first to examine the relationship 
between objectively measured sedentary time and PA with measures of CGM assessed 
glycemic variability and oxidative stress, future studies will be able to utilize this critical 
review as a basis for the development of interventions aimed to decrease sedentary time, 
increase PA, and improve measures of glycemic variability and oxidative stress in adults 
at an increased risk for the development of, or in the presence of, metabolic and 
cardiovascular disease. 
STUDY 2 METHODOLOGY- SEDENTARY TIME AND PHYSICAL ACTIVITY’S ASSOCIATION 
WITH GLYCEMIC VARIABILITY AND OXIDATIVE STRESS 
 
Purpose 
 This study addresses Specific Aim #2, which was to examine the cross-sectional 
associations between sedentary time and PA, glycemic variability, and biological markers 
of oxidative stress in overweight or obese adults. 
Sub-Aim 2.1: To examine the associations between daily sedentary time, 
glycemic variability, and oxidative stress. 
Sub-Aim 2.2: To examine the associations between daily LPA and MVPA, 




Sub-Aim 2.3: To examine the associations between daily total PA, glycemic 
variability, and oxidative stress. 
Hypothesis 
 Sedentary time will be positively associated with glycemic variability and 
oxidative stress, while PA of varying intensities and total PA will be negatively 
associated with glycemic variability and oxidative stress. 
Study Design 
 This study utilized a cross-sectional design. 
Study Population and Enrollment Process 
 For both the WORDS and A-TEAM studies, 28 participants were recruited from 
the Columbia, South Carolina metropolitan area. The WORDS study openly recruited 
from January 2015 to October 2016, while the A-TEAM study openly recruited from 
October 2017 to December 2018. Participants were required to be currently healthy, 
sedentary, overweight or obese adults (males and females), age 35-55 years, have 
25≤BMI≤40 kg/m2, be weight stable (±2%) during the previous 3 months, have ˂120 
minutes of resistance or endurance exercise per week during the previous 3 months, and 
for females, be eumenorrheic, or post-menopausal for ≥1 year. Also, potential 
participants self-reporting medical conditions (e.g. diabetes), cardiovascular diseases, 
chronic or recurrent respiratory conditions (e.g. uncontrolled asthma or chronic 
obstructive pulmonary disease), active cancer, and eating, or neurological disorders, 
medications that affect metabolism (e.g. thyroid medications, statins), psychological 
issues, including but not limited to untreated depression and attention deficit disorder, 




females, unwillingness to provide informed consent were additional criterion for 
exclusion from the study. All participants in the studies met in the same laboratory 
setting, with the same research staff, which conducted all pertinent tests towards this 
dissertation in the same manner during the time of recruitment through study termination. 
Sedentary Time and Physical Activity 
Sedentary time and PA will be measured for all participants at 7 consecutive days 
and all participants were instructed to continue their normal daily routine during 
monitoring. Participants wore the Sensewear Mini Armband on the left arm at the mid-
point between the olecranon and acromion processes. Participants recorded when they 
removed the monitor for any activities that required water-based activities, such as 
showering/bathing or swimming. Participants were instructed to record times they 
removed and replaced the monitor if removed over the 7-day wear time period. Data will 
be considered valid for analysis if participants wore the monitor for at least 5 days 
including a weekend day, with a minimum wear time of 20 hours each day. 
Sedentary time and PA levels will be assessed using manufacture provided 
software (BodyMedia Sensewear Version 7.0). The Sensewear Mini Armband provides 
objectively measured PA. Sedentary time will be set as <1.5 metabolic equivalents 
(METs) (excluding sleep time), light-intensity PA as 1.5≤3.0 METs, moderate-intensity 
PA as 3.0≤6.0 METs, and vigorous-intensity PA as ≥6.0 METs, moderate-to-vigorous-
intensity PA as ≥3.0 METs, and total PA intensity as ≥1.5 METs. In addition to time 
spent sedentary and performing PA of varying intensity, total daily energy expenditure 
(TDEE) and physical activity energy expenditure (PAEE) for total PA (≥1.5 METs) and 




and performing PA, TDEE, and PAEE will be calculated for each valid day of wear time 
and will be analyzed as an average of those days. Estimated PA time and energy 
expenditure during non-wear times will be excluded from analysis.  
Glycemic Variability 
Glycemic variability will be assessed by a CGM (Dexcom G4 Platinum 
Professional, San Diego, CA, USA). Participants had a sensor inserted under the skin on 
the preferred side of the abdomen, approximately 2 cm to the side of the umbilicus, and 
were required to carry a recording device for 7 consecutive days. The participants were 
trained to manually perform a capillary blood measurement (fingerstick) using a provided 
glucometer twice a day during wear time per manufacturer’s instructions. The CGM 
device was blinded so that participants could not see the live readings to deter any 
alterations in diet, PA, or general lifestyle. Data was considered valid for analysis if 
participants wore the monitor for 5 days including a weekend day, with a minimum of 20 
hours’ data each day. 
Software provided by the manufacturer (Dexcom Studio 12.0.4.6) was used to 
download and export the CGM data to Excel datafiles. The data were assessed in 5-
minute intervals per 24-hour period. CGM data was transferred into and glycemic 
variability was analyzed per day using the EasyGV Version 9.0.R2, which is an Excel-
enabled workbook that utilizes macros to calculate glycemic variability (University of 
Oxford, Oxford, England, UK). The MAGE and the CONGA-4 will be calculated and 
utilized as measurements of inter- and intra-day glycemic variability for each valid day of 




variability will be assessed as the standard deviation and coefficient of variation between 
the valid days analyzed. 
Oxidative Stress 
Oxidative stress will be assessed in serum (n=20; WORDS study) and plasma 
(n=8; A-TEAM study) from all participants who completed the studies and had fasting 
venous blood samples available at the end of the 7-day monitoring period. Prior to 
analysis, as samples are collected, they will be centrifuged at 3,000 rpm at 4 degrees 
Celsius for 20 minutes and stored at -80 degrees Celsius until all samples are collected. 
Once all sample were collected and ready for analysis, samples will be thawed and re-
centrifuged to separate any particulate. Two biological biomarkers or oxidative stress, 
nitric oxide and myeloperoxidase, will be measured using two separate enzyme-linked 
immunoabsorbant assays (ELISA). The nitric oxide ELISA kit (ThermoFicher Scientific, 
Waltham, MA) will be quantitatively determined by the concentrations of nitrate and 
nitrite in serum and plasma samples. This ELISA utilized the enzyme nitrate reductase to 
convert nitrate to nitrite, which was then detected as a colored azo dye product of the 
Griess reaction which absorbs light at 540 nm. The interaction of nitrate and nitrite 
concentrations measured will determine the concentration of nitric oxide in both serum 
and plasma (Fareed D, Tqbal O, Tobu M, Hoppensteadt DA, & Fareed J, 2004). Proper 
sample dilution and preparation will allow for a low percent coefficient of variation, and 
both human serum and plasma samples have ≥90% sample recovery for both nitrite and 
nitrate concentrations which will be utilized to calculate nitric oxide, alleviating potential 
error due to intra-assay and inter-assay variability per manufacturer’s product information 




NH) will be utilized to quantify the determination of myeloperoxidase utilizing a two-site 
“sandwich” technique that binds to different epitopes of myeloperoxidase. Antibodies 
bind to myeloperoxidase and, after several incubation periods and plate washes, will be 
ready to analyze by detecting the immunocomplex and the absorbency of the sample. 
Intra-assay and inter-assay variability for concentrations of myeloperoxidase were 
comparable in serum and plasma utilized per manufacturer’s product information sheet in 
which they measured two sample extracts in a single assay with twelve replicate 
determinations for intra-assay variability, and by measuring two controls in duplicate in 
six individual assays. 
Fasting Glucose Concentration and Oral Glucose Tolerance Test 
 For the WORDS study, on the final day of 7-day CGM monitoring period each 
participant completed an OGTT at baseline and post-intervention. Following an overnight 
fast (~12 hours other than water), participants reported to an approved clinical site and 
performed a venous blood sample collection in which a catheter was inserted into the 
antecubital space of the arm. Time was recorded when am initial venous blood sample 
was collected to establish fasting blood glucose time point. Following the venous blood 
collection, participants were then instructed to  consume a standard 10-ounce, 75-gram 
glucose infused drink (Azer Scienmtific, Morgantown, PA) within 5 minutes of the 
venous blood collection and time consumption completed was recorded and utilized as 
time point zero (0-). Every 30-minute interval was then recorded until 2 hours was 
complete (30-,60-,90-,120-minutes post-consumption), which is the standard procedure 
for a 75-gram OGTT (Institute for Quality and Efficiency in Healthcare 2011). During 




to limit the impact of muscle contraction on glucose concentrations. All venous blood 
samples were collected into 1.5 mL centrifuge tubes and placed on ice until completion 
of the 2-hour OGTT and subsequently stored at -80 degrees Celsius until all samples are 
collected. Fasting and 30-,60-,90-, and 120-minute post-consumption concentrations of 
blood glucose were analyzed utilizing a YSI 2300 STAT Plus (YSI Life Sciences, Yellow 
Spring, OH), which was calibrated according to manufacturer instruction prior to 
analysis.  
For the A-TEAM study, on the final day of 7-day CGM monitoring period, while 
participants were still wearing the CGM monitor, each participant completed an OGTT at 
baseline and post-intervention. Following an overnight fast (~12 hours other than water), 
participants reported to an approved clinical site and performed a venous blood sample 
collection. Time was recorded and matched with the CGM to the venous blood collection 
to establish fasting blood glucose time point. Following the venous blood collection, 
participants were then instructed to  consume a standard 10-ounce, 75-gram glucose 
infused drink (Azer Scienmtific, Morgantown, PA) within 5 minutes of the venous blood 
collection and time consumption completed was recorded and utilized as time point zero 
(0-). Every 30-minute interval was then recorded until 2 hours was complete (30-,60-,90-
,120-minutes post-consumption), which is the standard procedure for a 75-gram OGTT 
(Institute for Quality and Efficiency in Healthcare 2011). During the 2-hour OGTT, 
participants were instructed to limit their movement, unless necessary, to limit the impact 
of muscle contraction on glucose concentrations. As CGM assessed glucose 




B, Anderson S, Heinemann L, & Clarke W, 2008), no subsequent blood draws were 
performed at each time point after fasting. 
Software provided by the manufacturer (Dexcom Studio 12.0.4.6) was used to 
download and export the CGM data to Excel datafiles. Time points recorded during the 
OGTT were identified and matched with exported CGM data for time point 0 and 
subsequent 30-,60-,90-,120-minute post-consumption time points. If any of the time 
points fell between CGM concentration readings, as the CGM assesses every 5 minutes, 
the average between the previous and following CGM concentration readings were 
calculated. Additionally, OGTT area under the curve (AUC) was calculated utilizing the 
equation Glucose AUC=1/2×30×(y0-+2y30-+2y60-+2y90-+y120-), where y represents glucose 
concentration at the different time points (Tai MM 1994). 
Statistical Analysis 
Descriptive statistics were calculated and reported as means and standard 
deviations. To address all sub-aims, the average of valid daily sedentary time, and LPA, 
MPA, VPA, and MVPA, total PA time, TDEE, and PAEE (≥1.5 and ≥3.0 METs) will be 
calculated. Furthermore, the average of valid daily glycemic variability assessed via 
MAGE, CONGA-4, and MODD will be calculated, and fasting concentrations of nitric 
oxide and myeloperoxidase will be measured. To address sub-aim 2.1, Pearson product 
correlations between sedentary time and MAGE, CONGA-4, and MODD, and nitric 
oxide and myeloperoxidase will be performed. To address sub-aim 2.2, Pearson product 
correlations will be performed between LPA and MVPA time, TDEE, and PAEE (≥3.0 
METs) between both measures MAGE and CONGA-4 and nitric oxide and 




performed between total PA time and PAEE (≥1.5 METs) and MAGE and CONGA-4, 
and nitric oxide and myeloperoxidase. Furthermore, to address the relationship between 
daily glycemic variability and oxidative stress, Pearson product correlations will be 
performed between both measures of glycemic variability and oxidative stress (i.e. 
MAGE and nitric oxide, MAGE and myeloperoxidase, CONGA-4 and nitric oxide, and 
CONGA-4 and myeloperoxidase). Additionally, for sub-aims 2.1 and 2.2, and 2.3, age, 
sex, race, and/or BMI will be adjusted for to examine the role of participant 
characteristics on the associations between measures of glycemic variability and 
oxidative stress. Lastly, as we are including participants from two different studies, with 
slightly different methodology, we plan to adjust for study involvement (WORDS and A-
TEAM) for all three sub-aims to assess whether sample type may affect the associations 
of interest. Lastly, to assess potential day-to-day variability of sedentary and PA 
measures and variation in glycemic variability on their relationship with oxidative stress, 
Pearson product correlations will be performed between the standard deviation and 
coefficient of variation for sedentary and PA measures and measures of glycemic 
variability with fasting oxidative stress concentrations.  
Statistical Power 
There is currently no info in the literature examining the relationship between 
sedentary time, PA of varying intensities, and measures of glycemic variability and 
oxidative stress. Therefore, power analysis calculations were performed using G*Power 
3.0.10 and found that when testing for the sensitivity of a required significant correlation, 
28 participants would allow for 80% power with a medium- to large-correlation (-1.0--




variables of interest, sedentary time and PA of varying intensities with glycemic 
variability and oxidative stress. As this is the first study to examine the relationship 
between daily sedentary time, PA of varying intensities, measures of glycemic variability, 
and fasting concentrations of biomarkers associated with oxidative stress, results will be 
utilized to provide evidence for power calculations for future studies. 
Strengths and Limitations of Study 2 
 This study is among the first to examine the relationship between sedentary time, 
PA of varying intensities, glycemic variability, and oxidative stress. The use of CGM 
technology to assess glycemic variability is another strength, which allows for the 
observation of a “free-living” condition as opposed to standard clinical measures. The 
strengths of this study also included the use of trained staff for the placement and 
implementation of not only the Sensewear Mini Armband, but also the Dexcom CGM 
device, trained phlebotomists completed the blood collection and processing prior to 
analysis of oxidative stress biomarkers, nitric oxide and myeloperoxidase. There are 
limitations for this proposed study, including the demographics of the population, which 
is considered a convenience sample, and only makes the results generalizable to 
sedentary, overweight or obese individuals that are between the ages of 35 and 55 years. 
Additionally, undiagnosed diabetics were not excluded from the study, which may 
influence the results. In order to limit this, no participants were currently taking diabetic 
medications during measurement time period. Following completion of the 7-day 
monitoring period, each participant’s CGM glucose levels were analyzed and none of the 
completers fell into the prescribed diabetic range (fasting blood glucose ≥126 mg/dL). 




provided, which has been known to be unreliable. In order to limit this, we recommended 
that each participant attempt to maintain their daily dietary routines during the 7-day 
monitoring process. However, not controlling for diet may also be considered a strength 
as their “normal” dietary patterns may provide an insightful examination into the “free-
living” glycemic variability observed. For females, current cycle of menstruation was not 
taken into account, as current cycle in the menstrual period may influence hormones 
associated with glucose metabolism and cardiovascular outcomes. Past research has 
found that both glucose metabolism and oxidative stress may be altered during various 
phases of the menstrual cycle (Widom B, Diamond MP, Simonson DC, & 1992; Browne 
RW, Bloom MS, Schisterman EF, Hovey K, Trevisan M, Wu C, Liu A, & Wactawski-
Wende J, 2008). As we have no way of retroactively examining menstrual cycle in 
female participants, this limitation will persist, but provide future directions for the 
consideration of menstrual cycle phase in subsequent research studies. 
STUDY 3 METHODOLOGY-THE IMPACT OF AEROBIC EXERCISE TRAINING ON PA, 
GLYCEMIC VARIABILITY, AND OXIDATIVE STRESS 
 
Purpose 
This study addressed Specific Aim #3, which was to examine the effect of a 12-
week aerobic exercise intervention on glycemic variability and oxidative stress. 
Sub-Aim 3.1: To examine the effect of a 12-week aerobic exercise intervention on 
glycemic variability. 
Sub-Aim 3.2: To examine the effect of a 12-week aerobic exercise intervention 







 An aerobic treadmill-based intervention aimed at increasing structured PA 
through aerobic-exercise training will positively impact and improve measures of 
glycemic variability through reduction of glycemic variability assessed as MAGE and 
CONGA-4, and measured biomarkers of oxidative stress by increasing concentrations of 
circulating nitric oxide and decreasing circulating concentrations of myeloperoxidase. 
Study Design 
 This study utilized an interventional design. 
Study Population and Enrollment Process 
For the A-TEAM study, eight participants were recruited from the Columbia, 
South Carolina metropolitan area between October 2017 and December 2018. Potential 
participants were required to be currently healthy, sedentary, overweight or obese adults 
(males and females), age 35-55 years, have 25≤ BMI≤40 kg/m2, be weight stable (±2%) 
during the previous 3 months, have ˂120 minutes of reported resistance or endurance 
exercise per week during the previous 3 months, and for females, be eumenorrheic, or 
post-menopausal for ≥1 year. Also, potential participants self-reporting medical 
conditions (e.g. diabetes), cardiovascular diseases, chronic or recurrent respiratory 
conditions (e.g. uncontrolled asthma or chronic obstructive pulmonary disease), active 
cancer, and eating, or neurological disorders, medications that affect metabolism (e.g. 
thyroid medications, statins), psychological issues, including but not limited to untreated 
depression and attention deficit disorder, excessive caffeine use (>500 mg/day), smoking 
during the past year, pregnant or lactating females, and unwillingness to provide 




All participants answered a medical history questionnaire and underwent a series 
of medical tests to identify and medical conditions that could potentially interfere with 
participation in the exercise intervention, which included resting blood pressure, resting 
electrocardiogram (ECG), graded exercise test, and CGM assessed fasting glucose 
concentrations. If potential participants are found to fall in the range of diabetic without 
prior diagnosis following the week wearing the CGM, they were provided the daily 
glucose concentrations obtained from the CGM and instructed to see a physician. 
Study Intervention 
Participants completed a 12-week moderate-intensity aerobic treadmill-based 
exercise intervention. Participants walked 3 times a week on treadmills in a controlled 
research facility under trained supervision. The exercise volume was achieved by varying 
the duration, speed, and grade to reach each participant’s energy expenditure goal 
according to body weight (10-12 kcal per kg of body weight each week). Weekly energy 
expenditure was determined by multiplying each participant’s body weight by the energy 
expenditure goal (10-12 kcal per kg of body weight each week) and was closely 
monitored throughout the 12-week intervention. Adherence to the exercise prescription 
(weekly energy expenditure of 10-12 kcal per kg of body weight each week) was 
monitored by calculating the amount of energy expenditure each exercise session using 
the standard American College of Sports Medicine formula: {0.1×(speed[miles per hour] 
×26.8)+1.8×(speed[miles per hour] ×26.8)×grade(%)+3.5}×body weight(kg)÷5(L per 
minute)×time(minutes) (American College of Sports Medicine 2017). 12 weeks of 
aerobic exercise training has been extensively studied and is considered an appropriate 




Hills AP, & Pal S, 2012). The prescribed training volume, 10-12 kcal per kg of body 
weight each week, is considered a higher volume of aerobic exercise energy expenditure 
compared to past guidelines, which suggest 8 kcal per kg of body weight each week 
should elicit physiological alterations; however, as that study design also noted 
physiological changes at 12 kcal per kg of body weight each week, and utilized a 6 month 
intervention, 10-12 kcal per kg of body weight each week for 12 weeks of moderate-
intensity aerobic exercise was assigned (Morss GM, Jordan AN, Skinner JS, Dunn AL, 
Church TS, Earnest CP, Kampert JB, Jurca R, & Blair SN, 2004; Sisson SB, Katzmarzyk, 
Earnest CP, Bouchard C, Blair SN, & Church TS, 2009; Rosenkilde M, Reichkendler 
MH, Auerbach P, Bonne TC, Sjödin A, Ploug T, & Stallknecht BM, 2015). 
Due to the physically inactive state of the participants, the exercise intensity and 
weekly energy expenditure was gradually increased to reduce risk of injury. Training 
intensity increased during the first 4 weeks of aerobic treadmill-based exercise 
intervention until the target level of 50-55% of participant’s heart rate reserve (HRR) was 
met, which was determined during the baseline graded exercise test. Participants began at 
a weekly energy expenditure of 6-8 kcal/kg of body weight during the first week of the 
intervention and then progressed until their weekly energy expenditure (10-12 kcal/kg of 
body weight) was attained by week 4. Each exercise session began and ended with a 3-
minute warm-up and cool-down. Heart rate (HR) monitors (FT1; Polar, Lake Success, 
NY, USA) were worn to monitor exercise intensity continuously throughout each 
exercise session and HR was recorded every five minutes. If HR monitors were unable to 




pressure was measured before, during warm-up, at the mid-point of the exercise session, 
during cool-down, and following each exercise session. 
Compliance to the weekly weigh-ins and prescribed exercise intervention 
(frequency, intensity, and duration) for each participant was reviewed weekly and any 
participant missing an exercise session without notifying study personnel was contacted 
via phone or e-mail to reschedule and encourage further attendance. 
Glycemic Variability 
Glycemic variability will be assessed by a CGM (Dexcom G4 Platinum 
Professional, San Diego, CA, USA). Participants had a sensor inserted under the skin on 
the preferred side of the abdomen, approximately 2 cm to the side of the umbilicus, and 
were required to carry a recording device for 7 consecutive days at baseline and end-
intervention. The participants were trained to manually perform a capillary blood 
measurement (fingerstick) using a provided glucometer twice a day during wear time per 
manufacturer’s instructions. The CGM device was blinded so that participants could not 
see the live readings to deter any alterations in diet, PA, or general lifestyle. Data was 
considered valid for analysis if participants wore the monitor for 5 days including a 
weekend day, with a minimum of 20 hours’ data each day. 
Software provided by the manufacturer (Dexcom Studio 12.0.4.6) was used to 
download and export the CGM data to Excel datafiles. The data were assessed in 5-
minute intervals per 24-hour period. CGM data was transferred into and glycemic 
variability was analyzed per day using the EasyGV Version 9.0.R2, which is an Excel-
enabled workbook that utilizes macros to calculate glycemic variability (University of 




utilized as measurements of intra-day glycemic variability for each valid day of wear 
time and will be analyzed as an average of those days. Additionally, day-to-day 
variability will be assessed as the standard deviation and coefficient of variation between 
the valid days analyzed. 
Oxidative Stress 
Oxidative stress will be assessed in plasma (n=8) from all participants who 
completed the studies and had fasting venous blood samples available at the end of the 7-
day monitoring period at baseline and end-intervention. Prior to analysis, as samples are 
collected, they will be centrifuged at 3,000 rpm at 4 degrees Celsius for 20 minutes and 
stored at -80 degrees Celsius until all samples are collected. Once all sample were 
collected and ready for analysis, samples will be thawed and re-centrifuged to separate 
any particulate. Two biological biomarkers or oxidative stress, nitric oxide and 
myeloperoxidase, will be measured using two separate enzyme-linked immunoabsorbant 
assays (ELISA). The nitric oxide ELISA kit (ThermoFicher Scientific, Waltham, MA) 
will be quantitatively determined by the concentrations of nitrate and nitrite in serum and 
plasma samples. This ELISA utilized the enzyme nitrate reductase to convert nitrate to 
nitrite, which was then detected as a colored azo dye product of the Griess reaction which 
absorbs light at 540 nm. The interaction of nitrate and nitrite concentrations measured 
will determine the concentration of nitric oxide in both serum and plasma (Fareed D, 
Tqbal O, Tobu M, Hoppensteadt DA, & Fareed J, 2004). Proper sample dilution and 
preparation will allow for a low percent coefficient of variation, and both human serum 
and plasma samples have ≥90% sample recovery for both nitrite and nitrate 




due to intra-assay and inter-assay variability per manufacturer’s product information 
sheet. The myeloperoxidase serum/plasma ELISA kit (Eagle Biosciences, Inc., Nashua, 
NH) will be utilized to quantify the determination of myeloperoxidase utilizing a two-site 
“sandwich” technique that binds to different epitopes of myeloperoxidase. Antibodies 
bind to myeloperoxidase, after several incubation periods and plate washes, will be ready 
to analyze by detecting the immunocomplex and the absorbency of the sample. Intra-
assay and inter-assay variability for concentrations of myeloperoxidase were comparable 
in serum and plasma utilized per manufacturer’s product information sheet in which they 
measured two sample extracts in a single assay with twelve replicate determinations for 
intra-assay variability, and by measuring two controls in duplicate in six individual 
assays for inter-assay variability. Additionally, all samples were collected within 10 to 14 
days following the final bout of exercise to limit the effect of acute exercise on markers 
of oxidative stress, as well as within a time frame that does not allow for the effect of 
detraining on the markers of oxidative stress utilized in this study (Maeda S, Miyauchi T, 
Kakiyama T, Sugawara J, Iemitsu M, Irukayama-Tombe Y, Murakami H, Kumagi Y, 
Kuno S, Matsuda M, 2001). 
Cardiorespiratory Fitness (CRF) 
CRF for all participants was measured at baseline and end-intervention using a 
maximal graded exercise test. A ramped medium protocol was determined to be ideal for 
these participants as it is an incremental protocol where speed and grade increase every 
30-60 seconds until each participant reached volitional fatigue. Volume of oxygen 
consumed (V̇O2) via a metabolic cart (True Max 2400; ParvoMedics, Sandy, UT, USA) 




Bothell, WA, USA) were monitored continuously during the progression of the test. 
Blood pressure was measured, and rating of perceived exertion was obtained every two-
minutes during the test. Two of four generally recognizable criteria for the test to be 
considered satisfactory needed to be achieved: a respiratory exchange ratio greater than 
or equal to 1.10; a rating of perceived exertion greater than or equal to 17 on the Borg 
scale ranging from 6-20; achieving a maximum heart rate greater than 90% age-predicted 
maximum heart rate (220-age); and/or a plateau in V̇o2. Peak oxygen consumption 
(V̇O2peak) was determined by the highest 30-second average V̇O2 value measured during 
the test. 
Sedentary Time and Physical Activity 
Sedentary time and PA will be measured for all participants for 7 consecutive 
days at baseline and post-intervention and all participants were instructed to continue 
their normal daily routine during monitoring. Participants wore the Sensewear Mini 
Armband on the left arm at the mid-point between the olecranon and acromion processes. 
Participants recorded when they removed the monitor for any activities that required 
water-based activities, such as showering/bathing or swimming. Participants were 
instructed to record times they removed and replaced the monitor if removed over the 7-
day wear time period. Data will be considered valid for analysis if participants wore the 
monitor for at least 5 days including a weekend day, with a minimum wear time of 20 
hours each day. 
Sedentary time and PA levels will be assessed using manufacture provided 
software (BodyMedia Sensewear Version 7.0). The Sensewear Mini Armband provides 




(METs) (excluding sleep time), light-intensity PA as 1.5≤3.0 METs, moderate-intensity 
PA as 3.0≤6.0 METs, and vigorous-intensity PA as ≥6.0 METs, moderate-to-vigorous-
intensity PA as ≥3.0 METs, and total PA intensity as ≥1.5 METs. In addition to time 
spent sedentary and performing PA of varying intensity, total daily energy expenditure 
(TDEE) and physical activity energy expenditure (PAEE) for total PA (≥1.5 METs) and 
moderate-to-vigorous-intensity PA (≥3.0 METs) will be analyzed. Time spent sedentary 
and performing PA, TDEE, and PAEE will be calculated for each valid day of wear time 
and will be analyzed as an average of those days. Estimated PA time and energy 
expenditure during non-wear times will be excluded from analysis. 
Fasting Glucose Concentration and Oral Glucose Tolerance Test 
 On the final day of 7-day CGM monitoring period, while participants were still 
wearing the CGM monitor, each participant completed an OGTT at baseline and post-
intervention. Following an overnight fast (~12 hours other than water), participants 
reported to an approved clinical site and performed a venous blood sample collection. 
Time was recorded and matched with the CGM to the venous blood collection to 
establish fasting blood glucose time point. Following the venous blood collection, 
participants were then instructed to  consume a standard 10-ounce, 75-gram glucose 
infused drink (Azer Scienmtific, Morgantown, PA) within 5 minutes of the venous blood 
collection and time consumption completed was recorded and utilized as time point zero 
(0-). Every 30-minutes interval was then recorded until 2 hours was complete (30-,60-
,90-,120-minutes post-consumption), which is the standard procedure for a 75-gram 
OGTT (Institute for Quality and Efficiency in Healthcare 2011). During the 2-hour 




impact of muscle contraction on glucose concentrations. As CGM assessed glucose 
concentrations have been validated with venous blood glucose concentrations (Kovatchev 
B, Anderson S, Heinemann L, & Clarke W, 2008), no subsequent blood draws were 
performed at each time point after fasting. 
 Software provided by the manufacturer (Dexcom Studio 12.0.4.6) was used to 
download and export the CGM data to Excel datafiles. Time points recorded during the 
OGTT were identified and matched with exported CGM data for time point 0 and 
subsequent 30-,60-,90-,120-minute post-consumption time points. If any of the time 
points fell between CGM concentration readings, as the CGM assesses every 5 minutes, 
the average between the previous and following CGM concentration readings were 
calculated. Additionally, OGTT area under the curve (AUC) was calculated utilizing the 
equation Glucose AUC=1/2×30×(y0-+2y30-+2y60-+2y90-+y120-), where y represents glucose 
concentration at the different time points (Tai MM 1994). 
Caloric Intake Recording 
 Caloric intake will be recorded for all participants for 7 consecutive days at 
baseline and post-intervention and all participants were instructed to continue their 
normal daily dietary routine during this time. All participants self-reported caloric 
consumption, including any calorie containing beverages or snacks, for one week during 
baseline and post-intervention testing. They were instructed on using the MyFitnessPal 
application (MyFitnessPal, Inc.) that is available on smartphone devices or computer 
based. If a smartphone or computer was unavailable, participants were provided a self-
report paper form to record any calorie containing food or drink consumed, including 




utilizing The Calorie King® Calorie Counter (Borushek A 2015). Caloric intake and 
macronutrient breakdown will be calculated for each valid recording day and will be 
analyzed as an average of those valid days. 
Statistical Analysis 
 Baseline descriptive statistics will be calculated and reported as means and 
standard deviations. Change values will be calculated by subtracting baseline values from 
post-intervention values. Paired sample t-tests will be utilized to determine how 
participant characteristics, clinical measurements of glycemic health, fitness, and lifestyle 
factors changed from baseline to post-intervention (body weight, CRF, sedentary and PA 
measures, fasting glucose concentration, 120-minute OGTT concentration, glucose AUC, 
and caloric intake). To address sub-aim 3.1, a repeated measure analysis of variance 
(ANOVA) will be performed from baseline to end-intervention for the MAGE and 
CONGA-4 to establish changes in glycemic variability. To address sub-aim 3.2, similar 
to sub-aim 3.1, a repeated measure ANOVA will also be performed to analyze changes in 
nitric oxide and myeloperoxidase.  For each sub-aim, separate models will be performed 
for both measures of glycemic variability and oxidative stress. Additionally, for sub-aim 
3.1 and 3.2, change in body weight, sedentary and PA measures, CRF, fasting glucose 
concentration, 120-minute OGTT concentration, glucose AUC, and/or caloric intake will 
be adjusted for to examine the role of participant characteristics, as well as clinical 
measurements of glycemic health, fitness, and lifestyle factors as covariates on the 
changes in measures of glycemic variability and oxidative stress. Lastly, to explore a 
potential relationship between glycemic variability and oxidative stress following aerobic 




measurements of glycemic variability and change in measurements of oxidative stress, 
which will also be adjusted for using the previously mentioned variables as covariates. 
Statistical Power 
There is currently no literature examining the effect of a chronic aerobic 
treadmill-based exercise intervention on changes in glycemic variability and oxidative 
stress, or the associations that exist between these two variables. To date, one study has 
examined the influence of aerobic exercise, 7 days of structured aerobic exercise, on 
glycemic variability and control assessed by CGM technology in adults with type 2 
diabetes mellitus not using exogenous insulin (Mikus CR, Oberlin DJ, Libla J, Boyle LJ, 
& Thyfault JP, 2012). Therefore, this study was utilized for sample size estimations. 
Sedentary, overweight or obese adults diagnosed with type 2 debates mellitus (n=13; 
age=53.0±2.0 years; BMI=34.1±1.3 kg/m2) underwent glycemic variability and control 
assessment utilizing CGM technology during 3 days of habitual activity and during the 
final 3 days of a 7 day aerobic exercise training program, which consisted of 60 minutes 
of supervised exercise for 7 consecutive days at 60-75% HRR, and found that “free-
living” glycemic excursions were lower for the 3 days while completing the aerobic 
exercise program compared to the 3 days of habitual activity (maximum blood glucose: 
13.6±1.2 mmol/l to 10.9±0.8 mmol/l, p<0.01; ∆min–max blood glucose:10.0±1.1 mmol/l 
to 6.9±0.7 mmol/l, p<0.01; number of glucose excursion per day: 0.8±0.2 to 0.2±0.1, 
p=0.02). Additionally, another study that examined basal nitric oxide production in 
hypercholesterolemic patients (n=9; age=44.0±3.0; BMI=27.0±1.0 kg/m2) undergoing 4 
weeks of home-based cycle training 3 times per week at 65% V̇O2max for 30 minutes each 




indicated net extraction=6.8±4.0 nmol/100mL/min) (Lewis TV, Dart AM, Chin-Dusting 
JPF, & Kingwell BA, 1999). Therefore, further power analysis calculations were 
performed using G*Power 3.0.10 and found that when testing for the sensitivity of 
required effect size, 8 participants would allow for 20% power with a small- to medium-
effect size (0.1-0.3) with alpha set to 0.05 when testing for the difference between two 
dependent means, baseline compared to end-intervention for measures of glycemic 
variability and oxidative stress. Thus, this study will also serve to provide additional 
resources for future effect size examining alterations in measures of glycemic variability 
and oxidative stress following an aerobic treadmill-based exercise intervention in 
sedentary, overweight or obese adults. 
Strengths and Limitations of Study 3 
 This study is among the first to examine the effects of exercise on glycemic 
variability and how glycemic variability relates to oxidative stress both before and after 
becoming physically active. The strengths of this study included the use of center-based, 
individually designed aerobic treadmill-based intervention in overweight or obese 
individuals that was intended to not only meet a desired intensity, but volume of exercise 
quantified by estimated caloric expenditure each week. In addition, each exercise session 
was performed under supervision in a laboratory setting which allowed for adherence to 
exercise protocol to be monitored. The use of CGM technology to assess glycemic 
variability is another strength. There are limitations for this proposed study, including the 
demographics of the population, which only makes the results generalizable to 
individuals that are between the ages of 35 and 55 years. Additionally, undiagnosed 




limit this, each participant’s CGM glucose levels were analyzed prior to the intervention, 
and none of the completers fell into the prescribed diabetic range. Furthermore, diet was 
not fully taken into account, as only self-report dietary intake was provided at baseline 
and end-intervention, which has been known to be unreliable. In order to limit this, we 
recommended that each participant attempt to maintain their daily dietary routines 
throughout the intervention and not participate in any other interventions that may have 
affected their weight. For females, current cycle of menstruation was not taken into 
account, as current cycle in the menstrual period may influence hormones associated with 
glucose metabolism and cardiovascular outcomes. Past research has found that both 
glucose metabolism and oxidative stress may be altered during various phases of the 
menstrual cycle (Widom B, Diamond MP, Simonson DC, 1992; Browne RW, Bloom 
MS, Schisterman EF, Hovey K, Trevisan M, Wu C, Liu A, Wactawski-Wende J, 2008). 
As we have no way of retroactively examining menstrual cycle in female participants, 
this limitation will persist, but provide future directions for the consideration of menstrual 
cycle phase in subsequent research studies. Lastly, the small sample size (n=8) may limit 
the statistical power needed to detect a true effect size of the outcomes of interest. 
However, this study was designed to add to the mostly non-existent literature and aid in 
the prediction of future effect sizes for studies wishing to examine the effect of exercise 
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Glycemic variability has recently been thought of as a potentially more sensitive 
assessment of glycemic health as opposed to traditional clinical measures of glucose 
metabolism and glucose tolerance. The ability for glycemic variability to consider all 
glucose concentrations in a given distribution and account for the oscillations that occur 
in these distributions provide clinicians with more in-depth insight into how individuals 
regulate and/or maintain their glycemic health. With the advancement of continuous 
glucose monitoring (CGM) technology to allow examination of real-time, free-living 
glucose concentrations over a single or multiple days, more reliable assessment and 
treatment of dysregulated glycemic health, specifically in impaired glucose tolerant and 
type 1 and type 2 diabetic adults, is possible. CGM assessment along with lifestyle 
management techniques implemented to influence glucose concentrations, such as 
sedentary behavior and physical activity, including structured physical activity, known as 
exercise, allow for a greater perspective to be established linking lifestyle factors with 
glycemic health. Therefore, the aim of this review is to critically evaluate and provide 
evidence regarding the importance of glycemic variability, how glycemic variability is 
measured, the relationship glycemic variability possesses with sedentary time and 
physical activity, the influence of a single bout or repeated bouts of exercise, as well as 
exercise training on glycemic variability in non-diabetic adults, and adults diagnosed with 
type 1 or type 2 diabetes. Additionally, this review plans to provide strengths and 
limitations of the studies discussed, which will allow insight into future design of 





Glycemic variability has been considered a novel and sensitive measure of 
glycemic health in addition to clinical assessment of glucose metabolism and tolerance 
(Monnier L, Colette C, & Owens DR, 2008). Glycemic variability accounts for glucose 
fluctuations throughout the day or during specified durations (Hirsch IB & Brownlee M, 
2005). Glycemic variability has been observed to be greater in overweight to obese 
adults, as well as in adults diagnosed with type 1 and type 2 diabetes, compared to 
healthy, normal weight adults  (Buscemi S, Cosentino L, Rosafio G, Morgana M, Mattina 
A, Sprini D, Verga S, & Rini GB, 2013). As glycemic variability has been related to risk 
of the development of cardiovascular disease risk factors, specifically increased 
endothelium-derived oxidative stress (Saisho Y 2014), the clinical implications for the 
assessment of glycemic variability have become of great importance. 
The use of continuous glucose monitoring (CGM) allows for the inclusion and 
evaluation of all glucose concentration oscillations over an extended monitoring period 
(Standl E, Schnell O, & Ceriello A, 2011). CGM assesses real-time glucose 
concentrations and instantaneously allows for users and practitioners to make more 
informed decisions throughout the day on how to balance self-management techniques to 
maintain glycemic control (Hirsch IB, Armstrong D, Bergenstal RM, Buckinghom B, 
Childs BP, Clarke WL, & Wolpert H, 2008). In addition, CGM measurements can take 
place every few minutes, over multiple hours throughout the day, for several days to aid 
in assessment of habitual glycemic health (Vincze G, Barner JC, & Lopez D, 2004). 
CGM works through a sensor inserted in subcutaneous tissue and measures interstitial 




Djurhuus CB, Gravholt CH, Carus AC, Granild-Jensen J, Orskov H, & Christiansen JS, 
2005). CGM-measured glucose concentrations have been validated against venous blood 
glucose concentrations (Bailey TS 2017). Even though a delay may occur between 
measurements of glucose concentrations, with the delay occurring in interstitial fluid 
assessment compared to venous blood assessment, this delay has been shown to be 
minimal and often varies marginally by individual (Garg SK, Voelmle M, & Gottlieb PA, 
2010). Thus, when utilized in research, CGM measured glucose concentrations can aid in 
establishment of time spent at hypo-, hyper-, and euglycemia, and allows for the 
assessment of glycemic variability (Klonoff DC 2005). 
Decreased sedentary time and increased physical activity of any intensity have 
been shown to be beneficial for overall health, specifically glycemic health (Høstmark 
AT, Ekeland GS, Beckstrøm AC, & Meen HD, 2006; Carnethon MR, Evans NS, Church 
TS, Lewis CE, Schreiner PJ Jacobs Jr DR, Sternfel B, & Sidney S, 2010; Nygaard H, 
Grindaker E, Rønnestad BR, Holmboe-Ottesen G, & Høstmark AT, 2017). Structured 
physical activity, commonly known as exercise, has been shown to have additional 
glycemic health benefits beyond non-exercise related physical activity (Boulé NG, 
Haddad E, & Kenny GP, 2001). Recently, it has been suggested that even a single bout of 
exercise or repeated bouts of exercise improve glycemic variability in healthy and 
metabolically compromised adults, with potential improvements following exercise 
training noted primarily in type 2 diabetic adults (Blankenship JM, Granados K, & Braun 
B, 2014). 
Therefore, the aim of this review was to express the importance of glycemic 




single bout of exercise or repeated bouts of exercise, as well as exercise training 
influences glycemic variability in a variety of populations. Further, with more recent 
technological advancement of CGM to aid in assessment of glycemic health, glycemic 
variability has become an integral assessment for prevention and/or treatment in those at 
risk of or currently diagnosed with cardiometabolic diseases. Based on evidence provided 
in this review, practical implications for use of glycemic variability in assessment of 
glycemic health in relation to physical activity and exercise, will be provided. 
METHODS 
To address the overall study purpose, we searched the electronic databases 
PubMed, Google Scholar, Web of Science, BioMed Central, Cumulative Index of 
Nursing and Allied Health Literature (CINAHL), and SCOPUS. We limited the date 
range until December 2019 with a secondary search strategy included scanning 
bibliographies of the retrieved articles. Initial selection was based on title and abstract. 
The original article was obtained and subsequently determined whether the research 
study met the inclusion criteria established for the critical review. Articles were reviewed 
based on the criteria provided in Table 3.1. and 3.2. and extracted details included 
population, treatment, summary results of primary findings, and potential strength and 
limitations of each study. 
Glycemic variability included only CGM-assessed glycemic variability. Glycemic 
variability has commonly been utilized interchangeably with glycemic excursions and 
glucose or glycemic control, which were therefore included in the search terms. Further, 
multiple brands and models of CGM devices exist that have been proven reliable and 




Dexcom (San Diego, CA), FreeStyle (Abbott Laboratories; Chicago, IL), Guardian 
(Medtronic; Dublin, Ireland), and Eversense (Senseonics Holdings; Germantown, MD). 
Hence, it was ensured that the CGM devices utilized in the present review had been 
previously tested for accuracy in comparison to blood glucose concentrations. 
Sedentary behaviors were included, which comprised of time spent sedentary and 
the classical definition of sedentary behavior, which has been expressed as any waking 
behavior characterized by an energy expenditure ≤1.5 metabolic equivalents (Tremblay 
MS, Aubert S, Saunders TJ, CarsonV, Latimer-Cheung AE, Chastin SFM, Altenberg TM, 
& Chinapaw MJM, 2017). Physical activity included outcomes measured by subjectively 
validated questionnaires or objectively utilizing accelerometry and/or pedometers. 
Exercise has been classically defined as structured physical activity performed with a 
purpose or goal (Caspersen CJ, Powell KE, & Christenson GM, 1985). Therefore, we 
also examined how a single bout of exercise or repeated bout of exercise, as well as 
exercise training, affects glycemic variability. When examining the influence of exercise, 
we included any modality or duration of submaximal and maximal bouts of exercise tests 
and defined the acute response as immediately post-exercise up to 48 hours post-exercise. 
Further, we included exercise interventions of any duration if they met the minimum 
guidelines established for being considered physically active by a reputable governing 
body, such as the Department of Health and Human Services, American Diabetes 








Importance of Glycemic Variability 
Glycemic control often refers to hemoglobin A1c (HbA1c); however, glycemic 
control is often utilized interchangeably with glycemic variability. Yet, these 
measurements more so complement each other in addition to portraying similar concepts. 
As glycemic variability accounts for oscillations in glucose concentrations over a period 
of time, glycemic control has historically been comprised of HbA1c evaluation, which 
accounts for the average volume of glucose bound to the hemoglobin of circulating red 
blood cells over ~3 months (American Diabetes Association, 2020). Most type 1 and type 
2 diabetic patients tend to have HbA1c measured every 3 months in hopes of determining 
whether their glycemic control targets have been obtained and/or maintained (Wei N, 
Zheng H, & Nathan DM, 2014). Impaired glycemic control assessed by HbA1c has a 
strong predictive value for diabetes onset and diabetic complications (Stratton IM, Adler 
AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, & Holman RR, 
2000; Little RR, Rohlfing CL, Sacks DB, National Glycohemoglobin Standardization 
Program Steering Committee, 2011; Laiteerapong N, Ham SA, Gao Y, Moffet HH, Liu 
JT, Huang ES, & Karter AJ, 2019). Thus, glycemic control assessed as HbA1c has been 
established as a useful tool for a point-of-care opportunity between healthcare providers 
and patients for more timely treatments for optimizing glycemic management to deter the 
progression of diabetic complications. 
However, HbA1c assessed glycemic control has its limitations as a sole measure 
of glycemic health, as the cut-point of HbA1c from the diagnostic point of view is still 




The HbA1c test is considered an indirect measure of average glycemia and uncertain 
variability is often unaccounted for as red blood cells may be affected by cell turnover, 
anemia, blood transfusions, and pregnancy (Jovanovič L, Savas H, Mehta M, Trujillo A, 
& Pettitt DJ, 2011; Beck RW, Connor CG, Mullen DM, Wesley DM, & Bergenstal RM, 
2017). Additionally, population differences exist in HbA1c, in which ethnicity/race, sex, 
and age may influence reference HbA1c concentrations and potential diabetic-related 
complications (Cavagnolli G, Pimental AL, Freitas PAC, Gross JL, & Carmargo JL, 
2017). Specifically, HbA1c has been observed to be greater in African Americans 
compared to Caucasians, males compared to females, as well as increases with age (Ma 
Q, Liu H, Xiang G, Shan W, & Xing W, 2016). 
Recently, evaluation of HbA1c has been accompanied by further testing, to 
examine glucose concentrations in a non-clinical setting, i.e. 24-hour, diurnal, and 
nocturnal, in addition to traditional clinical examinations of glycemic health, such as 
fasting or in a glucose challenged state (Battelino T, Danne T, Bergenstal RM, Amiel SA, 
Beck R, Biester T, Bosi E, Buckingham B, Cefalu WT, Close KL, Cobelli C, Dassau E, 
DeVries JH, Donaghue KC, Dovc K, Doyle FJ, Garg S, Grunberger G, Heller S, 
Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, 
Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin 
CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, & 
Phillip M, 2019). The relationship between glucose concentrations and HbA1c within an 
individual correlate over time (Chehregosha H, Khamesh ME, Malek M, Hosseinpanah 
F, & Hosseinpanah F, 2019). More specifically, the more time-point measurements to 




correlation observed with HbA1c (Hirsch IB, Welsh JB, Calhoun P, Puhr S, Walker TC, 
& Price DA, 2019). Additionally, glycemic states, including euglycemia and 
hyperglycemia, have been previously reported to strongly correlate with HbA1c (Hirsch 
IB, Welsh JB, Calhoun P, Puhr S, Walker TC, & Price DA, 2019). Therefore, with the 
advent of new technology, CGM has evolved rapidly in both accuracy and affordability 
and allows for evaluation of free-living glucose concentrations and glycemic variability 
in addition to glycemic control established as HbA1c. 
Glycemic Variability Measures 
Currently, several measures of glycemic variability are utilized and range in 
sensitivity and specificity (Rodbard D 2018). These include measurements to establish 
intra-day and inter-day glycemic variability, with many designed for CGM technology 
(Suh S & Kim JH, 2015). Glycemic variability measurements include those commonly 
used for ease of analysis, such as the standard deviation (SD) of the mean glucose 
concentration and percentage coefficient of variation (%CV). Additionally, more 
sensitive analyses of glycemic variability have been adopted, including the mean 
amplitude of glycemic excursions (MAGE), continuous overlapping net glycemic action 
over an n-hour period (CONGA-n), and the mean of daily differences (MODD). In the 
following section, the most frequently used, but not all-inclusive, measurements of 
glycemic variability will be discussed, with strengths and limitations listed (Table 4.1.). 
Prior to validation of more sensitive measures of glycemic variability, the SD of 
mean glucose concentration and %CV were utilized (Kovatchev B, Anderson S, 
Heinemann, & Clark W, 2008). Statistically, SD and %CV are often thought of as the 




(Altman DG & Bland JM, 2005). Additionally, %CV is considered potentially more 
inclusive and sensitive compared to SD alone as it incorporates both the mean and SD of 
the distribution (Kovatchev B, Anderson S, Heinemann, & Clark W, 2008). Even though 
these measurements include all glucose concentrations, there exists an inherent limitation 
that does not account for individual physiological differences or differences in lifestyle 
factors, such as physical activity, exercise, and dietary consumption, which should be 
considered. Even so, a large body of evidence supports that a direct linear relationship 
exists between SD and %CV for a large series of CGM data with more sensitive 
measures of glycemic variability (Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld 
D, Heine RJ, & ADAG Study Group, 2008; Kuenen JC, Borg R, Kuik DJ, Zheng H, 
Schoenfeld D, Diamant M, Nathan DM, Heine RJ, & ADAG Study Group, 2011). 
One of the initial measurements of intra-day glycemic variability was MAGE 
(Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, & Taylor WF, 
1970). MAGE is calculated by taking the arithmetic mean of the blood glucose increases 
or decreases (from blood glucose nadirs to peaks or vice versa) when both ascending and 
descending segments exceeded the value of one SD of the mean blood glucose for the 
same 24-hour period (Service FJ & Nelson RL, 1980). MAGE does not account for time 
spent in euglycemia, or periods of low-level hypo- or hyper-glycemia (Service FJ, 
O’Brien PC, & Rizza RA, 1987). This creates ambiguity as to where glycemic excursions 
occur, potentially limiting the ability to measure the magnitude of glycemic excursions 
(Rodbard D 2009). However, MAGE provides insight into the extent that glycemic 





Further consideration for time-dependent glycemic variability, which utilizes the 
continuous nature of CGM, was established with other measures. CONGA-n was 
formulated to account for each observation after the first n hours of observations 
(McDonnell CM, Donath SM, Vidmar SI, Werther GA, & Cameron FJ, 2005). Further, 
the difference between the current observation and the observation n hours previous is 
calculated with CONGA-n defined as the SD of the differences. (McDonnell CM, Donath 
SM, Vidmar SI, Werther GA, & Cameron FJ, 2005). CONGA-n can be calculated from 1 
to 24-hour time intervals; yet, has been utilized most frequently for 1- to 4-hour time 
intervals to account for time between certain activities throughout the day, with accuracy 
decreasing beyond the 4-hour time interval (McDonnell CM, Donath SM, Vidmar SI, 
Werther GA, & Cameron FJ, 2005; Kuenen JC, Borg R, Kuik DJ, Zheng H, Schoenfeld 
D, Diamant M, Nathan DM, Heine RJ, & ADAG Study Group, 2011; Nathan DM, 
Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, & ADAG Study Group, 2008). For 
example, CONGA-1 was initially created as a measurement of glycemic variability to 
account for glycemic excursions throughout a 24-hour period, while CONGA-2 accounts 
for time between snacks, and CONGA-4 as the variability observed between standard 
meals, which include breakfast, lunch, and dinner (McDonnell CM, Donath SM, Vidmar 
SI, Werther GA, & Cameron FJ, 2005). CONGA-n continues to be a more promising 
measure of intra-day glycemic variability and provides practitioners with more flexibility 
in the evaluation of intra-day glycemic variability (McDonnell CM, Donath SM, Vidmar 
SI, Werther GA, & Cameron FJ, 2005). 
In addition to intra-day glycemic variability, use of CGM allows for analysis of 




designed as a meticulous protocol occurring over two consecutive days during in-house 
clinical testing (Service FJ & Nelson RL, 1980; Service FJ, O’Brien PC, & Rizza RA, 
1987). MODD is traditionally calculated as the absolute value of the difference between 
glucose concentrations measured at the same time over a 24-hour period on two 
consecutive days (Service FJ & Nelson RL, 1980; Service FJ, O’Brien PC, & Rizza RA, 
1987). MODD may also be calculated as a continuous time series over an extended 
period (>2 days), which has been shown to strongly correlate with MODD over the initial 
two consecutive days under standardized conditions (Rodbard D 2009). 
With the advancement and incorporation of CGM technology, the ability to 
design and implement more sensitive and time specific measures of glycemic variability 
have become a viable option when delineating glycemic health. In addition to the SD and 
%CV of measured glucose concentrations over an extended period, the ability to measure 
inter- and intra-day variability has been further incorporated using MAGE, CONGA-n, 
and MODD. Even though multiple measures of glycemic variability have been 
developed, most of the research has been performed in those with impaired glucose 
tolerance or type 1 and type 2 diabetes. Thus, inclusion of these more sensitive measures 
should be considered when evaluating the variation in glucose concentrations in other 
populations at an increased risk for the development of cardiometabolic disorders, such 
as sedentary healthy weight, and/or overweight or obese adults. 
Relationship with Sedentary Behavior and Physical Activity 
 
Decreasing sedentary time and increasing physical activity of any intensity is 
widely accepted to be beneficial for overall and cardiometabolic health (Young DR, 




Perry CK, & Yong CM, 2016; Katzmarzyk PT, Powell KE, Jakicic JM, Troiano RP, 
Piercy K, & Tennant B, 2019 2017). Further, sedentary time and physical activity are 
independently associated with elevated fasting glucose concentrations, impaired glucose 
metabolism, and glucose tolerance in non-diabetic and diabetic adults (Høstmark AT, 
Ekeland GS, Beckstrøm AC, & Meen HD, 2006; Helmerhorst HJ, Wijndaele K, Brage S, 
Wareham NJ, & Ekelund U, 2009; Dunstan DW, Barr EL, Healy GN, Salmon J, Shaw 
JE, Balkau B, & Owen N, 2010; Ford ES, Zhao G, & Li C, 2010; Thorp AA, Healy GN, 
Owen N, Slamon J, Ball K, Shaw JE, & Dunstan DW, 2010; Veerman JL, Healy GN, 
Cobiac LJ, Vos T, Winkler EA, Owen N, & Dunstan DW, 2012; Lahjibi E, Heude B, 
Dekker JM, Højlund K, Laville M, Nolan Jn & Balkau B, 2013; Nygaard H, Grindaker E, 
Rønnestad BR, Holmboe-Ottesen G, & Høstmark AT, 2017). In adults diagnosed with 
type 2 diabetes, increased time spent sedentary has previously been shown to predict 
significant increases in time spent in hyperglycemia (Fritchi C, Park, H, Richardson, A, 
Park C, Collins EG, Mermelstein R, Riesche L, & Quinn L, 2016). These findings 
highlight the relationship between time spent sedentary and performing physical activity 
with glucose concentrations and glucose tolerance. However, there remains limited 
evidence of a relationship between sedentary behavior and/or physical activity with 
glycemic variability (Table 4.2.). 
A prospective repeated measures designed study that included 35 young adults 
(18-35 years of age) diagnosed with type 1 diabetes found no relationship between total 
physical activity minutes and the SD of the 24-hour mean glucose concentration (β 
estimate=2.2031, p=0.127) (Martyn-Nemeth P, Quinn L, Penckofer S, Park C, Hofer V, 




associations between objectively measured sedentary time with 24-hour glycemic control 
in 37 type 2 diabetic adults (>18 years of age) (Paing AC, McMillan KA, Kirk AF, 
Collier A, Hewitt A, & Chastin SFM, 2018). This study found that time spent sedentary 
was positively associated with poorer CGM-assessed glycemic control, and in those who 
spent more time sedentary there was a noted reduction for time spent in euglycemia (β 
estimate=-0.44, p=0.04) and a trending relationship with increased time spent 
hyperglycemic (β estimate=0.36, p=0.08). However, breaks in sedentary time was 
positively associated with time spent in euglycemia (β estimate=0.38, p=0.04). Further, a 
cross-sectional study of non-diabetic and diabetic adults participating in the A Estrada 
Glycation and Inflammation Study had a subsample of 511 adults (12% diagnosed type 1 
and 2 diabetic) complete the International Physical Activity Questionnaire and had valid 
CGM monitoring data for analysis (Gude F, Díaz-Vidal P, Rúa-Pérez C, Alonso-
Sampedro M, Fernández-Merino C, Rey-García J, Cadarso-Suárez C, Pazos-Couselo M, 
García-López JM, & Gonzalez-Quintela A, 2017). This study found no relationship 
between physical activity status with glycemic variability measures, including the SD of 
24-hour mean glucose concentration, MAGE, and CONGA-1 in the non-diabetic adult 
population (p≥0.264 for all), but did not report findings in the diabetic population. 
These studies highlight the potential importance of sedentary behavior and 
physical activity with glycemic control and glycemic variability assessed by CGM in a 
variety of populations. Even though most previous findings are limited to glycemic 
control assessed as HbA1c, these studies provide insight into how CGM may be 
incorporated as a measure of glycemic control and glycemic variability in addition to 




differences between non-diabetic and diabetic adults or utilized subjective rather than 
objective assessments of sedentary behavior and physical activity. Hence, evidence 
suggests that a potential and impactful relationship between sedentary behavior and 
physical activity with CGM-assessed glycemic control and glycemic variability exists in 
adults with a compromised metabolic profile, such as type 2 diabetes. However, when 
examining non-diabetic adults and/or adults which may utilize other lifestyle 
management techniques or medications to influence their glycemic health, such as type 1 
diabetics, further consideration for other lifestyle factors, including free-living dietary 
patterns or structured physical activity (e.g. exercise), may be pertinent when evaluating 
glycemic health with CGM technology. 
Influence of Single Bout or Repeated Bouts of Exercise on Glycemic Variability 
Exercise has been shown to beneficially influence insulin resistance and glucose 
tolerance, and is commonly utilized as a treatment for both non-insulin and insulin-
dependent type 2 diabetes (Joslin EP, Root HF, White P, & Marble A, 1935; Goodyear 
LJ & Kahn BB, 1998). Even a single bout of exercise can have a beneficial impact on 
glucose homeostasis, whole-body glucose disposal, and increase glucose uptake into 
skeletal muscle (Pruett EDR & Oseid S, 1970; Bogardus C, Thuillex P, Ravussin E, 
Vasquez B, Narimiga M, & Azhar S, 1983; Richter EA, Mikines KJ, Galbo H, & Kiens 
B, 1989; Wang X, Patterson BW, Smith GI, Kampelman J, Reeds DN, Sullivan SA, & 
Mittendorfer B, 2013). Further, a single bout of exercise may have persistent effects on 
glucose uptake and insulin sensitivity for several hours after completion of exercise 
(Devlin JT & Horton ES, 1985; Devlin JT, Hirshman MF, Horton ES, & Horton ED, 




have examined the impact of a single bout of exercise or repeated bouts of exercise on 
CGM-assessed glycemic control and glycemic variability. 
 Previous studies examining the influence of a single bout of exercise or repeated 
bouts of exercise on CGM-assessed glycemic control and glycemic variability in non-
diabetic, healthy weight and overweight or obese adults have found comparable and 
consistent results (Table 4.3.) (Little JP, Jung ME, Wright AE, Wright W, & Manders JF, 
2014; Parker L, Shaw CS, Banting L, Levinger I, Hill KM, McAinch AJ, & Stepto NK, 
2017; Figueira FR, Umpierre D, Bock PM, Waclawovsky G, Guerra AP, Donelli A, 
Andrades M, Casali KR, & Schaan BD, 2019). Figueira et al., found that a single bout of 
moderate-intensity aerobic exercise and eccentric resistance exercise had comparable 
decreases in glycemic variability compared to pre-exercise control period 15 young 
healthy adults (Figueira FR, Umpierre D, Bock PM, Waclawovsky G, Guerra AP, 
Donelli A, Andrades M, Casali KR, & Schaan BD, 2019). Additionally, Little et al., 
found that postprandial glycemic excursions decreased following high-intensity interval 
training (HIIT) compared to continuous moderate-intensity exercise and control 
conditions, in 10 inactive overweight adults (Little JP, Jung ME, Wright AE, Wright W, 
& Manders JF, 2014). Lastly, Parker et al., found that 24-hour average glucose 
concentration and hyperglycemic excursions decreased following either low-volume 
high-intensity interval exercise or continuous moderate-intensity exercise in 27 
overweight or obese normoglycemic adults (Parker L, Shaw CS, Banting L, Levinger I, 
Hill KM, McAinch AJ, & Stepto NK, 2017) These studies highlight that a single bout of 
moderate-intensity aerobic exercise, HITT, and eccentric resistance exercise improve 




variability were measured in a variety of ways, including 24-hour mean glucose 
concentration, SD and %CV of the 24-hour mean glucose concentration, and postprandial 
glycemic excursions. Therefore, in normal weight and overweight or obese adults, a 
single bout of exercise or single session of repeated bouts of exercise, regardless of 
modality or duration, potentially provides beneficial and lasting effects on 24-hour 
glycemic control and glycemic variability. 
Even though observable effects of a single bout or repeated bouts of exercise on 
glycemic control and glycemic variability in adults have been found, the effects on those 
with diagnosed glycemic dysfunction may be of greater importance. The ability to 
improve glycemic control and glycemic variability with exercise in those who rely on 
lifestyle self-management techniques to control their glucose levels, such as adults 
diagnosed with type 1 diabetes, potentially has profound implications. Previous research 
under free-living or clinic-based conditions have found that increasing structured physical 
activity, or exercise, may have differential effects on glycemic control and glycemic 
variability, depending on type of exercise, in type 1 diabetic adults (Manohar C, Levine 
JA, Nandy DK, Saad A, Man CD, McCrady-Spitzer SK, Basu R, Cobelli C, Carter RE, 
Basu A, & Kudva YC, 2012; van Dijk J-W, Eijsvogels TM, Nyakayiru J, Schreuder 
THA, Hopman MT, Thijssen DH, & van Loon LJC, 2016). In turn, there are mixed 
findings, as one study noted differential changes in free-living glycemic control or 
glycemic variability following repeated bouts of exercise, while clinic-based exercise 
influenced glycemic control and glycemic variability in type 1 diabetic adults (Manohar 
C, Levine JA, Nandy DK, Saad A, Man CD, McCrady-Spitzer SK, Basu R, Cobelli C, 




Schreuder THA, Hopman MT, Thijssen DH, & van Loon LJC, 2016). van Dijk et al., 
found that glycemic variability increased during a 4-day walking event compared to 
habitual physical activity control period in 10 type 1 diabetic adults; however, noted that  
insulin dosage decreased and total energy intake, specifically calories composed of 
carbohydrates, increased during the 4-day walking event compared to habitual physical 
activity (van Dijk J-W, Eijsvogels TM, Nyakayiru J, Schreuder THA, Hopman MT, 
Thijssen DH, & van Loon LJC, 2016). Yet, under controlled clinic-based assessment, 
Manohar et al., found that intermittent bouts of low-volume and low-intensity walking 
decreased post-meal glucose area under the curve and glycemic excursions compared to 
inactivity in 12 healthy control and 12 type 1 diabetic adults (Manohar C, Levine JA, 
Nandy DK, Saad A, Man CD, McCrady-Spitzer SK, Basu R, Cobelli C, Carter RE, Basu 
A, & Kudva YC, 2012). Therefore, alterations in insulin dosage and energy intake in a 
free-living condition may limit the impact of increased energy expenditure and exercise 
on glycemic control and glycemic variability in type 1 diabetics that may not be 
accounted for under clinic-based assessment. Additionally, free-living assessment may be 
more pertinent than clinic-based assessment as adults diagnosed with type 1 diabetes rely 
more heavily on lifestyle management techniques compared to non-diabetic and non-
insulin-treated type 2 diabetic adults to control their blood glucose concentrations. 
As previously highlighted, a single bout or repeated bouts of exercise have been 
shown to improve overall glycemic health, including glucose concentrations, glycemic 
excursions, and glycemic variability in healthy weight, overweight or obese adults, as 
well as adults diagnosed with type 1 diabetes. However, the most prevalent population 




variability are adults diagnosed with type 2 diabetes (Colberg SR, Sigal RJ, Fernhall B, 
Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, & Braun B, 
2010). Previous evidence in adults diagnosed with impaired glucose tolerance and type 2 
diabetes, whether insulin-treated or non-insulin treated, suggests improvements in 
glycemic control and glycemic variability regardless of modality of exercise (Praet SF, 
Manders RJ, Lieverse AG, Kuipers H, Stehouwer CD, Keizer HA, & van Loon LJ, 2006; 
Figueira FR, Umpierre D, Casali KR, Tetelbom PS, Henn NT, Ribeiro JP, & Schaan BD, 
2013; van Dijk J-W, Manders RJF, Canfora EE, Van Mechelen W, Hartgens F, 
Stehouwer CDA, & van Loon LJC, 2013; Farabi SS, Carley DW, Smith D, & Quinn L, 
2015). Farabi et al., found that in adults with impaired glucose tolerance or type 2 
diabetes, a single 30-minute bout or moderate-intensity exercise significantly and 
differentially decreased diurnal CONGA-1 when compared to pre-exercise values and 
change values compared to non-diabetic adults (Farabi SS, Carley DW, Smith D, & 
Quinn L, 2015). van Dijk et al., noted decreased CONGA-1, CONGA-2, and CONGA-4 
following a single bout of 45-60 minutes moderate-intensity aerobic exercise in 60 non-
insulin and insulin-treated type 2 diabetic adults (van Dijk J-W, Manders RJF, Canfora 
EE, Van Mechelen W, Hartgens F, Stehouwer CDA, & van Loon LJC, 2013). 
Additionally, Praet et al., observed decreases in hyperglycemic excursions following a 
single session of low-weight/high-volume resistance exercise, which incorporated upper- 
and lower-body, as well as abdominal exercise in 11 insulin-treated type 2 diabetic adults 
(Praet SF, Manders RJ, Lieverse AG, Kuipers H, Stehouwer CD, Keizer HA, & van Loon 
LJ, 2006). However, Figueira et al., found that despite comparable decreases in glucose 




aerobic exercise or combined aerobic plus whole-body resistance exercise, there were no 
changes in 24-hour glucose variance or %CV following either exercise modality in 14 
type 2 diabetic adults (Figueira FR, Umpierre D, Casali KR, Tetelbom PS, Henn NT, 
Ribeiro JP, & Schaan BD, 2013). Therefore, findings from these studies varied based on 
glycemic control and glycemic variability evaluation method, which suggested changes 
in only intra-day, but not inter-day, glycemic control and glycemic variability occurred 
following a single bout or repeated bouts of exercise. Additionally, those studies that 
presented findings extending into the subsequent day following exercise session found 
that there were no persistent changes in glycemic control or glycemic variability beyond 
the initial 24-hour period (Praet SF, Manders RJ, Lieverse AG, Kuipers H, Stehouwer 
CD, Keizer HA, & van Loon LJ, 2006; Figueira FR, Umpierre D, Casali KR, Tetelbom 
PS, Henn NT, Ribeiro JP, & Schaan BD, 2013). These studies highlight the importance 
of a single bout or repeated bouts of exercise, regardless of modality, on short-term 
glycemic control and glycemic variability in type 2 diabetic adults, which would 
potentially be the most impacted group to focus on when attempting to improve glycemic 
profiles through targeted exercise prescription. Yet, the findings indicate that glycemic 
control and glycemic variability may not persist past the subsequent 24-hour monitoring 
period, suggesting that continuous participation in exercise programs may be needed to 
implant long-term changes in glycemic control and glycemic variability in type 2 diabetic 
adults. 
Influence of Exercise Training on Glycemic Variability 
In the previous section, a single bout of exercise or repeated bouts of exercise 




metabolism, including glycemic excursions and glycemic variability that occur 
throughout the day. Even though a single bout or repeated bouts of exercise are beneficial 
for glycemic health, additional long-term adaptations and enduring improvements in 
glucose metabolism occur due to extended exercise participation. Improvements in 
glycemic control due to exercise training are primarily explained by an increase in whole-
body glucose disposal and insulin sensitivity (Scheider SH, Amorosa LF, Khachadurian 
AK, & Ruderman NB, 1984). Yet, these adaptations are reversible, and the effects of 
detraining begin within 5-10 days after cessation of exercise (Mikines KJ, Sonne B, 
Farrell PA, Tronier B, & Galbo H, 1988). Therefore, general involvement and, more 
importantly, continuation of regular exercise participation are necessary to impact long-
term glycemic health. 
Epidemiological studies have determined that regular exercise participation 
training can reduce the risk for developing non-insulin-dependent diabetes (Manson JE, 
Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS, Rosner B, Hennekens 
CH, & Speizer FE, 1991; Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett 
WC, & Hennekens CH, 1992; Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS, 
1991). Furthermore, a brief review and preliminary evidence published by Holloszy et al., 
suggested that a decline in glucose tolerance and insulin sensitivity can be prevented by 
performing regular exercise (Holloszy JO, Schultz J, Kusnierkiewicz J, Hagberg JM, & 
Ehsani AA, 1986). They also provided evidence that prolonged and frequent exercise can 
normalize glucose tolerance by decreasing insulin resistance in some individuals with 
impaired glucose tolerance. However, to date, few published studies have evaluated 




opposed to general participation in exercise. Furthermore, these studies examining the 
effects of exercise training on glycemic variability have primarily included adults 
diagnosed with type 2 diabetes. Therefore, exercise training interventions of a week or 
greater are included in this section to aid the inclusion of pertinent literature, as there are 
limited published findings (Table 4.4.). 
Despite the limited number of exercise training studies on this topic, the evidence 
remains consistent with previous literature observing the influence of a single bout of 
exercise or repeated bouts of exercise in non-diabetic, as well as type 1 and type 2 
diabetic adults. Mikus et al., suggested that even a week (7 days ) of moderate-intensity 
aerobic exercise training (~60 minutes per exercise session) positively influences 
glycemic control and glycemic variability in 13 type 2 diabetic adults, in the absence of 
alterations to traditional clinic-based assessment of glycemic health, including fasting and 
OGTT glucose concentrations (Mikus CR, Oberlin DJ, Libla J, Boyle LJ, & Thyfault JP, 
2012). Additionally, studies which incorporated extended exercise programs have found 
that alterations in glycemic control and glycemic variability may be intensity dependent 
rather than due to general participation in exercise. These studies found that high-
intensity interval exercise, including HIIT and interval walking, as opposed to low-
intensity continuous exercise may be more beneficial for glycemic control and glycemic 
variability in type 2 diabetic adults (Karstoft K, Winding K, Knudsen SH, Nielsen JS, 
Thomsen C, Pedersen BK, & Solomon TPJ, 2013; Francois ME, Durrer C, Pistawka KJ, 
Halperin FA, Chang C, & Little JP, 2017). Karstoft et al., found that CGM-assessed 
glycemic control group worsened in a non-exercise control group (n=8), while glycemic 




with no changes following 4 months of 60 minutes per day of continuous walking (n=12). 
Further, Francois et al., found that 12 weeks of prescribed HIIT, which met exercise 
prescription criteria established by the American Diabetes Association and the American 
College of Sports Medicine, decreased glycemic variability measured as SD of 24-hour 
mean glucose concentration and MAGE compared to pre-exercise training values in 53 
type 2 diabetic adults (Francois ME, Durrer C, Pistawka KJ, Halperin FA, Chang C, & 
Little JP, 2017). 
Therefore, these findings provide evidence that regular exercise participation, 
specifically high-intensity or interval exercise, has the potential to improve glycemic 
control and glycemic variability in type 2 diabetic adults. Additionally, the use of 
supervised exercise, including aerobic and resistance, or free-living walking 
interventions, support feasibility of implementation of exercise of varying modalities as a 
therapeutic for improvements in glycemic control and glycemic variability in adults 
diagnosed with type 2 diabetes. Thus, this allows for further consideration to be made for 
type 1 diabetic adults and overweight or obese, but otherwise healthy adults, to aid in the 
implementation of preventive approaches to decrements in metabolic health as opposed 
to treatment in those metabolically compromised. 
Strengths and Limitations 
Overall, there is a lack of well-documented studies that examine the relationship 
between sedentary time and physical activity with CGM-assessed glycemic control and 
glycemic variability, and even less information regarding the effect of a single bout or 
repeated bouts of exercise and chronic exercise training on these outcomes of interest. 




regarding sedentary time and physical activity with glycemic variability and compile 
evidence to delineate the gaps in the literature that need to be addressed. This review also 
reported findings of a single bout of exercise or repeated bouts of exercise and exercise 
training and their respective effects on glycemic control and glycemic variability. 
Inclusion of multiple source databases, including PubMed, Google Scholar, Web of 
Science, BioMed Central, CINAHL, and SCOPUS up until December 2019 was another 
strength. Additionally, a variety of search terms for each outcome variable of interest 
were utilized. 
There are several limitations to this study. The first was incorporation of 
subjectively assessed, in addition to objectively assessed, sedentary time and physical 
activity, as subjectively assessed sedentary time and physical activity often lack not only 
validity and reliability, but also reproducibility (Prince SA, Adamo KB, Hamel ME, 
Hardt J, Gorber SC, & Tremblay M, 2008). Additionally, primarily compiling articles 
utilizing CGM assessed glycemic variability is another limitation, as additional measures 
of glycemic control and glycemic variability exist. Yet, the accuracy of CGM 
measurements have been validated with clinical measures, such as venous blood 
sampling and allow for assessment of free-living glycemic control and glycemic 
variability (Akintola AA, Noordam R, Jansen SW, de Craen AJ, Ballieux BE, Cobbaert 
CM, Mooijaart SP, Pijl H, Westendorp RG, & van Heemst D, 2015). Lastly, the inclusion 
of a variety of populations is a limitation but allows for meaningful observations as to 
how sedentary time and physical activity relate to glycemic control and glycemic 




repeated bouts of exercise, or exercise training on glycemic control on glycemic 
variability. 
With these strengths and limitations in mind, future studies should potentially 
focus on increasing both exercise and non-exercise related physical activity, as well as 
selecting and employing an appropriate volume of exercise depending on the population 
in question. Further, other exercise characteristics, such as frequency and intensity may 
be utilized to tailor exercise interventions to match individual preferences and abilities in 
addition to targeting beneficial changes in glycemic control and glycemic variability. 
Therefore, practitioners should encourage participants to decrease sedentary behavior and 
increase physical activity throughout the day, as well as to implement exercise, regardless 
of modality, into their everyday life to improve cardiometabolic health outcomes, 
specifically long-term glycemic control and glycemic variability. 
CONCLUSION 
Although physical activity and exercise are important treatment strategies to 
improve long-term glycemic control, the relationship between sedentary time and 
physical activity, and the impact of exercise on free-living glycemic control and glycemic 
variability remains largely unexplored. The introduction and advancement of CGM 
technology enables researchers and practitioners to assess, as well as evaluate how 
lifestyle factors impact glycemic health in a free-living environment. As evidenced in this 
review, the current literature utilizing CGM technology has demonstrated that potential 
relationships exist between glycemic control and glycemic variability with habitual 
sedentary time and physical activity. Further, this review found that a single bout of 




impact glycemic control and glycemic variability immediately following exercise, 
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Table 4.1. provides frequently used measurements of glycemic variability, 
which includes calculation definition of each glycemic variability 
measurement with further consideration for strengths and limitations of each 








































Table 4.2. Relationship between sedentary behavior and physical 
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Table 4.2. presents studies that provided information regarding the 
association between sedentary time and physical activity with glycemic 
control and glycemic variability in non-diabetic, as well as type 1 and type 
2 diabetic adults. The table includes: 1) author information; 2) study design; 
3) findings related to the association between sedentary time and physical 
activity with glycemic control and glycemic variability; 4) conclusions 
derived from the findings between the relationship between sedentary time 
and physical activity with glycemic control and glycemic variability; 5) 












































Table 4.3. Influence of a single bout of exercise or repeated bouts of exercise on 
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Table 4.3. presents studies that provided information regarding the influence of a 
single bout of exercise or following repeated bouts of exercise on glycemic control 
and glycemic variability in non-diabetic, as well as type 1 and type 2 diabetic adults. 
The table includes: 1) author information; 2) study design; 3) findings related to the 
alterations in glycemic control and glycemic variability; 4) conclusions derived from 
the findings on changes in glycemic control and glycemic variability; 5) strength and 
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Table 4.4. presents studies that provided information regarding the influence 
of exercise training on glycemic control and glycemic variability in type 2 
diabetic adults. The table includes: 1) author information; 2) study design; 3) 
findings related to the alterations in glycemic control and glycemic 
variability; 4) conclusions derived from the findings on changes in glycemic 
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Introduction: Overweight or obese adults have a higher risk for the development of 
cardiometabolic disorders. Glycemic variability acts as a more sensitive analysis of 
glycemic health compared to other clinical measures. Oxidative stress plays a key role in 
the development of cardiovascular disease. Decreased sedentary time and increased 
physical activity (PA) reduce the risk of cardiometabolic diseases. The purpose of this 
study was to examine the relationship between sedentary time and PA measures with 
glycemic variability and oxidative stress in overweight or obese adults. 
Methods: Adults (n=28; BMI=32.3±6.3 kg/m2) completed 7-day accelerometer and 
continuous glucose monitor (CGM) monitoring. Time spent sedentary and performing 
light- (LPA), moderate-to-vigorous-intensity (MVPA), and total PA, as well as associated 
energy expenditure (EE) were measured using a Sensewear Mini Armband. The average 
daily sedentary time, PA minutes, and PA EE per day were calculated. The standard 
deviation (SD) across all days for these PA variables were used to indicate the 
consistency of PA across days. The 24-hour glycemic variability was calculated as mean 
amplitude of glycemic excursion (MAGE), continuous overlapping net glycemic action 
of 1-hour, 2-hour, and 4-hour (CONGA-1, -2, and -4) and mean of daily differences 
(MODD). After a 12-hour fast, a blood sample was collected on either the first or last day 
of the monitoring period and concentrations of nitric oxide and myeloperoxidase were 
measured, and the oxidative stress ratio was calculated as nitric oxide 
concentration÷myeloperoxidase concentration. Pearson product correlations between 
measures of sedentary time and PA, glucose concentrations, glycemic variability, and 




Results: MVPA was negatively correlated with diurnal glucose concentration (r=-0.42, 
p=0.03), while total PA was negatively correlated with 24-hour mean glucose (r=-0.41, 
p=0.04). LPA EE was negatively correlated with fasting glucose concentration (r=-0.41, 
p=0.03) and diurnal glucose concentration (r=-0.41, p=0.03), while LPA and MVPA EE 
were negatively correlated with diurnal glucose concentration (r=-0.42, p=0.03; r=-0.41, 
p=0.04). Additionally, the SD across average daily LPA EE negatively correlated with 
the oxidative ratio (r=-0.39, p=0.04). Nitric oxide was positively correlated with fasting 
glucose concentration (r=0.47, p=0.01), while myeloperoxidase was negatively correlated 
with fasting glucose concentration (r=-0.41, p=0.03), MAGE (r=-0.46; p=0.02), 
CONGA-2 (r=-0.39, p=0.04), and CONGA-4 (r=-0.38, p=0.04). After adjustment for age, 
BMI, and/or time spent sedentary and performing PA, myeloperoxidase continued to be 
negatively correlated with fasting glucose concentration and MAGE. 
Conclusion: PA of varying intensities, regardless of PA consistency, may impact 
glycemic health. The relationship between glycemic variability and oxidative stress may 
be more pertinent when evaluating cardiometabolic health, rather than the relationship 





The prevalence of adults in the United States classified as overweight or obese 
continues to increase, with ~40% designated obese in 2015-2016, and is widely 
considered a major public health crisis of the current generation (Flegal MF, Kruszon-
Moran D, Carroll MD, Fryar CD, & Ogden CL, 2016; Hales CM, Carroll MD, Fryar CD, 
& Ogden CL, 2017). Overweight or obese adults are at an increased risk for the 
development of type 2 diabetes mellitus and cardiovascular disease (National Institutes of 
Health 1998; National Institutes of Health 2013; Centers for Disease Control and 
Prevention 2017). Further, overweight or obesity-related cardiometabolic disorders may 
lead to increased medical care cost to prevent or treat potential preventable disorders, 
such as impaired glycemic health or cardiovascular disease risk factors (Bray GA 2004; 
O’donovan G, Kearney EM, Nevill AM, Woolf-May K, & Bird SR, 2005).  
It is suggested that overweight and obesity may not directly translate to increased 
risk of cardiovascular disease, rather it may be the interaction of obesity-related insulin 
resistance causing pathophysiological changes in the cardiovascular system that lead to 
cardiovascular disease (Reaven G 2005). Further, oxidative stress increases the risk for 
development of cardiovascular disease and has been shown to be elevated in overweight 
and obesity (Alberti K & Zimmet PZ, 1998; Amirkhizi F, Siassi F, Minaie S, Djalali M, 
Rahimi A, & Chamari M, 2007; Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, 
Di Rosa G, Gitto E, & Arrigo T, 2015). When an imbalance between accumulation and 
detoxification of reactive oxygen species arises, an induction of oxidative stress occurs, 
resulting in vascular endothelium-related vasoconstriction (Wu JQ, Kosten TR, & Zhang 




F, Altavilla D, & Bitto A, 2017). Hyperglycemia has been mechanistically related to 
increased production of oxidative stress, as increases in glucose concentrations are a 
known cause of enhanced free radical activation and elevated reactive oxygen species 
(Ceriello A 2000). 
Additionally, glycemic variability has been utilized to determine glycemic 
control, including glucose excursions, and potentially acts as a more sensitive analysis of 
glycemic health compared to clinical assessments (Monnier L, Colette C, & Owens DR, 
2008). Frequent or exacerbated fluctuations of glucose concentrations may contribute to 
deleterious complications linked to impaired glucose metabolism, and has been found to 
be increased in overweight or obese adults (Wang S, Lv L, Yang Y, Chen D, Liu G, Chen 
L, Song Y, He L, Li X, Tian H, Jia W, & Ran X, 2012; Satya Krishna SV, Kota SK, & 
Modi KD, 2013; Salkind SJ, Huizenga R, Fonda SJ, Walker MS, & Vigersky RA, 2014; 
Suh S & Kim JH, 2015). Furthermore, glycemic variability has also been found to be 
positively associated with oxidative stress in type 2 diabetes mellitus (Taniyama Y & 
Griendling KK, 2003; Monnier L, Mas E, & Ginet C, 2006; Rodrigues R, de Medeiros 
LA, Cunha LM, Garrote-Filho MDS, Bernardino Neto M, Jorge PT, Resende ES, & 
Penha-Silva N, 2018). As technology has continued to advance, free-living glycemic 
variability assessment has become a minimally invasive procedure utilizing continuous 
glucose monitoring (CGM). 
Overweight or obese adults tend to spend more time being sedentary and less time 
performing physical activity (PA) than healthy weight adults (Tudor-Locke C, Brashear 
MM, Johnson WD, & Katzmarzyk PT, 2010; Ortega FB, Artero EG, Jiménez-Pavón D, 




of any intensity is beneficial for cardiometabolic health, including decreases in body 
mass index (BMI), dyslipidemia, and fasting glucose concentrations (Chan CB, Ryan 
DAJ, & Tudor-Locke CT, 2004; Van Gaal FL & Maggioni AP, 2013; Wing RR, Bolin P, 
Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland 
MA, Evans M, & The Look AHEAD Research Group, 2013). 
Objectively-measured sedentary time, light-intensity PA (LPA), and moderate-to-
vigorous-intensity PA (MVPA) are each independently associated with 2-hour glucose 
concentration in overweight adults not diagnosed with type 2 diabetes mellitus (Healy 
GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, & Owen N, 2007). Yet, no 
study has reported sedentary time and PA of varying intensities with glycemic variability. 
Additionally, subjectively evaluated light-intensity, high-intensity, and total leisure-time 
PA were associated with high antioxidant enzyme activity, which decreases oxidative 
stress (Covas M-I, Elosua R, Fitό M, Alcántara M, Coca L, & Marrugat J, 2002). 
However, whether these associations exist using objectively measured sedentary time and 
PA are unclear. 
Therefore, the purpose of this study was to examine the associations of time spent 
sedentary time and performing PA and related PA energy expenditure (EE) with 
measures of glycemic variability and biological markers of oxidative stress in sedentary, 
overweight or obese adults. The overarching hypothesis was that less time spent 
sedentary time and more time performing PA of any intensity would be associated with 
better measures of glycemic variability and oxidative stress. A secondary hypothesis was 






Data were obtained from the Weight Outlooks by Restriction of Diet and Sleep 
(WORDS; NCT: 02413866) and Aerobic Treadmill Exercise and Metabolism (A-TEAM; 
NCT: 03162991) studies. The WORDS study openly recruited from January 2015 to 
October 2016, while the A-TEAM study openly recruited from October 2017 to 
December 2018. The WORDS study was designed to examine the effects of chronic 
moderate sleep restriction on body composition in individuals undergoing a hypocaloric 
dietary weight loss program (Wang X, Sparks JR, Bowyer KP, & Youngstedt SD, 2018). 
The A-TEAM study was designed to examine the effects of a moderate-intensity aerobic 
treadmill-based exercise intervention on glucose concentrations utilizing CGM 
technology in sedentary, overweight or obese adults. Study protocols were approved by 
the University of South Carolina Institutional Review Board and all participants signed 
an informed consent form prior to participation. There were no repeat participants 
between the two studies. The present study includes 28 participants that had valid CGM 
and PA data, as well as fasting blood samples available for analysis at baseline, prior to 
either study’s intervention. All participant visits and testing were completed by the same 
trained research staff and took place in the Clinical Exercise Research Center (CERC) 
housed within the Norman J. Arnold School of Public Health at the University of South 
Carolina. 
Participants 
Both the WORDS and A-TEAM studies had similar inclusion and exclusion 
criteria with the WORDS study criteria previously described (Wang X, Sparks JR, 




(reported ˂120 minutes of resistance or endurance exercise per week during the previous 
3 months), overweight or obese (25≤BMI≤40 kg/m2) males and females, age 35-55 years, 
weight stable (±2%) during the previous 3 months, and females were eumenorrheic or 
post-menopausal for ≥1 year. Exclusion criteria included any self-reported medical 
conditions such as diabetes, cardiovascular diseases, chronic or recurrent respiratory 
conditions (e.g. uncontrolled asthma or chronic obstructive pulmonary disease), active 
cancer, and eating or neurological disorders, medications that affect metabolism (e.g. 
thyroid medications, statins), psychological issues, including but not limited to untreated 
depression and attention deficit disorder, excessive caffeine use (>500 mg/day), smoking 
during the past year, pregnant or lactating females, and/or unwillingness to provide 
informed consent. 
Measurements 
Height, Body Weight, and Body Mass Index (BMI) 
Height and body weight were measured at the first baseline visit using a 
stadiometer and an electronic scale that was calibrated annually (CC Vaughan & Sons, 
Incorporated, Columbia, SC). BMI was calculated using the following calculation: BMI 
(kg/m2) = Body Weight (kg) ÷ [Height (m)]2. 
Sedentary Time and Physical Activity Measures 
At the first baseline visit, participants reported to the CERC and were trained on 
use of the SenseWear Mini Armband device (BodyMedia®, Pittsburgh, PA), which was 
initially placed by trained research staff on the posterior aspect of the left arm at the mid-
point between the olecranon and acromion processes. The SenseWear device provides 




energy expenditure compared to the doubly labeled water method (Johannsen DL, 
Calabro MA, Stewart J, Franke W, Rood JC, & Welk GJ, 2010) and more accurate than 
the standard World Health Organization Global Physical Activity Questionnaire for 
estimating PA (Laermans M, Dons E, Avila-Palencia I, Carrasco-Turigas G, Orjuela JP, 
Anaya E, Brand C, Cole-Hunter T, de Nazelle A, Götschi T, Kahlmeier S, 
Nieuwenhuijsen M, Standaert A, Boever PD, & Panis LI, 2017). Participants wore the 
device for 7 consecutive days, before either study intervention, and were instructed to 
maintain their normal daily routine during monitoring. Participants recorded when they 
removed the device for any activities that required water-based activities, such as 
showering/bathing or swimming over the 7-day monitoring period. On the final day of 
the 7-day monitoring period, participants reported back to the CERC for their second 
baseline visit and returned the SenseWear device. Data were considered valid for analysis 
if participants wore the monitor for at least 5 days including at least one weekend day, 
with a minimum wear time of 20 hours each day. 
Sedentary time and PA measures were assessed utilizing manufacture provided 
software (BodyMedia® Sensewear Version 7.0). Sedentary time was established as 
activity <1.5 metabolic equivalents (METs) (excluding sleep time), and time spent 
performing LPA as 1.5 to <3.0 METs, MVPA as ≥3.0 METs, and total PA as ≥1.5 METs. 
In addition to sedentary time and time spent performing PA of varying intensities, EE for 
LPA (≥1.5 METs) and MVPA (≥3.0 METs) were obtained. Sedentary time and time 
spent performing PA of varying intensity, LPA EE, and MVPA EE were obtained for 
each valid day of wear time and the average of those days were calculated. Additionally, 




were calculated as a measure of day-to-day variability. Estimated PA time and EE during 
non-wear times was excluded from analysis. 
CGM-Assessed Glucose Concentrations and Glycemic Variability 
A CGM device (Dexcom G4 Platinum Professional, San Diego, CA, USA) was 
used to assess interstitial glucose concentrations throughout the same 7 consecutive days 
as the SenseWear Mini Armband device monitoring. At the first baseline visit 
participants reported to the CERC for placement and instruction of use for the CGM 
device by trained research staff. Participants had a catheter inserted under the skin on the 
preferred side of the abdomen with an attached sensor and transmitter, approximately 2 
cm to the side of the umbilicus. They were instructed to carry a recording device which 
received and stored interstitial glucose concentration readings every 5 minutes over the 7 
days. This specific CGM device model requires participants to manually perform a 
capillary blood measurement by fingerstick using a provided glucometer twice a day 
during days of wear per manufacture instructions. Participants were instructed on how to 
perform a capillary blood measurement and enter the glucometer readings into the CGM 
device. The Dexcom G4 Platinum Professional CGM device has been validated and 
proven accurate against directly evaluated blood glucose concentrations (Facchinetti A, 
Favero SD, Sparacubi G, & Cobelli C, 2015). The CGM device was blinded so that 
participants could not observe the live readings to deter any alterations in diet, PA, or 
general lifestyle, and participants were requested to maintain their normal daily routine 
during the 7-day monitoring period. On the final day of the 7-day monitoring period, 
participants reported back to the CERC for their second baseline visit and the CGM 




device for at least 5 days including at least one weekend day, with a minimum available 
glucose measure over 20 hours each day. 
Software provided by the manufacturer (Dexcom Studio 12.0.4.6) was used to 
download and export CGM data. 24-hour mean, diurnal, and nocturnal glucose 
concentrations were calculated for each valid day and expressed as the average of those 
valid days. 24-hour mean glucose concentration was assessed from midnight to midnight 
for each valid day. Diurnal and nocturnal glucose concentrations were assessed each 
valid day during each participant’s self-reported time-in-bed and time-out of-bed. The 
continuous overlapping net glycemic action over 1, 2, and 4 hours (CONGA-1, CONGA-
2, and CONGA-4) was calculated manually in Excel, while the mean amplitude of 
glycemic excursion (MAGE) and mean of daily differences (MODD) measures of 
glycemic variability was calculated using EasyGV Version 9.0.R2 (University of Oxford, 
Oxford, England, UK), which is an Excel-enabled workbook that utilizes macros. MAGE 
was calculated for each participant by taking the arithmetic mean of increased or 
decreased glucose concentrations (nadirs and peaks or vice-versa) when both ascending 
and descending concentration exceeds one SD from the 24-hour mean glucose 
concentration for the same 24-hour monitoring period (Service FJ, Molnar GD, Rosevear 
JW, Ackerman E, Gatewood LC, & Taylor WF, 1970; Service FJ & Nelson RJ, 1980; 
Service FJ, O’Brien PC, & Rizza RA, 1987). CONGA-1, CONGA-2, and CONGA-4 
were calculated as the SD of the differences between each observation and the previous 
1-hour, 2-hour, and 4-hour observations (McDonnell CM, Donath SM, Vidmar SI, 
Werther GA, & Cameron FJ, 2005; Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld 




Heine RJ, & Nathan DM, 2011). CONGA-1, CONGA-2, and CONGA-4 were chosen for 
this study because the 1-hour, 2-hour, and 4-hour time periods approximate the time 
intervals between different activities (CONGA-1), time between snacks (CONGA-2), and 
time between meals (CONGA-4), respectively (McDonnell CM, Donath SM, Vidmar SI, 
Werther GA, & Cameron FJ, 2005). MODD accounts for the mean of absolute 
differences between glucose concentrations obtained at exactly the same time of day on 
consecutive days and has been highly correlated with the SD for between day variability 
(Rodbard D, Matsubara B, Nakamura K, Bailey T, Jovanovic L, Zisser H, Kaplan R, & 
Garg SR, 2008). MAGE and CONGA-1, CONGA-2, and CONGA-4 were utilized as 
measurements of within-day glycemic variability for each valid day of wear time and 
averages of those days calculated, while MODD was utilized as a measurement of 
between-day glycemic variability for all valid days combined. 
Venous Blood Sample Collection 
For the WORDS study, participants reported to the CERC and had a fasting blood 
sample collected following a minimum of a 12-hour fast (not including water) at the first 
baseline visit (day 1). Fasting blood samples were collected into a BD Vacutainer serum 
collection tube, allowed to clot for approximately 30 minutes, and then centrifuged at 
3000 rpm at 4ºC for 20 minutes. For the A-TEAM study, participants reported to the 
CERC following a minimum of a 12-hour fast (not including water) at the second 
baseline visit (day 7) and had a blood sample collected into a BD Vacutainer EDTA 
plasma collection tube, which was immediately centrifuged at 3000 rpm at 4ºC for 20 
minutes. Serum separated after centrifugation was aliquoted and stored at -80ºC until all 




samples were thawed and re-centrifuged at 3000 rpm and 4ºC for 20 minutes to ensure 
separation of any particulate. 
Fasting Glucose Measurement 
A YSI 2300 STAT Plus (YSI Life Sciences, Yellow Spring, OH), which was 
calibrated according to manufacture instruction prior to analysis, was used to analyze 
serum glucose. The time of blood sample collection was recorded and matched with the 
CGM to establish the fasting glucose time point. If the fasting blood sample time point 
fell between CGM glucose concentration readings, as the CGM assesses glucose 
concentrations every 5 minutes, the average between the previous and following CGM 
concentration readings was calculated. The CGM-assessed glucose concentrations have 
been validated with venous blood glucose concentrations, which maintained an accuracy 
rate between 95-99% during periods of euglycemia (Kovatchev B, Anderson S, 
Heinemann L, & Clarke W, 2008). 
Biological Markers of Oxidative Stress 
Fasting venous blood samples were used to measure biological markers of 
oxidative stress. Two biological markers of oxidative stress, nitric oxide, which acts as a 
potent vasodilator (Palmer RMJ, Ashton DS, & Moncada S, 1988), and myeloperoxidase, 
a potent vasoconstrictor (Klebanoff SJ 2005), were measured using two separate enzyme-
linked immunoabsorbant assays (ELISA). The nitric oxide ELISA kit (ThermoFisher 
Scientific, Waltham, MA) quantitatively determines the concentrations of nitrate and 
nitrite, with ≥90% sample recovery rate, in serum and plasma samples. The 
myeloperoxidase ELISA kit (Eagle Biosciences, Inc., Nashua, NH) quantifies 




epitopes of myeloperoxidase. However, myeloperoxidase concentrations have been 
observed to be lower in plasma compared to serum based on previous tests performed by 
the manufacturer. The oxidative stress ratio was calculated by the concentration of nitric 
oxide divided by the concentration of myeloperoxidase to examine balance between 
vasodilation (nitric oxide) and vasoconstriction (myeloperoxidase). All assays were 
performed and analyzed on the same day by the same trained research staff with an intra-
assay variability of <10%. 
Statistical Analysis 
Statistical analysis was performed using SAS version 9.4 (Cary, NC). Participant 
characteristics were calculated and reported as mean and SD as a combined sample and 
for each study. Descriptive statistics were calculated for sedentary time and PA of 
varying intensity, measures of glycemic variability, and biological markers of oxidative 
stress. Participant characteristics for each study were compared utilizing independent 
sample t-tests, or chi-square test when necessary, to determine whether any variables 
were different between the two studies. Pearson product correlations were performed to 
examine the associations between sedentary time and PA measures, fasting and CGM 
glucose concentrations, glycemic variability, and biological markers of oxidative stress. 
Furthermore, the relationship between glucose concentrations, glycemic variability 
measures, and biological markers of oxidative stress with the day-to-day variability in 
sedentary time and PA measures, expressed as SD, was examined. Effect size 
correlations were based upon standards set at r=0.1 (-0.1), 0.3 (-0.3), or 0.5 (-0.5), 
representing a small, medium, or large effect size correlation, respectively (Cohen J, 




to determine their influence on the relationship between the outcome variables of interest. 
Additionally, as time spent sedentary or performing varying intensities of PA were 
primary outcomes of interest for this study, adjustments for these measures were 
performed when evaluating the relationship between measures of glycemic variability 




Participant characteristics are shown in Table 5.1 for all participants and 
separately for the WORDS and A-TEAM studies. Overall, participants were 
approximately 70% female and 57% African American with 54% considered obese (BMI 
≥30 kg/m2). Between the studies, participants only differed in the oxidative stress ratio 
(p=0.03), but did not differ for any participant characteristic, anthropometric, PA, glucose 
concentration, glycemic variability measurements, or concentration of oxidative stress 
biological markers (p≥0.05; Table 5.1.).  
Association between Sedentary Time and Physical Activity Measures with Glucose 
Concentrations, Measure of Glycemic variability, and Biological Markers of 
Oxidative Stress 
The correlation between sedentary time and PA measures with glucose 
concentrations, measures of glycemic variability, and biological markers of oxidative 
stress are shown in Table 5.2. We observed negative correlations between LPA EE and 
fasting and diurnal glucose concentrations, MVPA minutes and EE with diurnal glucose 
concentration, and total PA minutes with 24-hour mean glucose concentration. In 
addition, several other negative correlations between PA variables and glucose 




value>0.30), although statistically not significant (0.05<p<0.10), such as LPA and 
MVPA minutes and EE with 24-hour mean glucose (0.05<p≤0.07 for all). 
Following adjustment for age alone, negative correlations remained between LPA 
EE and MVPA minutes and EE with diurnal glucose concentration, while negative 
correlations between MVPA minutes and 24-hour mean glucose concentrations were 
found (p<0.05 for all). However, after adjusting for BMI alone, all prior significant 
correlations were no longer significant (p≥0.05 for all). Though, after adjustment for age 
and BMI combined, LPA EE was found to be negatively correlated with diurnal glucose 
concentrations (r=-0.43, p=0.04). 
There were no significant correlations between sedentary time or any PA measure 
with any glycemic variability measure (Table 5.2.). However, there were medium effect 
size negative correlations between minutes of LPA and total PA with MAGE and 
CONGA-4, while LPA EE also expressed a medium effect size negative correlation with 
MAGE and CONGA-2 (0.31≤absolute r≤0.33, 0.10≤p≤0.14 for all).  Yet, there were no 
significant correlations between sedentary time and PA measures with concentrations of 
nitric oxide or myeloperoxidase, which persisted after adjustment for age and/or BMI 
(p≥0.06 for all). 
We further examined the day-today variability in sedentary time and PA measures 
expressed as the SD across valid SenseWear monitoring days with glucose 
concentrations, glycemic variability, and oxidative stress, which is shown in table 5.3. 
Interestingly, there were significant negative correlations between the SD of MVPA and 
total PA minutes, as well as LPA and MVPA EE, with 24-hour mean, diurnal, and 




medium effect size correlations between the SD of MVPA minutes, LPA and MVPA EE 
with MODD were observed, which persisted following adjustment for age and/or BMI 
(absolute r≥0.30 for all). However, there was a significant negative correlation between 
SD of LPA EE with the oxidative stress ratio (r=-0.39, p=0.04). 
Association between Glucose concentrations and Measures of Glycemic Variability 
with Biological Markers of Oxidative Stress 
Correlations between glucose concentrations and measures of glycemic variability 
with biological markers of oxidative stress are shown in Table 5.4. When examining the 
relationship between glucose concentrations with biological markers of oxidative stress, 
nitric oxide concentration and the oxidative stress ratio were found to be positively 
correlated with fasting glucose concentration, which persisted after adjustment for age or 
BMI (p≤0.04 for both), but no longer significant following adjustment for age and BMI 
(p=0.07). Myeloperoxidase concentration was found to be negatively correlated with 
fasting glucose concentration (r=-0.41, p=0.03), which persisted after adjustment for age 
and/or BMI (p≤0.03 for all). Further, the oxidative stress ratio positively correlated with 
fasting glucose concentration (r=0.60, p≤0.001), which persisted after adjustment for age 
and/or BMI (p≤0.004 for all).  
Furthermore, we examined the relationship between measures of glycemic 
variability and biological markers of oxidative stress and found that myeloperoxidase 
concentration was negatively correlated with MAGE, CONGA-2 and CONGA-4, which 
remained following adjustment for age and/or BMI (p≤0.02 for all). However, neither 
nitric oxide or myeloperoxidase concentrations significantly correlated with CONGA-1 




the model, the oxidative stress ratio was positively correlated with MAGE, CONGA-1, 
and CONGA-2 measures of glycemic variability (p<0.05 for all). 
Lastly, to examine the role of time spent sedentary and performing PA on the 
relationship between glucose concentrations and glycemic variability with biological 
markers of oxidative stress, adjustments for sedentary time and all intensities of PA were 
performed. Following this adjustment, nitric oxide and the oxidative stress ratio remained 
positively correlated with fasting glucose concentration (p=0.04 and 0.001, respectively), 
while myeloperoxidase remained negatively correlated with fasting glucose concentration 
(p=0.02). Moreover, a positive correlation between the oxidative stress ratio and MAGE 
presented itself (p=0.03), while myeloperoxidase remained negatively correlated with 
MAGE (p=0.01), CONGA-2 (p=0.04), and CONGA-4 (p=0.04). 
DISCUSSION 
To our knowledge, this is the first study to examine the relationship between 
objectively measured sedentary time and PA with CGM-assessed glucose concentrations 
and glycemic variability, and biological markers of oxidative stress in sedentary, 
overweight or obese adults. Notably, MVPA and total PA minutes were found to be 
negatively correlated with 24-hour mean and diurnal glucose concentrations, while LPA 
and MVPA EE were found to be negatively correlated with fasting and diurnal glucose 
concentrations, respectively. However, no significant correlations were found between 
sedentary time or PA measures with measures of glycemic variability. Yet, day-to-day 
variability in PA minutes and EE of varying intensities were significantly positively 




with the oxidative stress ratio expressed as nitric oxide concentration÷myeloperoxidase 
concentration. 
Relationship between Sedentary Time and Physical Activity with Glucose 
Concentrations, Glycemic Variability, and Oxidative Stress 
 
Impaired fasting glucose concentration and glycemic control have been observed 
during periods of decreased PA (Lipman RL, Raskin P, Love T, Triebwasser J, Lecocq 
FR, & Schnure JJ, 1972). Most previous studies examining the impact of sedentary time 
and PA measures with glycemic health have found beneficial effects of increasing PA of 
any intensity and decreasing sedentary time on varying glucose concentrations (Sardinha 
LB, Magalhães JP, Santos DA, & Júdice PB, 2017; Swindell N, Mackintosh K, McNarry 
M, Stephens JW, Sluik D, Fogelholm M, Drummen M, MacDonald I, Martinez JA, 
Handjieva-Darlenska T, Poppitt SD, Brand-Miller J, Larsen TM, Raben A, & Stratton G, 
2018). However, few studies have examined this relationship utilizing objective, 
accelerometry measured sedentary time and PA. One study examined the cross-sectional 
associations between objectively measured sedentary and PA time with cardiometabolic 
disease risk biomarkers in overweight or obese adults with type 2 diabetes and found that 
LPA minutes per day was favorably associated with fasting glucose concentration (Healy 
GN, Winkler EAH, Brakenridge CL, Reeves MM, & Eakin EG, 2015). Additionally, a 
study conducted by Hamasaki et al., examined the association between objectively 
assessed daily PA with metabolic risk factors in adults with prediabetes and untreated 
early type 2 diabetes mellitus and found that PA level was negatively associated with 
fasting glucose concentration (Hamasaki H, Noda M, Moriyama S, Yoshikawa R, 
Katsuyama H, Sako A, Mishima S, Kakei M, Ezaki O, & Yanai H, 2015). These studies 




glucose concentration; however, our study further expanded the evidence to support this 
relationship exists with 24-hour mean, diurnal, and nocturnal glucose concentrations. 
Additionally, there exists limited evidence regarding the relationship between 
objectively measured sedentary time and PA with glycemic variability. One cross-
sectional study performed by Gude et al., found that glycemic variability indices, which 
included MAGE, CONGA-1, and MODD, were not associated with subjective 
assessment of time spent sedentary or performing PA, utilizing the International Physical 
Activity Questionnaire, in adults without type 2 diabetes mellitus, regardless of 
categorized PA status, which included inactive, minimally active, and high active 
categories (Gude F, Díaz-Vidal P, Rúa-Pérez C, Alonso-Sampedro M, Fernández-Merino 
C, Rey-García J, Cadarso-Suárez C, Pazos-Couselo M, García-López JM, Gonzalez-
Quintela A, 2017). Another study performed in type 1 diabetic adults found that 
objectively assessed total PA time did not significantly correlate with glycemic 
variability assessed as the standard deviation of the 24-hour mean glucose concentration 
(Martyn-Nemeth P, Quinn L, Penckofer S, Park C, Hofer V, & Burke L, 2017). 
Therefore, these studies are in line with our findings that increases in PA and their related 
PA EE are not necessarily related to improvement in glycemic variability. However, 
though in line with our findings, the inclusion of older adults, utilization of adults with 
diagnosed type 1 and 2 diabetes, or the use of subjective assessment of time spent 
sedentary and performing PA, do not allow for direct translation of their findings to ours. 
Previous literature has expressed that decreases in sedentary time and increases in 
leisure-time PA of varying intensities relate to improvements in antioxidants known to 




Additionally, increases in sedentary behavior have been linked to decreases in 
endothelium-derived nitric oxide vasodilation (Demiot C, Dignat-George F, Fortrat JO, 
Sabatier F, Gharib C, Larina I, Gauquelin-Koch G, Hughson R, & Custaud MA, 2007). In 
our study, no measure of sedentary time or PA of any intensity were associated with 
nitric oxide or myeloperoxidase concentration, or the oxidative stress ratio. A previous 
study examined the relationship between subjective leisure-time PA EE (Met-
minutes/day) with antioxidants related to lower oxidative stress in adult females and 
found that low-intensity, high-intensity, and total-intensity PA EE were positively 
associated with antioxidant concentration (Covas M-I, Elosua R, Fitό M, Alcántara M, 
Coca L, & Marrugat J, 2002). This illustrates that PA of varying intensities may be 
related to decreases in oxidative stress; however, their study utilized subjective evaluation 
of PA which has been shown to be unreliable for reproducibility (Sallis JF & Saelens BE, 
2000), rather than objective accelerometer-based measurements, which provide a more 
valid examination of this relationship. 
Unexpectedly, increased day-to-day variability across daily average PA and EE of 
varying intensities were significantly related to decreases in glucose concentrations, as 
well as expressed medium effect size, though insignificant, relationships with MODD. 
These findings suggest that increases in day-to-day variability in PA relate to decreased 
glucose concentrations and inter-day glycemic variability. However, increases in day-to-
day PA variability related to a decrease in the oxidative stress ratio, which suggests that 
decreased variability in PA relates to lower oxidative stress. 
Most studies have primarily examined day-to-day variability to assess habitual 




outcomes related to these variability measures (Baranowski T & de Moor C, 2000). 
Additionally, previous research suggests it is difficult to account for the day-to-day 
variability in sedentary time and PA in adults, but has observed that stability or 
variability in daily PA and their subsequent associations with aspects of physical health, 
such as chronic disease and mortality, is equivocal  (Maher JP, Huh J, Intille S, Hedeker 
D, & Dunton GF, 2018). Data from the Harvard Alumni Health Study found that men, 
without major risk factors, who sporadically engaged in PA (1-2 days per week), but met 
recommended levels of PA (≥1000 kcal per week), had a lower relative risk of mortality 
compared to men who were considered inactive, but similar to those considered 
insufficiently active (500-999 kcal per week) or regularly active (≥1000 kcal per week; 
>2 days per week) (Lee IM, Sesso HD, Oguma Y, & Paffenbarger Jr RS, 2004). 
Moreover, a longitudinal study which examined insufficiently active, sporadically active, 
and regularly active participants found similar reductions in risk for all-cause and 
cardiovascular disease mortality compared to inactive participants (O’Donovan G, Lee 
IM, Hamer M, & Stamatakis E, 2017). Therefore, the stability or variability in PA may 
not directly relate to clinical implications in health outcomes associated with glycemic or 
cardiovascular health if adherence to prevailing PA guidelines are fulfilled. As the 
participants in our study were achieving on average ~65.5 minutes of MVPA per day 
during the 7 days of SenseWear wear time, it may be generally accepted they were 
meeting current PA guidelines (Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton 
JE, Galuska DA, George SM, & Olson RD, 2018) regardless of the extent of their day-to-
day PA variability. Even though there was notable day-to-day variability in sedentary 




days as opposed to increased sedentary time on others. This aids in supporting our 
findings that general participation in PA may potentially be more important for glycemic 
health, rather than PA stability. 
Relationship between Glucose Concentrations and Glycemic Variability with 
Oxidative Stress 
The relationship between glucose concentrations and glycemic variability with 
oxidative stress has been evaluated primarily in type 1 and type 2 diabetics (Saisho Y 
2014). Additionally, it has been shown that there exists long-term vascular complications 
in diabetic patients during periods of chronic hyperglycemia, as well as those with greater 
postprandial glucose fluctuations (Giugliana D, Ceriello A, & Paolisso G, 1996; Monnier 
L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P, & Colette C, 2006). However, no 
studies have examined the relationship between glucose concentrations, glycemic 
variability, and oxidative stress in sedentary, overweight or obese, but normoglycemic 
adults. 
Surprisingly, our study found that nitric oxide concentration, a potent vasodilator 
and measure of vascular health, was positively associated, rather than negatively 
associated, with fasting glucose concentration. Current evidence suggests 
contraindicatory findings when examining the relationship between fasting glucose and 
nitric oxide concentrations. It has been hypothesized that chronic hyperglycemia acts to 
uncouple receptor-mediated signal transduction and decrease availability of nitric oxide 
synthase substrates and cofactors essential for synthesis of nitric oxide (Honing MLH, 
Morrison PJ, Banga JD, Stroes ESG, & Rabelink TJ, 1998). Li et al., found that 
experimentally increased activation of the nitric oxide pathway partially contributed to 




Holman GD, & Young LH, 2004). Furthermore, Hoshiyama et al., found that 
experimentally high-level glucose exposure reduced nitrite levels and subsequently 
decreased nitric oxide production, but upregulated endothelial cell nitric oxide synthase 
protein expression (Hoshiyama M, Li B, Yao J, Harada T, Morioka T, & Oite T, 2003). 
These studies suggest that under hyperglycemic conditions, decreased nitric oxide 
production may be due to reduced nitric oxide predecessors or nitric oxide synthase 
agonists, and increased activation of nitric oxide scavengers acting to inactivate nitric 
oxide synthase activity. However, Cosentino et al., provided evidence that experimentally 
increased glucose exposure increased nitric oxide synthase and subsequent nitric oxide 
release (Cosentino F, Hishikawa K, Katusic ZS, & Lüscher TF, 1997). More recently, 
Adela et al., observed a positive relationship between fasting blood glucose and nitric 
oxide concentration in patients diagnosed with type 2 diabetes mellitus, while also 
providing evidence that experimentally high glucose exposure increases nitric oxide 
production (Adela R, Nethi SK, Bagul PK, Baui AK, Mattapally S, Kuncha M, Patra CR, 
Reddy PNC, & Banerjee SK, 2015). These findings suggest that the mechanisms by 
which high glucose concentration simultaneously increases nitric oxide synthase 
expression and production may be due to an increase in glucose-induced endothelial cell 
nitric oxide gene expression and activation related to diminished vascular function in 
those with impaired glycemic health. Based on previous findings, along with the findings 
in our study, it may be hypothesized that, even in the absence of glycemic dysfunction, 
participants with higher fasting glucose concentration may have higher activation of 
nitric oxide synthase and in turn greater nitric oxide production compared to those with 




Unexpectedly, myeloperoxidase concentration, a potent vasoconstrictor and 
measure of declined vascular health, was negatively associated with not only fasting 
glucose concentration, but MAGE, CONGA-2, and CONGA-4 measures of glycemic 
variability. The relationship between glycemic health and myeloperoxidase has been 
previously investigated but arrived at contradicting conclusions. Zhang et al., found that 
fasting glucose and myeloperoxidase concentrations were positively associated, with 
increases in glucose concentration directly relating to increases in myeloperoxidase 
concentration in non-diabetic adults with acute coronary syndrome (Zhang X, Dong L, 
Wang Q, & Xie X, 2015). However, Uchimura et al., found that fasting glucose 
concentration was higher and myeloperoxidase concentration was lower in non-insulin 
dependent type 2 diabetes mellitus compared to non-diabetic controls, but found no 
relationship between fasting glucose and myeloperoxidase concentrations (Uchimura K, 
Nagasaka A, Hayashi R, Makino M, Nagata M, Kakizawa H, Kobayashi T, Fujiwara K, 
Kato T, Iwase K, Shinohara R, Kato K, & Itoh M, 1999). Furthermore, a previous study 
in adult patients with type 2 diabetes mellitus who had either poor or optimal glycemic 
control found that those with poor glycemic control had decreased myeloperoxidase 
activity compared to those with optimal glycemic control (Unubol M, Yavasoglu I, Kacar 
F, Guney E, Omurlu IK, Ture M, Kadikoylu G, & Bolaman Z, 2015). The authors 
concluded that decreases in myeloperoxidase activity found in adults with non-insulin 
dependent type 2 diabetes mellitus may be caused by diabetic complications due to the 
altered state of free radical concentrations. Additionally, increased protein glycation in 
type 2 diabetes patients with poor glycemic control may contribute to hyperglycemic-




which may subsequently lead to decreased myeloperoxidase, as previously described 
(Brownlee M 2001; de Souza Ferreira C, Araújo TH, Ángelo ML, Pennacchi PC, Okada 
SS, de Araújo Paula FB, Migliorini S, & Rodrigues MR, 2012). Thus, our results are 
consistent with some of the literature; however, our participants were normoglycemic and 
most previous literature have suggested these findings in adults with cardiovascular 
complications or diagnosed with type 2 diabetes mellitus. 
Strengths and Limitations 
The primary strengths of this study include the use of the SenseWear Mini 
Armband accelerometer to objectively measure sedentary time and PA, as well as CGM 
technology to assess glycemic variability, which allows for the observation of a “free-
living” condition as opposed to standard clinical measures. The primary limitation is that 
the participants were from a convenience sample, which makes the results only 
generalizable to sedentary, overweight or obese individuals without overt diabetes that 
are between the ages of 35 and 55 years. Another limitation was that diet was not fully 
taken into account, as only self-report dietary intake was provided. However, we 
recommended that each participant attempt to maintain their daily dietary routines during 
the 7-day monitoring process. Alternatively, this was also considered a strength of the 
study, as not controlling for diet provides insight into each participant’s “free-living” 
glucose concentrations and glycemic variability. Other limitations include the small 
sample size, which does not allow for analysis between sexes and races that may be 
pertinent to address the relationships between outcomes of interest related to sedentary 






Our hypotheses were supported as there were significant relationships between 
MVPA and total PA minutes with diurnal and 24-hour mean glucose concentrations, LPA 
EE with fasting and diurnal glucose concentrations, and MVPA EE with diurnal glucose 
concentrations. Additionally, medium effect size correlations were found between time 
spent performing LPA and total PA with MAGE and CONGA-4 and LPA EE with 
MAGE and CONGA-2. However, no significant relationships were found between 
sedentary time or PA measures with nitric oxide or oxidative stress. Further, the SD of 
daily MVPA and total PA minutes, and LPA and MVPA EE were negatively associated 
with 24-hour, diurnal, and nocturnal glucose concentrations, while the SD of LPA EE 
was found to be negatively correlated with the oxidative stress ratio. Additionally, nitric 
oxide, myeloperoxidase, and the oxidative stress ratio were found to be associated with 
fasting glucose concentration, while myeloperoxidase was found to be associated with 
MAGE, CONGA-2, and CONGA-4. After adjustment for age and/or BMI, as well as 
time spent sedentary or performing PA, many of the relationships remained significant, 
which leads us to support our claims that sedentary time and participation in PA, 
regardless of PA consistency, play a vital role in glycemic health, while glycemic 








WORDS (n=15) A-TEAM (n=13) 
Participant 
characteristics 
   
Age (years) 46.0±6.1 45.4±6.5 46.7±5.8 
Sex (M/F) 8/20 3/12 5/8 
Race (C/AA/AAA) 11/16/1 8/7/0 3/9/1 
Height (m) 1.7±0.1 1.7±0.1 1.7±0.1 
Body Weight (kg) 92.6±21.4 93.3±12.0 91.8±29.3 
Body Mass Index 
(kg/m2) 
32.3±6.3 32.6±3.9 31.9±8.4 
Average daily 
sedentary time and 
physical activity 
measures 
   
Wear time (hours per 
day) 
23.4±0.5 23.4±0.5 23.4±0.6 
Sedentary Time 
(minutes per day) 
717.2±124.0 717.3±61.5 717.2±170.9 
LPA (minutes per 
day) 
247.0±94.7 249.5±81.9 244.3±110.2 
MVPA (minutes per 
day) 
65.5±42.2 74.6±47.0 55.7±35.6 
Total PA (minutes 
per day) 
312.5±121.8 321.1±109.3 300.0±137.4 
LPA EE (kilojoules 
per day) 
4405.9±1728.6 4958.5±2015.8 3810.7±1154.2 
MVPA EE 
(kilojoules per day) 




sedentary time and 
physical activity 
measures 
   
Sedentary Time SD 
(minutes per day) 
113.8±65.8 101.0±36.2 127.6±86.9 
LPA SD (minutes 
per day) 
61.4±29.1 59.7±29.0 63.2±30.3 
MVPA SD (minutes 
per day) 
32.5±24.3 38.9±30.5 25.6±13.2 
Total PA SD 
(minutes per day) 
74.5±36.6 73.2±35.4 75.8±39.2 
LPA EE SD 
(kilojoules per day) 




MVPA EE SD 
(kilojoules per day) 





   
CGM observations 




277.2±7.3; 96% 275.2±8.5; 95% 
Fasting (mg/dL) 89.1±18.3 84.8±19.3 94.1±16.4 
24-hour mean 
(mg/dL) 
101.2±16.7 99.4±12.1 103.0±21.0 
Diurnal (mg/dL) 101.8±16.0 99.0±11.2 104.7±20.0 
Nocturnal (mg/dL) 103.0±16.0 103.1±10.1 102.9±21.1 
MAGE (mg/dL) 43.0±12.1 40.3±12.8 45.9±11.1 
CONGA-1 (mg/dL) 19.3±5.0 18.6±5.5 20.0±4.4 
CONGA-2 (mg/dL) 23.3±6.3 22.5±6.9 24.1±5.6 
CONGA-4 (mg/dL) 25.5±6.6 24.4±7.0 26.1±6.3 
MODD (mg/dL) 19.9±4.5 19.5±4.1 20.3±4.9 
Oxidative stress 
biological markers 
   
 Nitric oxide 
(µmol/L) 
75.6±40.9 62.3±47.8 91.0±25.0 
Myeloperoxidase 
(ng/mL) 
25.2±8.2 26.8±8.7 23.2±7.6 
Oxidative stress ratio 
(µmol/L:ng/mL) 
3.3:1 2.6:1 4.2:1* 
Data presented as Mean±SD 
M=male, F=female, C=Caucasian, AA=African American, AAA=Asian/Asian 
American, PA=physical activity, LPA=light-intensity physical activity, 
MVPA=moderate-to-vigorous-intensity physical activity, LPA EE=light-intensity 
physical activity energy expenditure, MVPA EE=moderate-to-vigorous-intensity 
physical activity energy expenditure, number of observations per day (n; % of 
max)=(number of CGM observations per day/maximum observations per 
day)×100, CONGA-1, 2, and 4=continuous overall net glycemic action of 1-hour, 
2-hour, and 4-hour, MAGE=mean amplitude of glycemic excursion, 
MODD=mean of daily differences, oxidative stress ratio=nitric oxide 
concentration (µmol/L)÷myeloperoxidase concentration (ng/mL) 




Table 5.2. Pearson product correlations between average daily sedentary time 
and physical activity measures with glucose concentrations, measures of 
glycemic variability, and biological markers of oxidative stress 
  
Time spent sedentary time performing 





































































Measures of glycemic 
variability (mg/dL) 






















































































































Data represented as correlation coefficient (p value) with bolded entries 
corresponding to significant values (p<0.05) 
PA=physical activity, LPA=light-intensity physical activity, MVPA=moderate-to-
vigorous-intensity physical activity, LPA EE=light-intensity physical activity 
energy expenditure, MVPA EE=moderate-to-vigorous-intensity physical activity 
energy expenditure, METs=metabolic equivalents 





Table 5.3. Pearson product correlations between day-to-day variability, 
expressed as SD, across daily average sedentary time and physical activity 
measures with glucose concentrations, measures of glycemic variability, and 
biological markers of oxidative stress 
  
Time spent sedentary time performing 











































































Measures of glycemic 
variability (mg/dL) 






















































































































Data represented as correlation coefficient (p value) with bolded entries 
corresponding to significant values (p<0.05) 
PA=physical activity, LPA=light-intensity physical activity, MVPA=moderate-to-
vigorous-intensity physical activity, LPA EE=light-intensity physical activity 
energy expenditure, MVPA EE=moderate-to-vigorous-intensity physical activity 
energy expenditure, METs=metabolic equivalents 
*p<0.05 following adjustment for age; †p<0.05 following adjustment for BMI; 




Table 5.4. Pearson product correlations between glucose concentrations and 
measures of glycemic variability with biological markers of oxidative stress 










































Measures of glycemic 
variability (mg/dL) 





































Data represented as correlation coefficient (p value) with bolded entries 
corresponding to significant values (p<0.05) 
*p<0.05 following adjustment for age; †p<0.05 following adjustment for BMI; 
‡p<0.05 following adjustment for age and BMI; §p<0.05 following adjustment for 
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Introduction: The state of being overweight or obese leads to an increased risk of 
development of cardiometabolic disease. Increases in glycemic variability have been 
associated with greater induction of oxidative stress and decreased vascular health, which 
may be exacerbated by higher weight status and improved through exercise. The purpose 
was to examine the impact of a 12-week aerobic exercise intervention on glycemic 
variability, vascular health, and oxidative stress in overweight or obese adults. 
Methods: Eight overweight or obese adults (BMI=29.4±8.3 kg/m2; age=48.9±5.2 years; 
mean±SD) completed a 12-week aerobic exercise intervention. Participants walked 3 
times per week at moderate intensity and expended 10-12 kilocalories per kilogram of 
body weight each week. All participants wore a continuous glucose monitor (CGM) and 
completed a daily dietary intake diary for 7 consecutive days at baseline and post-
intervention. On the final day of monitoring, a fasting blood sample was collected and an 
oral glucose tolerance test (OGTT) was performed. Intra- and inter-day glycemic 
variability was assessed as the mean amplitude of glycemic excursions, continuous 
overlapping net glycemic action of 1-, 2-, and 4-hour, and the mean observation of daily 
differences. Vascular health and oxidative stress markers, plasma concentrations of nitric 
oxide and myeloperoxidase, were measured, and their ratio was calculated. 
Results: No OGTT glucose concentrations or measures of glycemic variability changed 
from baseline to post-intervention. However, myeloperoxidase concentration decreased 
(24.8±8.2 ng/mL to 16.4±4.6 ng/mL, p<0.01) and the ratio of nitric oxide concentration 




mealtime was delayed (13:30±00:40 hours to 14:00±00:39 hours, p=0.02) following the 
12-week intervention.  
Conclusion: Twelve weeks of aerobic exercise reduced oxidative stress and improved the 
ratio of nitric oxide concentration to myeloperoxidase concentration, but not glucose 






The prevalence of adults in the United States who are considered overweight or 
obese continues to rise with ~40% of the population designated obese in 2015-2016 
(Centers for Disease Control and Prevention, 2017). Obesity is widely considered a major 
public health crisis of the current generation (Finkelstein EA, Trogdon JG, Cohen JW, & 
Dietz, W, 2009; Flegal MF, Kruszon-Moran D, Carroll MD, Fryar CD, & Ogden CL, 
2016; Centers for Disease Control and Prevention, 2017). Overweight and obesity-related 
cardiometabolic disorders lead to an increased medical care cost, such as for treatment of 
impaired glycemic health and diagnosed cardiovascular disease (CVD) risk factors (Bray 
GA, 2004; O’donovan G, Kearney EM, Nevill AM, Woolf-May K, & Bird SR, 2005). 
Previous findings from a large community-based cohort study found that body 
mass index (BMI) positively correlated with circulating biological markers of oxidative 
stress (Keaney Jr JF, Larson MG, Vasan RS, Wilson PWF, Lipinska I, Corey D, Massaro 
JM, Sutherland P, Vita JA, & Benjamin EJ, 2003). Oxidative stress is preceded by an 
increased exposure to reactive oxygen species, and damage to proteins, nucleic acids, and 
cell membranes, and has been implicated in the pathogenesis related to increased CVD 
risk factors, such as impaired vascular health, and subsequent CVD (Witztum JL & 
Steinberg D, 1991; Ohara Y, Peterson TE, & Harrison DG, 1993; Stortz G & Imlay JA, 
1999; Cooke J 2004). Previously, oxidative stress was believed to be a key regulator in 
the development of diabetic complications (Baynes JW, 1991); however, evidence has 
suggested that an increase in oxidative stress is triggered by exacerbated oscillations in 
glucose concentrations (Hirsch IB & Brownlee M, 2005; Monnier L, Mas E, Ginet C, 




oscillations, known as glycemic variability, act to induce stress on the vascular 
endothelium and elicits endothelium-derived micro and macrovascular complications, 
which potentially increases CVD risk (Johnson EL 2013). In fact, the interaction between 
increased glycemic variability and elevated oxidative stress has recently been proposed as 
a mechanism for increased CVD risk and CVD progression in adults with and without 
diagnosed diabetes (Saisho Y 2014; Gorst C, Kwok CS, Aslam S, Buchan L, 
Kontopantelis E, Myint PK, Heatlie G, Loke Y, Rutter MK, & Marna MA, 2015). 
Greater glycemic variability, impaired vascular health, and increased oxidative 
stress have both been observed independently in overweight or obese adults in the 
presence and absence of diagnosed diabetes or CVD (Poirier P, Giles TD, Bray GA, 
Hong Y, Stern JS, Pi-Sunyer X, & Eckel RH, 2006; Vincent HK, Innes KE, & Vincent 
KR, 2007; Fysekidis M, Cosson E, Banu I, Duteil C, & Valensi P, 2014). Exercise is 
often utilized as a therapeutic treatment for overweight or obesity related insulin 
resistance and cardiovascular strain (Goodyear LJ & Kahn BB, 1998; Hawley JA, 2004; 
Church T, 2011). Exercise training in overweight or obese adults in the presence or 
absence of diabetes, elicits beneficial alterations in fasting glucose concentrations, 
glucose tolerance during an oral glucose tolerance test (OGTT), and glucose regulation 
during glycemic clamp procedures independent of changes in body weight or 
cardiorespiratory fitness (CRF) (Swartz AM, Strath SJ, Bassett Jr DR, Moore JB, 
Redwine BA, Groër M, & Thompson DL, 2003; Cox KL, Burke V, Morton AR, Beilin 
LJ, & Puddey IB, 2004; King DS, Dalsky GP, Clutter WE, Young DA, Staten MA, Cryer 
PE, Holloszy JO 1988). Yet, past studies have been largely limited to laboratory-based 




glucose monitor (CGM) technology allows for the inclusion of a free-living condition, 
which enables further determination as to how exercise influences glucose concentrations 
and glycemic variability throughout the day. 
Using CGM, Mikus et al. (2012), found that the frequency, magnitude, and 
duration of the number of glycemic excursions each day were decreased over the final 3 
days of a 7-day aerobic exercise training program compared to 3 days of performing 
habitual exercise in non-insulin dependent type 2 diabetes mellitus patients (Mikus CR, 
Oberlin DJ, Libla J, Boyle LJ, & Thyfault JP, 2012). Another study by Farabi et al. 
(2015) found that a single 30-minute bout of aerobic exercise reduced diurnal glycemic 
variability and urinary isoprostanes, a biological marker of oxidative stress, in obese 
adults diagnosed with type 2 diabetes mellitus or impaired glucose tolerance (Farabi SS, 
Carley DW, Smith D, & Quinn L, 2015). Thus, the majority of research examining 
glycemic variability and oxidative stress has focused on diabetic populations with even 
fewer studies examining changes due to exercise training (Tereda T, Friesen A, Chahal 
BS, Bell GJ, McCargar LJ, & Boulé NG, 2013; Van Dijk J-W, Manders RJ, Canfora EE, 
van Mechelen WV, Hartgens F, Stehouwer CD & van Loon LJC, 2015). 
Overweight or obese adults without diabetes may already have greater glycemic 
variability and oxidative stress, and impaired vascular health, but it is unknown whether 
they can be changed by exercise training in this population. Therefore, the primary 
purpose of this study was to examine glucose concentrations and glycemic variability 
using CGM in overweight or obese non-diabetic adults undergoing 12-weeks of 
moderate-intensity aerobic exercise. A secondary purpose was to evaluate the effects of 




potent vasodilator, and oxidative stress, myeloperoxidase, a potent vasoconstrictor. We 
also examined changes in body weight, CRF, and dietary intake following the aerobic 
exercise intervention, as changes in these measures may influence outcomes of interest 
(Gaesser GA, Tucker JW, Jarrett CL, Catherine L, & Angadi SS, 2015; Pronk NP, 2015). 
METHODS 
Design Overview 
The Aerobic Treadmill Exercise and Metabolism (A-TEAM; NCT: 03162991) 
study openly recruited from October 2017 to December 2018. The study protocol was 
approved by the University of South Carolina Institutional Review Board and all 
participants signed an informed consent form prior to participation. All participant visits, 
testing, and exercise sessions were completed and supervised by the same trained 
research staff and took place in the Clinical Exercise Research Center (CERC) housed 
within the Norman J. Arnold School of Public Health at the University of South Carolina. 
Participants 
Participants were not physically active (˂120 minutes of resistance or moderate-
intensity endurance exercise per week during the previous 3 months), overweight or 
obese (25≤BMI≤40 kg/m2) males and females, age 35-55 years, weight stable (±2%) 
during the previous 3 months, and, for females, eumenorrheic. Exclusion criteria included 
any self-reported medical conditions such as diabetes or taking medications that are 
known to affect metabolism (e.g. statins), CVD, chronic or recurrent respiratory 
conditions, including uncontrolled asthma or chronic obstructive pulmonary disease, or 
active cancer. Individuals self-reporting diagnosed eating or neurological disorders, and 




deficit disorder were also excluded. Additionally, excessive caffeine use (>500 mg/day), 
smoking during the past year, pregnant or lactating females, and/or unwillingness to 
provide informed consent were other reasons for exclusion. 
A total of 64 participants were initially screened by telephone (Figure 6.1.). Ten 
participants began the exercise intervention, with 8 completing the 12-week exercise 
intervention. The 2 participants who dropped-out during the intervention completed 1 and 
11, or ~3% and 30%, of the intervention visits, respectively. These participants did not 
provide specific reasons why they dropped-out and discontinued the study, as they ceased 
correspondence and were unable to be contacted to reschedule their intervention visits. 
Therefore, the 8 participants that completed the intervention were included in this 
analysis. 
Intervention 
Participants walked on treadmills 3 times per week in the CERC under 
supervision. Each week, participants had their body weight measured, which was utilized 
to calculate weekly exercise volume by multiplying each participants’ body weight by 
10-12 kilocalorie per kilogram of body weight each week (KKW). The frequency of the 
intervention visits was established as increases in exercise frequency has previously been 
shown to be a determinant of physiological responses to exercise training once 3 times 
per week have been achieved (Shephard RJ, 1968). As the participants in our study were 
not engaging in structured physical activity prior to the exercise intervention, 3 times per 
week was also chosen to limit exercise-related overuse injuries. The exercise volume was 
achieved by varying the duration, speed, and grade to reach each participants’ weekly 




was closely monitored throughout the 12-week intervention. Twelve weeks of aerobic 
exercise training has been previously studied and is considered a duration that 
physiological adaptations to aerobic exercise tend to occur (Ho SS, Dhaliwal SS, Hills 
AP, & Pal S, 2012). The prescribed training volume, 10-12 KKW, is a higher volume of 
aerobic exercise energy expenditure compared to current physical activity guidelines, 
which equates to 8 KKW (Morss GM, Jordan AN, Skinner JS, Dunn AL, Church TS, 
Earnest CP, Kampert JB, Jurca R, & Blair SN, 2004; Sisson SB, Katzmarzyk, Earnest 
CP, Bouchard C, Blair SN, & Church TS, 2009; Rosenkilde M, Reichkendler MH, 
Auerbach P, Bonne TC, Sjödin A, Ploug T, & Stallknecht BM, 2015; Piercy KL, Troiano 
RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, & Olson RD, 2018). 
To monitor adherence to the exercise prescription, the energy expenditure of each 
exercise session was calculated using the American College of Sports Medicine formula: 
{0.1×(speed[miles per hour] ×26.8)+1.8×(speed[miles per hour] 
×26.8)×grade(%)+3.5}×body weight(kg)÷5(L per minute)×time(minutes) (American 
College of Sports Medicine, 2017). 
All exercise intervention visits were completed and supervised by trained research 
staff members at the University of South Carolina. Due to the physically inactive state of 
the participants, the exercise intensity and weekly energy expenditure were gradually 
increased to reduce risk of injury. Training intensity increased during the first 4 weeks of 
the exercise intervention until the target level of 50-55% of participant’s heart rate 
reserve (HRR) was met, calculated as {[(peak heart rate-resting heart rate)×intensity (50-
55%)]+resting heart rate}, which was determined during the baseline graded exercise 




of the intervention and then progressed until week 4 when they attained their weekly 
energy expenditure of 10-12 KKW. Each exercise session began and ended with a 3-
minute warm-up and cool-down. Heart rate (HR) monitors (FT1; Polar, Lake Success, 
NY, USA) were worn to monitor exercise intensity continuously throughout each 
exercise session and HR was recorded every five minutes. If HR monitors were unable to 
detect HR, manual palpation at the radial artery was measured for 30-60 seconds. Blood 
pressure was measured before, during warm-up, at the mid-point of the exercise session, 
during cool-down, and following each exercise session. 
Compliance to prescribed exercise intervention (frequency, intensity, and 
duration) for each participant was reviewed weekly and any participant missing an 
exercise session without notifying study personnel was contacted via phone or e-mail to 
reschedule and encourage further attendance. 
Measurements and Testing 
Height, Body weight, and Body Mass Index (BMI) 
Height and body weight were measured at the first baseline and post-intervention 
visit using a stadiometer and an electronic scale that was calibrated annually (CC 
Vaughan & Sons, Incorporated, Columbia, SC). Additionally, body weight was collected 
weekly throughout the 12-week intervention. BMI was calculated at baseline and post-
intervention utilizing their respective height and body weight and the following equation: 
BMI(kg/m2)=Body Weight(kg)÷[Height(m)]2. 
Graded Exercise Test 
All participants performed a maximal graded exercise test on a treadmill at 




for these participants as it is an incremental protocol where speed and grade increase 
linearly every 30-60 seconds until each participant reached volitional fatigue (Hsia D, 
Casburi R, Pradhan A, Torres E, & Porszasz J, 2009). Volume of oxygen consumed 
(V̇O2) via metabolic cart (TrueOne 2400, ParvoMedics, Salt Lake City, UT) and HR 
using standard 12-lead electrocardiogram (Q-Stress®; Cardiac Science, Bothell, WA, 
USA) were monitored continuously during the progression of the test. Blood pressure 
was measured, and rating of perceived exertion was obtained every two-minutes during 
the test. Two of four generally recognizable criteria for the test to be considered 
satisfactory needed to be achieved: a respiratory exchange ratio ≥1.10; a rating of 
perceived exertion ≥17 on the Borg scale ranging from 6-20; achieving a maximum heart 
rate >90% age-predicted maximum HR (220-age); and/or a plateau in absolute V̇O2 ≤150 
ml/min with an increase in exercise intensity. Relative peak oxygen consumption 
(V̇O2peak; ml/kg/min) was determined by the highest 30-second average V̇O2 value 
measured during the test. All graded exercise tests took place after 12:00 hours and 
minimum of 24 hours after the final day of the CGM monitoring period. 
CGM Placement, Instruction, and Monitoring 
A Dexcom G4 Platinum Professional CGM device (San Diego, CA, USA) was 
used to assess interstitial glucose concentrations over 7 consecutive days at baseline and 
post-intervention. At the first baseline and post-intervention visit participants reported to 
the CERC for placement and instruction of use for the CGM device by trained research 
staff. At post-intervention, the CGM device was placed a minimum of 72 hours after the 
last exercise session to limit to influence of the last exercise session on glucose 




the side of the umbilicus, on the preferred side of the abdomen with an attached sensor 
and transmitter. They were instructed to carry a recording device which received and 
stored interstitial glucose concentration readings every 5 minutes over the 7 consecutive 
days. This specific CGM device model requires participants to manually perform a 
capillary blood measurement by fingerstick using a provided glucometer twice a day 
during days of wear per manufacture instructions. Participants were instructed on how to 
perform a capillary blood measurement and enter the glucometer readings into the CGM 
device. 
The Dexcom G4 Platinum Professional CGM device has been validated and 
proven accurate against directly evaluated blood glucose concentrations (Facchinetti A, 
Favero SD, Sparacubi G, & Cobelli C, 2015). The CGM device was blinded so that 
participants could not observe the live readings to deter any alterations in diet, physical 
activity, or general lifestyle, and participants were requested to maintain their normal 
daily routine during the 7-day monitoring period at baseline and post-intervention. On the 
final day of the 7-day monitoring period, participants reported back to the CERC to 
complete a 2-hour OGTT and have the device removed. Data were considered valid for 
analysis if data were obtained by the device for at least 5 days including at least one 
weekend day, with a minimum available glucose measure over 20 hours, which equated 
to a minimum 240 out of a possible 288 glucose readings each day. Software provided by 
the manufacturer (Dexcom Studio 12.0.4.6) was used to download and export CGM data 






Oral Glucose Tolerance Test (OGTT)  
 
The OGTT was conducted following an overnight fast (~12 hours other than 
water), participants reported to the CERC and had a venous blood sample collected. Time 
was recorded and matched with the CGM to establish fasting glucose time point. 
Following the venous blood collection, participants were instructed to consume a 
standard 10-ounce, 75-gram glucose infused drink (Azer Scienmtific, Morgantown, PA) 
within 5 minutes and the time consumption completed was recorded. Every 30-minutes 
afterwards, time was recorded until 2 hours were complete (Fasting, 30-, 60-, 90-, and 
120-minutes post-consumption), which is the standard procedure for a 75-gram OGTT 
(Institute for Quality and Efficiency in Healthcare, 2011). During the OGTT, participants 
were instructed to limit their physical movement, unless necessary, to lessen the impact 
of muscle contraction on glucose concentrations. Glucose concentrations during the 
OGTT were determined by the CGM device rather than from blood samples. If any of the 
time points fell between CGM glucose concentration readings, as the CGM assesses 
glucose concentrations every 5 minutes, the average between the previous and following 
CGM concentration readings were calculated. The CGM-assessed glucose concentrations 
have been validated with venous blood glucose concentrations (Kovatchev B, Anderson 
S, Heinemann L, & Clarke W, 2008). OGTT AUC was calculated utilizing the equation 
Glucose AUC=1/2×30×(yFasting+2y30+2y60+2y90+y120), where y represents glucose 
concentration at the different time points (Tai MM, 1994). All OGTTs took place 
between 06:00 and 09:00 HH:MM and at least 72 hours after the last bout of aerobic 





Daily Dietary Intake 
Daily dietary intake was recorded at baseline and post-intervention during the 
same 7 consecutive days as the CGM monitoring and all participants were instructed to 
continue their normal daily dietary routine during this time. All participants self-reported 
calorie consumption, including any calorie containing beverages or snacks and time of 
consumption for standard meals (breakfast, lunch, dinner, and snacks). In order to do this, 
they were instructed on basic measurement of portion sizes to aid in recording of each 
meal using the MyFitnessPal application (MyFitnessPal, Inc.) that is available on 
smartphone devices or computer based. If a smartphone or computer was unavailable, 
participants were provided a self-report paper form to record any calorie containing food 
or drink consumed, including portion size, calories, and macronutrient breakdown 
(carbohydrate, protein, and fat) utilizing The Calorie King® Calorie Counter (Borushek 
A, 2015). Calorie intake, macronutrient breakdown, and time of consumption were 
calculated for each standard meal and the total of each day’s standard meals was 
calculated for each valid recording day, which was analyzed as an average of those valid 
days. Additionally, the standard deviation (SD) of daily dietary intake across all valid 
days were calculated as a measure of day-to-day variability. 
Previously, habitual dietary intake has been related to fasting and OGTT glucose 
concentrations, as well as biological markers of oxidative stress (Feskens EJ & Kromhout 
D, 1990; Kleemola P, Freese R, Jauhiainen M, Pahlman R, Alfthan G, & Mutanen M, 
2002). Therefore, potential changes in habitual dietary intake and their influence on 






Twenty-four-hour mean, diurnal, nocturnal, pre- and post-waking, and post-meal 
glucose concentrations were calculated for each valid day and expressed as the average 
across those days. 24-hour mean glucose concentration was assessed from midnight to 
midnight for each valid day. Diurnal and nocturnal glucose concentrations were assessed 
each valid day during each participants’ self-reported time-in-bed and time out of bed. 
Further, analysis of exploratory measures of glucose metabolism were performed for pre-
waking, waking, post-waking, and post-meal glucose concentrations. 
Pre- and post-waking time-point glucose concentrations were established as 1-, 2-, 
and 3-hour time points prior to and after waking time-point, while pre- and post-waking 
average glucose concentrations were established as the average of over 1-, 2-, and 3-hour 
periods prior to and after waking time-point. These time points and periods were chosen 
as they potentially relate to episodes of nocturnal hypoglycemia and subsequent risk of 
rebound hyperglycemia, also described as the Somogyi effect, previously observed in 
insulin-treated diabetic patients (Campbell IW, 1976; Gale EA, Kurtz AB, & Tattersall 
RB, 1980). After awakening, none of the participants consumed any calorie containing 
food or drink items within the 3-hour post-waking timeframe on each valid day utilized. 
However, most participants reported coffee (caffeine) consumption within 2 hours post-
waking, with none reporting calorie containing additive, such as sugar, milk, or creamer. 
Post-meal glucose concentrations were assessed over a 2-hour time period 
following subjectively recorded time of consumption for each participants’ breakfast, 
lunch, dinner, and snacks, as well as the average of all meals combined for total daily 




points 0-, 30-, 60-, 90-, and 120-minutes were determined and AUC was calculated for 
each valid day, with the average across those days utilized for analysis. 
Glycemic Variability 
The continuous overlapping net glycemic action of 1-hour, 2-hour, and 4-hour 
(CONGA-1, CONGA-2, and CONGA-4) was calculated in Excel. CONGA-1, CONGA-
2, and CONGA-4 were calculated as the standard deviation of the difference between 
each observation and the previous 1-hour, 2-hour, and 4-hour observations (McDonnell 
CM, Donath SM, Vidmar SI, Werther GA, & Cameron FJ, 2005; Nathan DM, Kuenen J, 
Borg R, Zheng H, Schoenfeld D, & Heine RJ, 2008; Kuenen JC, Borg R, Zheng H, 
Schoenfeld D, Heine RJ, & Nathan DM, 2011). CONGA-1, CONGA-2, and CONGA-4 
were chosen for this study because the 1-hour, 2-hour, and 4-hour time periods 
approximates the time intervals between different activities (CONGA-1), time between 
snacks (CONGA-2), and time between meals (CONGA-4), respectively (McDonnell CM, 
Donath SM, Vidmar SI, Werther GA, & Cameron FJ, 2005). To calculate the mean 
amplitude of glycemic excursion (MAGE) and mean of daily differences (MODD) 
measures of glycemic variability the Excel data were transferred into the EasyGV 
Version 9.0.R2 (University of Oxford, Oxford, England, UK), which is an Excel-enabled 
workbook that utilizes macros. MAGE and CONGA-1, CONGA-2, and CONGA-4 were 
measurements of intra-day glycemic variability for each valid day of wear time and 
averages of those days calculated. MAGE was calculated for each subject by taking the 
arithmetic mean of increased or decreased glucose concentrations (nadirs and peaks or 
vice-versa) when both ascending and descending concentration exceeds one standard 




Ackerman E, Gatewood LC, & Taylor WF, 1970; Service FJ & Nelson RJ, 1980; Service 
FJ, O’Brien PC, & Rizza RA, 1987). MODD served as a measurement of inter-day 
glycemic variability, which was calculated for each two consecutive day period and 
averaged to include all valid days over the seven-day monitoring period. MODD 
accounts for the mean of absolute differences between glucose concentrations obtained at 
the same time of day on consecutive days (Rodbard D, Matsubara B, Nakamura K, 
Bailey T, Jovanovic L, Zisser H, Kaplan R, & Garg SR, 2009). 
Biological Markers of Vascular Health and Oxidative Stress 
Fasting venous blood samples were collected and used to determine biological 
markers of vascular health and oxidative stress. Blood samples were collected into a BD 
Vacutainer EDTA plasma collection tube. Immediately following collection, blood 
samples were centrifuged at 3000 rpm and 4ºC for 20 minutes immediately following 
collection. Plasma separated after centrifugation were aliquoted into 1.5mL 
centrifugation tubes and stored at -80ºC until all participant’s samples were ready for 
analysis. Prior to analysis, plasma samples were thawed and re-centrifuged at 3000 rpm 
and 4ºC for 20 minutes to ensure separation of any particulate. 
Nitric oxide, which acts as a potent vasodilator and measure of vascular health 
(Palmer RMJ, Ashton DS, & Moncada S, 1988), and myeloperoxidase, a potent 
vasoconstrictor and measure of oxidative stress (Klebanoff SJ, 2005), were measured 
using two separate enzyme-linked immunoabsorbant assays (ELISA). These biological 
markers of vascular health and oxidative stress were chosen for this study as they have 
previously been observed to be related to measures of glycemic health in adults 




Bradley SJ, & McConell GK, 2002; Unubol M, Yavasoglu I, Kacar E, Omurlu IK, Ture 
M, Kadikoylu G, & Bolaman Z, 2015). 
The nitric oxide ELISA kit (ThermoFicher Scientific, Waltham, MA) 
quantitatively determines the concentrations of nitrate and nitrite in plasma samples. This 
ELISA utilizes the enzyme nitrate reductase to convert nitrate to nitrite, which was then 
detected as a colored azo dye product of the Griess reaction which absorbs light at 540 
nm. The interaction of nitrate and nitrite concentrations determine the concentration of 
nitric oxide in plasma (Fareed D, Tqbal O, Tobu M, Hoppensteadt DA, & Fareed J, 
2004). The myeloperoxidase ELISA kit (Eagle Biosciences, Inc., Nashua, NH) quantifies 
myeloperoxidase utilizing a two-site “sandwich” technique that binds to different 
epitopes of myeloperoxidase. After several incubation periods and plate washed, 
antibodies bound to myeloperoxidase were ready to analyze by detecting the 
immunocomplex and the absorbency of the sample set at 405 nm with the reference filter 
set at 620-650 nm. The ratio or nitric oxide concentration to myeloperoxidase 
concentration was calculated by the concentration of nitric oxide divided by the 
concentration of myeloperoxidase to examine balance between measures of vasodilation 
and vasoconstriction. Proper sample dilution and preparation per manufacture product 
information sheet were followed. All assays were performed and analyzed on the same 
day by the same trained research staff with an intra-assay variability of <8%. 
Statistical Analysis 
Statistical analysis was performed using SAS version 9.4 (Cary, NC) for the 8 
participants to complete the intervention. Participant characteristics were calculated and 




were tested for normality using the Shapiro-Wilk and Kolmogorov-Smirnov tests. 
Change values were calculated by subtracting baseline values from post-intervention 
values. Paired sample t-tests were performed to determine if any values significantly 
changed from baseline to post-intervention. A general linear model was utilized to adjust 
for change in body weight and/or change in relative V̇O2peak for primary outcomes of 
interest, including glucose concentrations, glycemic variability measures, and biological 
markers of vascular health and oxidative stress. Pearson product correlations were 
performed between changes in glucose concentrations and measures of glycemic 
variability with changes in biological markers of vascular health and oxidative stress to 
determine the association between these primary outcomes of interest. Lastly, as change 
in body weight or V̇O2peak may influence our outcomes of interest, they were adjusted for 
in the analyses. A p value <0.05 was considered statistically significant. 
RESULTS 
Participant Characteristics 
Participant characteristics are included in table 6.1. The participants were 
overweight or obese, middle-aged adults, with an even distribution between males and 
females. The overall relative V̇O2peak (27.7±9.0 ml/kg/min) and relative V̇O2peak for both 
men (31.1±10.9 ml/kg/min) and women (24.4±6.2 ml/kg/min) was determined to be 
lower than the standard normal values for their age and sex and thus reflective of being 
sedentary prior to the intervention (Myers J, Kaminsky LA, Lima R, Christle JW, Ashley 






Exercise Intervention Effects 
Data on the prescribed and actual completed exercise for participants that 
completed the exercise intervention are included in table 6.2. The exercise intensity (50-
55% HRR), volume (10-12 kcal/kg/week), and number of sessions (36-37) were set 
standards throughout the intervention. If participants missed ≥3 exercise sessions, 
additional sessions were included to make-up for the missed sessions. All participants 
walked 120-135 minutes per week (128.8±4.4 minutes per week). 
Body Weight, BMI, and Graded Exercise Test 
 Body weight, BMI, and graded exercise test measurements obtained at baseline 
and post-intervention are included in table 6.3. Overall, there were no significant changes 
in body weight and BMI. Further, all participants met two of four generally recognizable 
criteria needed to be achieved for the graded exercise test to be considered satisfactory at 
baseline and post-intervention. Relative V̇O2peak, and maximal respiratory quotient, heart 
rate, and blood pressure, as well as rating of perceived exertion did not change 
significantly from baseline to post-intervention. Treadmill time, however, significantly 
increased indicating improved exercise tolerance and performance during maximal 
exercise. Additionally, individual changes from baseline to post-intervention for body 
weight and V̇O2peak were included (Figures 6.2. and 6.3., respectively). Although the data 
were normally distributed at baseline and post-intervention, one participant had a 
noticeably greater decrease in body weight (participant 6), while another participant had a 






Glucose Concentrations and Glycemic Variability Assessed by CGM 
 
Glucose concentrations and measures of glycemic variability at baseline and post-
intervention are included in table 6.4. There were no significant changes in fasting and 
glucose concentrations during OGTT, and OGTT AUC from baseline to post-
intervention. Also, there was not a significant difference from baseline to post-
intervention for 24-hour mean, diurnal, or nocturnal glucose concentrations. Further, no 
measure of intra-day glycemic variability, MAGE, CONGA-1, CONGA-2, CONGA-4, or 
inter-day glycemic variability, MODD, significantly changed from baseline to post-
intervention. Following adjustment for body weight and/or relative V̇O2peak, these 
findings persisted as all CGM-assessed glucose concentrations and glycemic variability 
measures did not significantly change from baseline to post-intervention (p≥0.05 for all). 
Vascular Health and Oxidative Stress 
Biological markers of vascular health and oxidative stress at baseline and post-
intervention are included in table 6.4. There was a significant decrease in 
myeloperoxidase concentration and a significant increase in the ratio of nitric oxide 
concentration to myeloperoxidase concentration, with neither remaining significant 
following adjustment for change in body weight and/or relative V̇O2peak (p≥0.13 for all). 
Relationship between Change in Glucose Concentrations and Glycemic Variability with 
Change in Vascular Health and Oxidative Stress 
 
The association between the change in glucose concentrations and glycemic 
variability with the change in vascular health and oxidative stress measurements are 
included in table 6.5. There were significant negative correlations found between change 




between change in nocturnal glucose concentration with change in myeloperoxidase 
concentration. 
Following adjustment for change in body weight and/or change in relative 
V̇O2peak, change in nitric oxide no longer significantly correlated with change in diurnal 
glucose concentrations (p=0.05). However, following adjustment for change in body 
weight only, change in myeloperoxidase concentration continued to negatively correlate 
with change in nocturnal glucose concentration (r=-0.97, p=0.03), while change in nitric 
oxide concentration negatively correlated with change in nocturnal glucose concentration 
(r=-0.97, p=0.03). Interestingly, following adjustment for relative V̇O2peak only, change in 
diurnal glucose concentration negatively correlated, while MAGE and CONGA-1 
measures of glycemic variability positively correlated, with myeloperoxidase 
concentrations (0.97≤absolute r≤0.99, p≤0.03 for all). 
Relationship between Change in Body Weight and/or V̇O2peak with Glucose 
Concentrations, Glycemic Variability, Vascular Health, and Oxidative Stress 
 
Further analyses were performed to examine the relationship between change in 
body weight, relative V̇O2peak (ml/kg/min), and absolute V̇O2peak (ml/min) with change in 
glucose concentrations, glycemic variability, vascular health, and oxidative stress (Table 
6.6). Change in body weight negatively correlated with change in nocturnal glucose 
concentration, while change in relative V̇O2peak did not correlate with any glucose 
concentration, glycemic variability measure, or biological marker of oxidative stress. 
Further, change in absolute V̇O2peak negatively correlated with change in nocturnal 






Waking Status and Post-Meal Glucose Concentrations 
Exploratory analysis for post-meal and pre-/post-waking glucose concentrations 
were performed and are included in table 6.7. There were no differences in post-meal 
glucose concentrations following breakfast, lunch, dinner, or snacks; therefore, the daily 
total post-meal glucose concentrations and AUC were examined. The majority of the 
post-meal glucose concentrations and AUC did not significantly change other than an 
observable increase in 30-minute post-meal glucose concentration (p=0.03), which was 
lost following adjustment for change in body weight and/or relative V̇O2peak (≥0.07 for 
all). Similarly, there were no changes in pre-waking, waking, or post-waking glucose 
concentrations (p≥0.25 for all), which persisted following adjustment for change in body 
weight and/or relative V̇O2peak (p≥0.18 for all).  
Daily Dietary Intake 
Further evaluation of changes daily dietary intake was analyzed and presented in 
table 6.8. The average total daily mealtime when combining all meals, which included 
breakfast, lunch, dinner, and snacks, was found to be significantly later following the 
intervention when compared to baseline. Similar results were found when examining the 
day-to-day variability for meal measurements, including no changes in variability in 
mealtime, calories consumed, or grams per day of carbohydrate, protein, and fat. 
DISCUSSION 
To our knowledge this is one of the first studies to examine the effect of chronic 
center-based aerobic exercise on glucose concentrations and glycemic variability 
assessed by CGM with the inclusion of biological markers of vascular health and 
oxidative stress in overweight or obese non-diabetic adults. The primary findings were 




concentration to myeloperoxidase concentration, significantly increased, suggesting 
reduced oxidative stress and improved ability to vasodilate compared to vasoconstrict 
following the intervention. However, there were no observable changes in CGM-assessed 
glucose concentrations or glycemic variability. Yet, average total daily mealtime was 
found to be significantly later following the 12-week intervention. 
Effect of Aerobic Exercise Intervention on Biological Markers of Vascular Health 
and Oxidative Stress 
 
A purpose of our study was to examine the effect of chronic exercise on 
circulating concentrations of nitric oxide, a potent vasodilator and measure of vascular 
health, and myeloperoxidase, a potent vasoconstrictor and measure of oxidative stress. 
Our study found a significant decrease in myeloperoxidase concentration and a 
significant increase in the ratio of nitric oxide concentration to myeloperoxidase 
concentration. A previous study aimed to assess whether a 12-week endurance exercise 
program could reduce biological markers of oxidative stress in adults at an increased risk 
of coronary events and found that myeloperoxidase concentration significantly decreased 
after training (Richter B, Niessner A, Penka M, Grdić M, Steiner S, Strasser B, Ziegker S, 
Zorn G, Maurer G, Simeon-Rudolf V, Wojta J, & Huber K, 2005). Another study 
examined the effect of 16 weeks of aerobic exercise, which incorporated 2 different 
intensities (30-40% V̇O2max or 55-65% V̇O2max) for 30 minutes each session, 3 times per 
week in sedentary, obese males that were non-diabetic (30-40% V̇O2max: n=6; 55-65% 
V̇O2max: n=6) or type 2 diabetics (30-40% V̇O2max: n=6; 55-65% V̇O2max: n=7) (Krause M, 
Rodrigues-Krause J, O’Hagan C, Medlow P, Davison G, Susta D, Boreham C, 
Newsholme P, O’Donnell M, Murphy C, & De Vito G, 2014). They found that skeletal 




increased following the 16 weeks of aerobic exercise at 55-65% V̇O2peak in only non-
diabetic participants, with no alterations in those performing lower-intensity aerobic 
exercise, or in adults diagnosed with type 2 diabetes following either exercise intensity. 
Therefore, our findings are in line with previous evidence that aerobic exercise training 
alters circulating biological markers of vascular health and oxidative stress, specifically 
decreasing myeloperoxidase concentration and increasing the potential to vasodilate. 
Effect of Aerobic Exercise Intervention on CGM-Assessed Glucose Concentrations 
and Glycemic Variability 
 
Unexpectedly, there were no significant changes in any glucose concentration or 
measure of glycemic variability from baseline to post-intervention. Mikus et al. (2012) 
examined the differences in glycemic variability during 3 days of habitual PA and during 
the final 3 days of a 7 day aerobic exercise program in obese adults diagnosed with type 2 
diabetes mellitus that were not currently taking exogenous insulin (Mikus CR, Oberlin 
DJ, Libla J, Boyle LJ, & Thyfault JP, 2012). Their study found that 24-hour mean 
glucose concentration was not different during the final 3 days of aerobic exercise 
compared to the 3 days of habitual exercise. Further, a randomized control trial examined 
the effects of a 4-month free-living continuous walking or interval-walking training on 
CGM-assessed glycemic control in adults diagnosed with type 2 diabetes (Karstoft K, 
Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, & Solomon TPJ, 2013). 
Their study found elevated 24-hour mean glucose concentration in the control group, who 
underwent no exercise, while 24-hour mean glucose concentration decreased in the 
interval-walking group with no changes noted in the continuous-walking group. A more 
recent clinical trial in type 2 diabetics examined the effects of 12 weeks of low-volume 




exercise, on cardiometabolic outcomes (Francois ME, Durrer C, Pistawka KJ, Halperin 
FA, Chang C, & Little JP, 2017). Their study found significant decreases in 24-hour 
mean glucose concentration and MAGE following the 12 weeks of HIIT training. These 
studies provide evidence that 24-hour glucose concentration and glycemic variability are 
potentially lowered by acute and chronic exercise in type 2 diabetics. However, findings 
from previous studies examining the influence of exercise on glucose concentrations and 
glycemic variability are not in line with findings from our study in overweight or obese 
non-diabetic adults undergoing chronic exercise training. 
Confounders to Our Findings 
 Reasons behind the absence of reductions in free-living glucose concentrations 
and glycemic variability in our study may be explained. Our study was designed for the 
CGM monitoring period to begin and subsequent fasting blood sample collection and 
OGTT to occur ≥72 hours after the last exercise session. This timeframe was determined 
in order to limit the acute effect of the last bout of exercise on glucose concentrations, 
glycemic variability, and oxidative stress, as even a single bout of exercise could 
influence our outcomes of interest (Mikines KJ, Sonne B, Farrell PA, Tronier B, & Galbo 
H, 1988; Radak Z, Chung HY, Koltai E, Taylor AW, & Goto S, 2008). Although this 
timing was within the time frame before potential detraining effects on biological 
markers of oxidative stress occur (Maeda S, Miyauchi T, Kakiyama T, Sugawara J, 
Iemitsu M, Irukayama-Tombe Y, Murakami H, Kumagi Y, Kuno S, & Matsuda M, 
2001), the effects of exercise on glucose homeostasis-related insulin sensitivity begins to 
be lost within 5-10 days following cessation of exercise training (Heath GW, Gavin III 




timing of CGM placement and subsequent first monitoring day may be a limiting factor 
as to why we observed no changes in glucose concentration or glycemic variability. 
Further, previous evidence has suggested that alterations and potential 
compensation in dietary intake exists in adults following acute exercise and undergoing 
chronic aerobic exercise training (Church TS, Martin CK, Thompson AM, Earnest CP, 
Mikus CR, & Blair SN, 2009; Melzer K, Renaud A, Zurbuchen S, Tschopp C, Lehnman 
J, Malatesta D, Ruch N, Schutz Y, Kayser B, & Mäder U, 2016). This potential 
confounder may provide further insight into why we found no differences in glucose 
concentrations or glycemic variability as dietary caloric intake has been shown to 
influence glucose metabolism (Young LL 1984). Moreover, previous evidence has 
suggested that meal-timing potentially influences glucose metabolism (Sensi S & Capani 
F, 1987). In our study, average total daily mealtime was significantly later at post-
intervention compared to baseline. A recent study examined the impact of a shift in 
mealtime at lunch for a week on postprandial glucose metabolism and glucose tolerance 
in healthy young women (Bandín C, Scheer FAJL, Luque, Ávila-Gandía V, Zamora S, 
Madrid JA, Gómez-Abellán P, & Garaulet M, 2015). Their study found that glucose 
concentrations were higher at 90- and 120-minutes post-meal consumption, and total 
post-meal glucose AUC was greater following consumption of a standardized lunch later 
in the afternoon (16:30 hours) compared to early afternoon (13:30 hours). The authors 
concluded that a shift in mealtime negatively influenced glucose tolerance in healthy 
young women. Although, we did not find any differences in the calorie amount or timing 




concentrations following specific meals, the overall later mealtime may aid in the 
explanation of our findings. 
Strengths and Limitations 
The primary strength of this study was that all exercise sessions were monitored 
by trained research staff in the CERC, which controlled for the structure and environment 
of the exercise intervention. Another strength was the use of CGM to assess free-living 
glucose concentrations and glycemic variability for multiple days. Further, evaluation of 
changes in biological markers of vascular health and oxidative stress in conjunction with 
glycemic variability, while also exploring the relationship between changes in the 
primary outcomes of interest, were strengths of this study. 
However, there exist several limitations. The primary limitation was the small 
sample size (n=8). Yet, there were significant changes observed in myeloperoxidase 
concentration and the ratio of nitric oxide concentration to myeloperoxidase 
concentration. Our study was initially designed to serve as a pilot and feasibility study to 
use CGM to assess glucose concentrations and glycemic variability in exercise training 
studies. We successfully used CGM in our study; however, the timing of placement of the 
CGM and collection of fasting blood samples may have influenced our findings. Even 
though we were attempting to limit the impact of the last bout of exercise on our 
outcomes of interest, we may have limited ourselves to evaluation of glucose 
concentrations during a de-training state as opposed to a trained state. Thus, placement of 
the CGM device earlier, even the same day as the last exercise bout, may provide greater 
insight into the effect of exercise training on free-living glucose concentrations and 




KKW), or duration (12 weeks) may not have been sufficient to observe changes in 
clinical or free-living measures of glucose concentrations and glycemic variability. 
Lastly, the inclusion of a free-living condition where we did not test the results of a 
standardized diet on glucose concentrations was a potential limitation. Yet, this was also 
believed to be a strength, as not completely controlling for diet allows for a greater 
insight and potential dietary changes in adults incorporating exercise training into their 
daily life. 
Conclusion 
Although we found a significant decrease in myeloperoxidase concentration and 
an improvement in the ratio of nitric oxide concentration to myeloperoxidase 
concentration, there were no changes in any clinical-based or free-living glucose 
concentrations or measure of glycemic variability. This may partially be explained by an 
overall delay in total daily meal-timing from baseline to post-intervention, timing of 
placement and subsequent monitoring of CGM glucose concentrations and glycemic 
variability following exercise training, exercise intensity and volume during the 
intervention, as well as the overall duration of the intervention. Future studies should 
consider timing of the CGM device and a higher intensity of exercise to determine 
changes in glucose concentrations and glycemic variability in sedentary, overweight or 




Table 6.1. Participant baseline characteristics (n=8) 
Variable  
Age (years) 48.9±5.2 
Height (m) 1.7±0.1 
Body weight (kg) 86.2±32.9 
Body mass index (BMI; kg/m2) 29.4±8.3 
Sex (M/F) 4/4 
Race (C/AA/AAA) 3/4/1 
College graduate [n (%)] 6 (75) 
Employed for wages [n (%)] 7 (87.5) 
Income ≥$80,000.00 [n (%)] 4 (50) 
Married [n (%)] 4 (50) 
Number of children ≥1 [n (%)] 3 (37.5) 
Data presented as Mean±SD or number (n) and percent (%) of participants 






Table 6.2. Exercise prescription and intervention adherence for 
participants who completed the study 
 Intervention average 
Exercise intensity 
Prescribed heart rate range (50 to 55% HRR, bpm) 124.9±8.8 to 129.2±9.1 
Actual heart rate (bpm) 127.7±1.9 
Exercise volume 
Prescribed exercise volume range (10 to 12 KKW) 
843.6±292.6 to 
1012.3±351.1 
Actual exercise volume* (KKW) 863.8±225.6 
Exercise compliance 
Prescribed number of exercise sessions‡ 36 to 37 
Actual number of exercise sessions 34.9±1.1 
Data presented as Mean±SD 
HRR=heart rate reserve; bpm=beats per minute; KKW=kilocalories per 
kilogram of body weight each week 
*, exercise volume calculated using the American College of Sports Medicine 
formula (American College of Sports Medicine, 2017) 





Table 6.3. Participant body weight, BMI, and graded exercise test 





Body weight (kg) 86.2±32.9 83.5±27.4 0.27 
BMI (kg/m2) 29.4±8.3 28.5±6.7 0.26 
Graded exercise test 
measurements 
   
Relative V̇O2peak 
(ml/kg/min) 
27.7±9.0 29.6±8.5 0.21 
Maximal respiratory 
quotient 
1.2±0.1 1.2±0.2 1.00 
Maximal rating of perceived 
exertion 
18.3±1.1 18.3±0.9 0.83 
Resting heart rate (bpm) 71.3±15.1 71.3±11.4 1.00 
Resting systolic blood 
pressure (mmHg)  
123.6±11.5 119.3±7.2 0.29 
Resting diastolic blood 
pressure (mmHg) 
79.3±7.5 79.9±7.5 0.82 
Maximal heart rate (bpm) 174.0±15.5 176.0±15.5 0.49 
Maximal systolic blood 
pressure (mmHg)  
171.0±26.7 171.0±14.9 1.00 
Maximal diastolic blood 
pressure (mmHg) 
76.5±9.5 80.8±6.8 0.25 
Treadmill time (minutes) 10.6±2.7 11.8±2.3 0.04 
Data presented as Mean±SD 
BMI=body mass index, V̇O2peak=peak volume of oxygen consumed 





Table 6.4. OGTT glucose concentrations, glycemic variability measures, and 
vascular health and oxidative stress biological markers at baseline and post-
intervention  
 Baseline Post-intervention p value 
CGM observations per day 
(n; % of max) 
271.3±11.2 
(94.2%) 
270.4±9.1 (93.9%) 0.92 
Glucose concentrations    
Fasting (mg/dL) 88.1±9.0 92.9±11.3 0.38 
30-minute (mg/dL) 125.2±28.8 138.4±33.8 0.31 
60-minute (mg/dL) 139.1±25.6 137.6±29.2 0.92 





OGTT AUC (mg/dL∙2-hour) 14810.4±2334.8 15353.6±2603.5 0.69 
24-hour mean (mg/dL) 100.5±13.5 103.4±9.7 0.29 
Diurnal (mg/dL) 101.1±13.9 106.4±7.8 0.19 
Nocturnal (mg/dL) 98.7±12.5 100.8±11.8 0.26 
Measures of glycemic 
variability 
   
MAGE (mg/dL) 42.3 (36.8-60.9) 43.3±7.6 0.67 
CONGA-1 (mg/dL) 18.7±3.9 20.3±3.4 0.56 
CONGA-2 (mg/dL) 21.7±4.6 23.0±3.6 0.68 
CONGA-4 (mg/dL) 22.9±4.8 25.4±3.3 0.34 
MODD (mg/dL) 19.4±3.5 22.5±6.2 0.31 
Vascular health and 
oxidative stress biological 
markers 
   
 Nitric oxide (µmol/L) 83.4±23.8 102.9±33.7 0.09 
Myeloperoxidase (ng/mL) 24.8±8.2 16.4±4.6 <0.01 
Nitric oxide to 
myeloperoxidase ratio 
3.5±1.1 6.4±1.7 <0.01 
Data presented as Mean±SD, non-normally distributed data presented as median 
(lower quartile-upper quartile) 
OGTT=oral glucose tolerance test, mg/dL=milligram per deciliter, AUC=area 
under the curve,  MAGE=mean amplitude of glycemic excursion, CONGA-1, -2, 
and -4=continuous overlapping net glycemic action of 1-hour, 2-hour, and 4-hour, 
MODD=mean of daily differences 




Table 6.5. Pearson product correlations between change in glucose 
concentrations and measures of glycemic variability with change in biological 
markers of vascular health and oxidative stress 
  Vascular health and oxidative stress biological markers 
  Nitric oxide Myeloperoxidase 













































































Data represented as correlation coefficient (p value) with bolded entries 
corresponding to significant values 
MAGE=mean amplitude of glycemic excursion, CONGA-1, -2, and -4=continuous 
overlapping net glycemic action of 1-hour, 2-hour, and 4-hour, MODD=mean of 
daily differences 
*, p<0.05 following adjustment for change in body weight; ‡, p<0.05 following 




Table 6.6. Pearson product correlations between change in body 
weight, relative V̇O2peak, and absolute V̇O2peak with change in glucose 
concentrations and measures of glycemic variability with change in 
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Data represented as correlation coefficient (p value) with bolded entries 
corresponding to significant values 
MAGE=mean amplitude of glycemic excursion, CONGA-1, -2, and -
4=continuous overlapping net glycemic action of 1-hour, 2-hour, and 4-




Table 6.7. Participant post-meal and wake status glucose concentrations 
at baseline and post-intervention 





   
0-minute (mg/dL) 94.4±17.5 105.1±16.1 0.08 
30-minute (mg/dL) 99.7±16.5 113.0±12.8 0.03 
60-minute (mg/dL) 107.8±13.6 114.7±9.4 0.32 
90-minute (mg/dL) 110.0±15.0 115.3±10.7 0.41 
120-minute (mg/dL) 106.2±13.5 108.9±11.3 0.55 
Post-meal AUC (mg/dL∙2-
hour) 
12557.0±1542.2 13593.5±1274.9 0.08 
Pre- and post-waking glucose 
concentrations 
   
3-hour pre-wake time-point 
(mg/dL) 
95.0±12.0 99.0±16.6 0.29 
3-hour pre-wake average 
(mg/dL) 
93.7±12.3 96.1±14.2 0.32 
2-hour pre-wake time-point 
(mg/dL) 
94.5±12.4 96.1±15.0 0.43 
2-hour pre-wake average 
(mg/dL) 
93.6±12.7 95.4±13.8 0.34 
1-hour pre-wake time-point 
(mg/dL) 
93.1±11.9 96.3±11.4 0.30 
1-hour average (mg/dL) 93.2±12.6 94.8±13.8 0.37 
Waking time-point (mg/dL) 91.8±13.4 93.0±11.9 0.38 
1-hour post-wake time-point 
(mg/dL) 
92.1±13.1 90.3±10.7 0.97 
1-hour post-wake average 
(mg/dL) 
92.6±16.9 92.5±8.7 0.48 
2-hour post-wake time-point 
(mg/dL) 
95.6±15.1 93.2±11.8 0.25 
2-hour post-wake average 
(mg/dL) 
93.6±13.5 92.7±8.7 0.64 
3-hour post-wake time-point 
(mg/dL) 
98.5±15.8 94.9±14.7 0.61 
3-hour post-wake average 
(mg/dL) 
95.3±13.4 94.9±8.8 0.36 
Data Presented as Mean±SD 












Table 6.8. Participant daily dietary intake at baseline and post-intervention  
 Baseline Post-intervention p value 
Average mealtime 
(HH:MM) 
13:30±00:40 14:00±00:39 0.02 
Average mealtime SD 
(HH:MM) 
01:12±00:50 01:11±00:33 0.44 
Calories per day 1366.0±389.4 1499.5±423.5 0.31 
Calories per day SD 404.2±225.0 382.6 (55.0-
374.8) 
0.35 
Carbohydrate (grams per 
day) 
163.7±32.3 183.4±72.7 0.41 
Carbohydrate SD (grams per 
day) 
60.7±12.3 56.1±13.8 0.46 
Protein (grams per day) 57.1±14.2 59.6±14.1 0.61 
Protein SD (grams per day) 24.6±8.9 21.6±9.4 0.29 
Fat (grams per day) 57.6±17.6 65.4±14.8 0.22 
Fat SD (grams per day) 23.0±13.6 32.3±18.7 0.27 
Data presented as Mean±SD, non-normally distributed data presented as 
median (lower quartile-upper quartile) 
Time expressed in a 24-hour system as HH:MM=hour and minute 






Figure 6.1. A-TEAM Study Participant Flow Diagram 
The A-TEAM study participant flow diagram from initial contact at eligibility phone 












Figure 6.2. Individual Participant ∆ Body Weight 
Body weight changes for each individual participant from baseline to post-intervention in 







































Figure 6.3. Individual Participant ∆ V̇O2peak 
V̇O2peak changes for each individual participant from baseline to post-intervention in 
milliliters per kilogram of body weight per minute (ml/kg/min) with mean V̇O2peak 
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The prevalence of adults in the United States classified as overweight or obese 
continues to increase (Flegal MF, Kruszon-Moran D, Carroll MD, Fryar CD, & Ogden 
CL, 2016; Hales CM, Carroll MD, Fryar CD, & Ogden CL, 2017). As overweight and 
obesity status has been linked to the development of cardiometabolic disorders, such as 
impaired glucose tolerance and CVD risk factors (Clinical Guideline on the 
Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The 
Evidence Report 1998; Managing Overweight and Obesity in Adults: Systematic 
Evidence Review from the Obesity Expert Panel 2013; Centers for Disease Control and 
Prevention 2017), the number of adults treated for cardiometabolic disorders will 
potentially trend similarly (Centers for Disease Control and Prevention 2017). Recently, 
glycemic variability has been introduced as a sensitive measurement of glycemic health 
and has been observed to be greater in overweight or obese adults compared to normal 
weight adults (Monnier L, Colette C, & Owens DR, 2008; Satya Krishna SV, Kota SK, & 
Modi KD, 2013; Suh S & Kim JH, 2015; Wang S, Lv L, Yang Y, Chen D, Liu G, Chen 
L, Song Y, He L, Li X, Tian H, Jia W, & Ran X, 2012; Salkind SJ, Huizenga R, Fonda 
SJ, Walker MS, & Vigersky RA, 2014). Additionally, greater glycemic variability has 




commonly associated with diabetic complications and CVD (Hirsch IB & Brownlee M, 
2005; Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, & Colette C, 2006; 
Johnson EL 2013).  
Sedentary behavior and PA of varying intensities have previously been associated 
with metabolic function and CVD risk factors, independent of diagnosed cardiometabolic 
disease status, such as type 2 diabetes and CVD (Covas M-I, Elosua R, Fitό M, Alcántara 
M, Coca L, & Marrugat J, 2002; Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, 
Zimmet PZ, & Owen N, 2007). Furthermore, exercise, which is a common component of 
daily PA, has been established as a modifiable lifestyle factor which positively influences 
compromised health outcomes associated with overweight or obesity status and 
cardiometabolic complications found in adults diagnosed with type 2 diabetes or CVD 
(Goodyear LJ & Kahn BB, 1998; Hawley JA 2004; Church T 2011). As findings are 
limited in how sedentary behavior and PA relate to glycemic variability and oxidative 
stress, as well as the influence of exercise on these outcomes of interest, in overweight or 
obese adults, without diagnosed type 2 diabetes or CVD, there remains a critical gap in 
the literature which remains to be addressed. 
Recent evidence examining the relationship between sedentary behavior and PA 
with glycemic variability and oxidative stress has produced mixed findings. This could 
potentially be due to populations incorporated, as well as methodology utilized to 
specifically assess sedentary behavior and PA and glycemic variability, and delineating 
which biological markers of oxidative stress may be best to evaluate in their given 
population. Previous literature suggests that decreases in sedentary time and increases in 




decrease oxidative stress (Thosar SS, Johnson BD, Johnston JD, & Wallace JP, 2012). 
Additionally, increases in sedentary behavior have been linked to decreases in 
endothelium-derived nitric oxide vasodilation (Demiot C, Dignat-George F, Fortrat JO, 
Sabatier F, Gharib C, Larina I, Gauquelin-Koch G, Hughson R, & Custaud MA, 2007). 
Further, subjectively assessed low-intensity, high-intensity, and total-intensity PA EE 
have been shown to positively associated with antioxidant concentration (Covas M-I, 
Elosua R, Fitό M, Alcántara M, Coca L, & Marrugat J, 2002). However, as evidenced in 
previous large sample cross-sectional studies, health status may be a key regulator of the 
relationship between sedentary time and PA with glycemic variability, as there is 
currently no support to substantiate that a relationship exists between these variables in 
non-diabetic adults (Gude F, Díaz-Vidal P, Rúa-Pérez C, Alonso-Sampedro M, 
Fernández-Merino C, Rey-García J, Cadarso-Suárez C, Pazos-Couselo M, García-López 
JM, Gonzalez-Quintela A, 2017). Yet, in medically compromised adults diagnosed with 
type 1 and type 2 diabetes, sedentary time and PA of any intensity has been shown to 
possess a direct relationship with glycemic variability (Wadén J, Tikkanen H, Forsblom 
C, Fagerudd J, Pettersson-Fernholm K, Lakka T, Riska M, Groop PH, & FinnDiane 
Study Group, 2005; Bohn B, Herbst A, Pfeifer M, Krakow D, Zimny S, Kopp F, Melmer 
A, Steinacker JM, Holl RW, the DPV Initiative, 2015; Paing AC, McMillan KA, Kirk 
AF, Collier A, Hewitt A, & Chastin SFM 2018). Therefore, the population utilized to 
address the specific relationship between sedentary behavior and PA of varying 
intensities with glycemic variability and oxidative stress should be considered and 




Even though glycemic variability has been proposed a prominent mechanism 
acting to induce oxidative stress, findings have been fairly constant as to what type of 
relationship they possess with each other in a variety of populations, including non-
diabetic, type 1, and type diabetic adults (Saisho Y 2014). Previous studies examining 
experimentally exacerbated glucose concentration oscillations found that the higher the 
oscillating glucose concentrations, the greater induction of oxidative stress that occurred 
in both normoglycemic and type 2 diabetic adults (Ceriello A, Esposito K, Piconi L, Ihnat 
MA, Thorpe JE, Testa R, Boemi M, & Giugliano D, 2008). Additionally, evidence has 
suggested the both intra-day and inter-day measures of glycemic variability exhibit strong 
positive associations with induction of oxidative stress in adults diagnosed with type 2 
diabetes (Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, & Colette C, 2006; 
Di Flaviani A, Picconi F, Di Stefano P, Giordani I, Malandrucco I, Maggio P, Palazzo P, 
Sgreccia F, Peraldo C, Farina F, Frajese G, & Frontoni S, 2011). This is promising as 
intra-day and inter-day glycemic variability may present different etiologies for the 
induction of oxidative stress (Wentholt IME, Kulik W, Michels RPJ, Hoekstra JBL, & 
DeVries JH, 2008); however, whether these relationships exist in overweight or obese 
non-diabetic adults has yet to be elucidated. 
Exercise is commonly utilized as therapeutic treatment for impaired glucose 
tolerance and CVD risk factors in the presence or absence of diabetes or CVD (Goodyear 
LJ & Kahn BB, 1998; Hawley JA 2004; Church T 2011). Exercise-induced 
improvements in oxidative stress has been previously studied, and chronic exercise 
training has been shown to decrease myeloperoxidase concentration and increase skeletal 




S, Strasser B, Ziegker S, Zorn G, Maurer G, Simeon-Rudolf V, Wojta J, & Huber K, 
2005; Krause M, Rodrigues-Krause J, O’Hagan C, Medlow P, Davison G, Susta D, 
Boreham C, Newsholme P, O’Donnell M, Murphy C, & De Vito G, 2014). However, 
there exists limited evidence to suggest that exercise training improves glycemic 
variability in adults without diagnosed type 2 diabetes (Tereda T, Friesen A, Chahal BS, 
Bell GJ, McCargar LJ, & Boulé NG, 2013; Van Dijk J-W, Manders RJ, Canfora EE, van 
Mechelen WV, Hartgens F, Stehouwer CD & van Loon LJC, 2015). Yet, evidence has 
suggested that, regardless of modality, that exercise training improves glycemic 
variability in type 2 diabetic adults, if moderate intensity during exercise is achieved 
(Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, & Solomon 
TPJ. 2013; Francois ME, Durrer C, Pistawka KJ, Halperin FA, Chang C, & Little JP, 
2017). Therefore, findings from previous studies necessitate the further exploration as to 
how glycemic variability may be influenced by exercise training. Further, the less than 
ideal literature available regarding alterations in glycemic variability in sedentary, 
overweight or obese adults, potentially at an increased risk for the development of type 2 
diabetes mellitus, undergoing an aerobic exercise intervention remains to be addressed. 
The overall study goals of this dissertation were to (study 1) evaluate the current 
known relationship glycemic variability possesses with sedentary behavior and PA, and 
how a single bout of exercise or repeated bouts of exercise, as well as exercise training 
influences glycemic variability in a variety of populations, (study 2) examine the cross-
sectional relationships between sedentary time and PA measures with glycemic 
variability and oxidative stress in non-diabetic overweight or obese adults, and (study 3) 




oxidative stress in non-diabetic overweight or obese adults. The first study was a critical 
review of the known literature revolving around the relationship between sedentary 
behavior and PA measures with, and the influence of single bout of exercise or repeated 
bouts of exercise and exercise training on, glycemic variability. The second study utilized 
data collected at baseline from the WORDS and A-TEAM prior to either study’s 
intervention, while the third study utilized data collected from the A-TEAM study alone. 
The WORDS study (ClinicalTrials.gov identifier: NCT02413866) was designed to 
examine the effects of chronic moderate sleep restriction on body composition and 
energy expenditure in individuals undergoing a hypocaloric dietary weight loss program, 
while the A-TEAM study (ClinicalTrials.gov identifier: NCT03162991) examined the 
effects of a moderate-intensity aerobic treadmill-based exercise intervention on glucose 
concentrations utilizing CGM technology in sedentary, overweight or obese adults. 
 The second and third studies comprising this dissertation utilized cross-sectional 
and intervention study design to evaluate varying lifestyle factors, including sedentary 
time and PA and exercise, respectively, that potentially influence glycemic variability 
and oxidative stress. Specifically, the second study included a sample of adults from the 
WORDS and A-TEAM study (n=28) who had a fasting blood sample, and valid 
SenseWear and CGM data available over 5 consecutive days including 1 weekend day. In 
the third study, non-diabetic overweight or obese adults enrolled in the A-TEAM study 
(n=8) were included if they completed the intervention and had valid CGM data and a 
fasting blood sample at baseline and post-intervention. Sedentary time and PA measures 
were measured as time spent sedentary and performing LPA and MVPA, as well as EE 




CONGA-1, CONGA-2, CONGA-4, and MODD. Oxidative stress was measured as nitric 
oxide and myeloperoxidase concentration, while the oxidative stress ratio was calculated 
as nitric oxide concentration÷myeloperoxidase concentration. 
 The first study found that the current literature utilizing CGM technology has 
demonstrated that potential relationships exist between glycemic control and glycemic 
variability with habitual sedentary behavior and PA. Additionally, a single bout of 
exercise or repeated bouts of exercise, regardless of modality, may reduce the 
prevalence of glycemic excursions and hyperglycemia immediately following, and over 
an extended period upon completion of, exercise in non-diabetic, as well as type 1 and 
type 2 diabetic adults. Lastly, exercise training has been suggested to improve glycemic 
control and glycemic variability in type 2 diabetic adults. 
The second study found that there were significant relationships between PA 
minutes and EE with glucose concentrations, but not glycemic variability, while fasting 
glucose concentration was significantly associated with nitric oxide concentration, 
myeloperoxidase concentration, and the oxidative stress ratio. This led us to supports our 
claims that participation in PA, play a vital role in glycemic health, while glycemic 
variability is related to oxidative stress in non-diabetic overweight obese adults. 
However, the third study found no observable changes in glycemic variability, but 
a significant decrease in myeloperoxidase concentration and improvement in the 
oxidative stress ratio. The results of the third study led us to conclude that the aerobic 
exercise training program improved oxidative stress, but not glycemic variability in non-
diabetic overweight or obese or obese adults. Yet, following examination of average daily 




baseline, which may explain no reductions in glycemic variability (Bandín C, Scheer 
FAJL, Luque, Ávila-Gandía V, Zamora S, Madrid JA, Gómez-Abellán P, & Garaulet M, 
2015). Additionally, as exercise-induced improvements in insulin sensitivity and glucose 
tolerance begin to be lost within 5-10 days of cessation of exercise, the timing of CGM 
potentially played a role in our results (Heath GW, Gavin III JR, Hinderliter JM, Hagberb 
JM, Bloomfield SA, & Holloszy JO, 1983). 
 When considering the results from the three studies combined, there are several 
interesting findings and questions that arise. Specifically, population choice may be 
pertinent to evaluate the relationship between sedentary time and PA with glycemic 
variability and oxidative stress, as findings in type 1 and type 2 diabetics did not 
generally agree with findings in non-diabetic adults. Further, in the second study, 
although the findings between PA and glucose concentrations were in agreeance with 
previous literature, the participants in our study may have been generally too healthy 
and/or active to observe relationships between PA and glycemic variability and oxidative 
stress. This is evident as participants completing the baseline assessment for study two 
performed on average ~65.5 minutes of MVPA per day. Therefore, it could be assumed 
they were not only meeting current PA guidelines but exceeding them (Piercy KL, 
Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, & Olson RD, 
2018). Lastly, oxidative stress findings from the third study provided evidence that the 
aerobic exercise intervention was effective for decreasing oxidative stress as 
myeloperoxidase concentration decreased and the oxidative stress ratio improved. Yet, 
non-significant findings in glucose concentrations and glycemic variability suggests that 




to wonder whether timing of CGM placement may play a significant role. Even though 
the fasting blood plasma sample was within the timeframe before detraining takes effect 
on biological markers of oxidative stress (Maeda S, Miyauchi T, Kakiyama T, Sugawara 
J, Iemitsu M, Irukayama-Tombe Y, Murakami H, Kumagi Y, Kuno S, & Matsuda M, 
2001), placement and monitoring of the CGM was well within the timeframe of 
detraining effects on glucose metabolism (Heath GW, Gavin III JR, Hinderliter JM, 
Hagberb JM, Bloomfield SA, & Holloszy JO, 1983). Thus, when considering future 
studies examining the relationship between sedentary time and PA with glycemic 
variability and oxidative stress, as well as the influence of chronic aerobic exercise 
training on glycemic variability and oxidative stress, practical considerations for sample 
population and timing of CGM placement are warranted. 
In conclusion, this dissertation found that habitual participation in PA of varying 
intensities are associated with glucose concentrations, but not glycemic variability, and 
oxidative stress in non-diabetic overweight or obese adults. Additionally, glucose 
concentrations and glycemic variability expressed a relationship with nitric oxide and 
myeloperoxidase concentrations, although opposite from what was expected. These 
findings suggest that PA potentially possesses a key role in glycemic health, while further 
exploration into the mechanisms of the relationship between oxidative stress and 
glycemic variability is necessary. Additionally, myeloperoxidase concentration 
decreased, and the oxidative stress ratio improved with exercise training, while there 
were no observable changes in glucose concentrations or glycemic variability. These 
findings lead us to believe that the exercise intervention positively influenced oxidative 




findings on meal timing, as well as placement of CGM lead us to suggest that 
consideration for the effect of detraining and influence of other lifestyle factors, such as 
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